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Introduction
Bacteriology in perspective
When  Antoni  van Leeuwenhoek first described his ‘kleine  dierkens’ –or 
animalcules- some three hundred and forty years ago (1), this was not just an 
interesting  observation, but probably  the  very  first conscious observation of 
bacteria, and with that the very first glimpse of the most important life force 
on earth. 
Given that bacteria are estimated to have lived and  thrived on earth 
since at least 3,25 billion years (2), they have thus been consciously 
observed  since van  Leeuwenhoeks  work in the seventeenth century  for only 
340/3,25*109  ≈  0,00001% of the time that they existed.  And even this is 
probably an exaggeration as van  Leeuwenhoeks  observations went largely 
unnoticed until halfway the nineteenth century, almost two hundred years later. 
Today,  bacteria  are known to  represent  the single  most important  and most 
prevalent  life  form  on earth, in number and in biomass (3).   And  while 
bacteria are recognized as  key players in  all essential global biogeochemical 
cycles, which enable the very existence of  all  higher life forms, most people 
display surprisingly little interest in them. In the USA there are some 20.000 
microbiologists, comprising 0,006% of the population. In Europe, numbers are 
similar, but outside the western world numbers are much lower. Overall, only 
an estimated 0,0005% of people are actively engaged in studying bacteria, and 
that since a mere  0,000009% of the  time that bacteria  existed. Given these 
numerical extremes, it is not so surprising then that we know very little about 
this highly  important life form. And most of the knowledge that we do have 
on bacteria is on a very small subset that may be harmful to humans. 
Of course, this focus on harmful bacteria is understandable, as bacteria weren’t 
making themselves very popular  in nineteenth century Europe, when  Louis 
Pasteur  -  arguably the first  clinical  microbiologist-  started examining 
bacteria in earnest.  Pasteur  found bacteria to be the source of  food spoilage 
and numerous diseases. When other microbiologists such as Robert Koch were 
subsequently able to demonstrate that bacteria were the cause of cholera, 
tuberculosis and even the plague -diseases that had ravaged Europe during the 
middle ages and were still rampant in many areas of the continent- the reputation of 
bacteria was sealed. And even today, the view of bacteria as harmful pests that 
should preferably be killed on sight persists. This is not just a view held by the 
general public, but it is  the cornerstone of clinical microbiology.  In clinical 
microbiology there is an almost complete focus on pathogenic bacteria, while 
non-pathogenic species are generally discarded and not even mentioned in 
results given to clinicians. And when a pathogen has been detected, the optimal 
regime for killing the pathogenic bacteria is chosen, generally not taking into 
account the potential collateral damage caused to our non-pathogenic bacterial 
symbionts. 
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As the focus of clinical microbiology has always been on pathogenic bacteria, 
most detection techniques  have  been developed to single  out and 
identify  these  bacteria.  This approach has led to a systematic disregard 
of bacteria not classified as pathogens,  including our own bacterial 
symbionts.  Ultimately,  non-pathogenic bacteria have become nearly invisible 
to clinical microbiologists: with increasing standardization of cultivation 
techniques, clinical microbiology laboratories became more and more efficient 
at almost exclusively detecting established pathogenic bacteria. And with passing 
generations of microbiologists being exposed only to the bacteria produced by 
these cultivation techniques, the outcomes of these highly selective methods 
gradually became regarded as microbiological truth instead of the very limited 
assessment of a small number of selected bacteria that they actually represent. 
By systematically suppressing  all species not established as pathogens, these 
species effectively became invisible and were gradually forgotten altogether. 
 
A brief history of bacterial detection
Of course, not all microbiology is diagnostic microbiology and long before 
selective cultivation techniques imposed a focus on the known cultivable 
minority, it was recognized that the human body is host to a diverse array of 
bacteria. Indeed, Antoni van Leeuwenhoek himself had described bacteria to be 
present in human feces in a letter to his fellow microscopist Robert Hooke (de 
ortu et defluvio capillorum de vivis animalculis existentibus in excrementis). 
Much later, Theodor Escherich extensively studied gut microbes in children. 
He used both microscopic techniques, applying Christian Grams new bacterial 
staining technique, and the novel culturing techniques developed by Robert 
Koch. In 1886 Escherich published his post-doctoral thesis ‘Die Darmbakterien 
des Säuglings und ihre Beziehungen zur Physiologie der Verdauung’ in which 
he described 19 different common bacterial species of the infant gut. Notably, 
all these species were identified by culture, thus the first monumental reference 
work on gut microbiota described only cultivable bacteria. It is therefore fitting 
that Escherich was immortalized in the genus name of Escherichia coli, the most 
famous and arguably the most amenable to culture of all bacterial species. And 
so, research was directed by culture and away from the uncultivable majority (4) 
from a very early stage.
The unravelling of the structure of DNA by Watson and Crick half a century 
later, in 1953, was a pivotal moment for biology as a whole, and also proved to 
be an essential step for liberating microbiology from the need for culture. Not 
only would the discovery itself prove essential in this, but one of the discoverers 
too would personally turn out to be instrumental. Francis Crick worked in the 
same institute as the biochemist Frederick Sanger and was able to inspire him 
to switch his research focus from proteins -for which work Sanger had already 
received a Nobel prize- towards nucleic acids. Sanger went on to invent a reliable 
method to analyze the nucleotide sequence of DNA, which he incidentally 
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   14 21-9-2016   15:08:53
Introduction
15
demonstrated with the DNA of Escherichia coli (5). The method was named 
Sanger sequencing in his honor and would win Fred Sanger his second Nobel 
prize in 1980.
During that same period, the biophysicist Carl Woese overturned one of the 
major dogmas of biology with the publication of his paper ‘Phylogenetic structure 
of the prokaryotic domain: The primary kingdoms’ in which he showed Archea 
to belong to a third domain of life, breaking with the established dichotomous 
division of all life into prokaryotes and eukaryotes (6). Woese was able to make 
this monumental discovery by applying for the first time a culture-independent 
method of taxonomic classification that he had developed himself. This method 
employed the nucleotide sequences of a subunit of the ribosomal RNA -present 
in all lifeforms- to classify bacteria and other organisms: the higher the similarity 
of this sequence, the higher the taxonomic relatedness of organisms (7). Woese 
did not yet employ the novel Sanger sequencing technique in this work, as 
Sangers and Woeses papers were published almost simultaneously, but when 
Woeses approach was later combined with Sangers technique, microbiology 
gained an entirely new approach to the systematic analysis of all bacteria, 
including the uncultivable majority, based fully on genotypic classification of 
bacteria by the sequence of their (16S) ribosomal RNA.
These transformative events received a final impulse only six years later when, 
in 1983, Kary Mullis invented the polymerase chain reaction (PCR), a universal 
DNA amplification technique, which was perfected in the following years and 
transformed DNA analysis from a laboratory art, available only to a highly 
skilled elite, into a mainstream commodity (8). Together, this new set of tools 
finally provided a culture-independent means of analyzing bacteria, which was 
broadly available and affordable. This approach of amplifying the 16S fragment 
of the ribosomal RNA by PCR followed by Sanger sequencing to determine its 
sequence rapidly became a universal standard and machinery to perform these 
analyses disseminated to laboratories over the world.  
Notwithstanding the major breakthrough that these techniques represented, 
some problems remained. Firstly, the whole process from PCR to Sanger 
sequencing to analyzed data remained rather laborious and slow. This did 
not necessarily pose a problem in a research setting, but did prevent its 
broad application in clinical microbiology. Therefore, in clinical microbiology 
laboratories, this approach did not replace standard cultivation based techniques 
but rather became an option of last resort when all else failed. Secondly, the 
Sanger sequencing technique exclusively allowed analysis of a single DNA 
sequence at a time. This did not pose a problem when analyzing pure cultures of 
bacteria, but did become a limiting factor when analyzing samples containing 
more than a single bacterial strain. Alas, this included the vast majority of 
clinical specimens and all samples of interest to microbial ecology. To study 
these poly-microbial niches, other techniques to analyze DNA became popular. 
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Fragment analysis
The techniques that were developed generally remained true to Woeses concept 
of classifying bacteria by their 16S ribosomal RNA, but employed novel 
ways to analyze these fragments. The most popular of these techniques were 
Denaturing Gradient Gel Electrophoresis (DGGE) (9) and Temperature Gradient 
Gel Electrophoresis (TGGE) (10). These techniques had been developed around 
the same time that Sanger published his sequencing method, but were adapted 
to microbial 16S ribosomal RNA analysis only in 1993 by Gerard Muyzer 
and colleagues at Leiden University in the Netherlands (11). In contrast to 
sequencing, these techniques did not determine the exact nucleotide sequence 
of a DNA fragment, but instead analyzed properties of the fragment as a whole 
by separating fragments by size and by their melting or denaturing point: the 
threshold at which double stranded DNA separates into single strands. These 
techniques became widely popular and were also successfully applied to analysis 
of the human gut microbiota (12). 
There were two more popular techniques that relied on measuring differences in 
lengths of fragments of DNA. A first application was based on Woeses original 
method of cutting up the 16S rRNA in smaller fragments with specific enzymes 
(restriction enzymes) and measuring the length polymorphisms of the resulting 
DNA fragments, which were unique to each bacterial species. This method was 
called Restriction Fragment Length Polymorphism analysis or RFLP. Because 
the number of fragments produced by this technique could become quite large, 
this method was not applicable in its original form to polymicrobial samples. 
Therefore it was adapted by binding a fluorescent label to the first and the last 
fragment of the 16S fragment. These fragments could be specifically measured, 
resulting in a technique that produced two fragments per bacterial species, 
rendering it suitable for bacterial community analysis. This adaptation of Woeses 
method was coined Terminal Restriction Fragment Length Polymorphisms 
(T-RFLP) and gained quite some popularity (13). The second of these fragment 
length based techniques, of particular interest to this thesis, was Ribosomal 
Intergenic Spacer Analysis (RISA). This technique focused on a different part 
of the ribosomal DNA than Woese had done. Instead of the 16S rRNA, it 
focused on a so-called spacer fragment, of unknown function, which separated 
the small 16S and the large 23S ribosomal units: the 16S-23S interspace (IS) 
sequence. This fragment was first analyzed to some extent in plants, before it 
was applied to the analysis of bacteria by Barry and colleagues in Ireland (14). 
These researchers from the University College Galway found that the 16S-23S 
IS region showed more sequence variation than the adjacent 16S region and 
demonstrated that it could be used to discriminate closely related bacterial 
species that shared identical 16S sequences. Mark Jensen, working at the 
chemical company DuPont, published a further adaptation of this method two 
years later. Jensen found that not only the sequence composition of the 16S-23S 
IS region could be used to identify bacterial species, but that the length of this 
region too was highly species specific. He showed that in bacteria that harbored 
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multiple alleles of the ribosomal operon, the length of the 16S-23S IS region 
often varied between the different alleles. Jensen went on to demonstrate that 
by specifically amplifying these 16S-23S IS fragments in 300 bacterial strains, 
he could discriminate all 300 strains to the species level by the analysis of the 
resulting 16S-23S length polymorphisms (15). Remarkably, while the method 
showed great promise, it never attracted a significant following outside the field 
of microbial ecology.
The breakthrough of the gut microbiota
All these advances had a huge impact on the whole of biology, but it was not 
until 2005 that the full impact of culture independent microbiology became 
broadly appreciated. In this year, just a few years prior to the start of the work 
in this thesis, a publication appeared in the journal Science, which made the 
topic of human intestinal microbiota an instant hit in academia and the world at 
large (16). Interestingly, E. coli would again play a central role. The publication 
came from a team of scientists at Stanford University who were investigating 
a possible role of gut bacteria in  inflammatory bowel disease, a disease of 
unknown origin in which parts of the human intestine are inflamed. To this 
end, they first wanted to create a reference of gut bacteria in healthy people. 
They sampled different areas of the large intestine of four subjects and analyzed 
the bacteria that were present there. To do this, they performed the first large-
scale 16S rRNA sequence analysis of the gut microbiota. In a scientific tour-de 
force, they amplified and sequenced tens of thousands of strands of bacterial 
16S DNA. However, as Sanger sequencing can only process one sequence 
at a time, they needed to separate the mixture of sequences that result from 
amplifying 16S rRNA in a polymicrobial environment. They did this by a process 
called cloning, in which individual sequences in a mixture are transferred into 
an E. coli host cell. Individual E. coli cells are then isolated on culture plates, 
after which they start to reproduce. As the cells contain the inserted sequence, 
this too is amplified. In this way specific sequences can be isolated and amplified 
from a mixture, after which they can be analyzed by Sanger sequencing. While 
this whole process was extremely laborious, the results were spectacular: our 
intestines did not just contain the limited number of species that were routinely 
found with culture, but instead consisted of hundreds of bacterial species, 
mostly unknown to science and greatly outnumbering even the most abundant 
cultivable species. 
 
Towards culture independent clinical microbiology
This study emphasized the need for culture independent bacterial analysis in 
clinical microbiology. If we knew so little about the bacteria that inhabit our 
bodies because of the constraint of culture, how much did we then know about 
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infections and what might the role of all these unknown bacteria be in human 
health and disease in a broader sense?
Fuelled by these questions, we set out to develop an accessible molecular 
technique that would detect and identify all bacteria:  established pathogens, 
known symbionts and the uncultivable majority alike. This technique should be 
available not only for research purposes, but also to routine clinical microbiology, 
so that in the future, uncultivable bacteria may be detected in clinical samples and 
whole bacterial communities might be taken into account when making clinical 
decisions. This might help microbiologists not only to detect the causative agent 
of an infection when culture fails, but it may also help us to better understand 
the effects of (medical) interventions on our symbiotic and potential beneficial 
microbes. Last, but certainly not least, such a technique may open up a whole 
new world of diagnostic opportunities: diagnostics in which disease is defined 
not by the presence of specific pathogens, but by changes in the composition of 
the ecosystems of our commensal bacteria. In turn, these insights might lead to 
new understanding of diseases that are now unexplained and possibly to new 
therapies for diseases that are now incurable.
 
What we came up with is the IS-pro technique. 
The IS-pro technique
In designing a novel approach for culture free bacteriologic diagnostics for 
clinical routine, it was evident that we had to move towards detection of 
bacteria by their DNA. We aimed for an open approach that was not directed 
towards a predefined set of species. Instead the method should be able to detect 
all bacteria, including unknown species. 
For such a universal approach, we needed to aim our assay at DNA that was 
present in all bacteria, yet variable enough between species to differentiate 
them. The most suitable piece of DNA seemed to be the ribosomal operon, 
as ribosomes are present in all life forms and contain sequences by which 
organisms can be taxonomically classified to the species level, as demonstrated 
by Carl Woese. However, reading these sequences was still a cumbersome 
process, and remained restricted to a single species at a time. New massively 
parallel sequencing techniques were upcoming, and promised to alleviate the 
problem of reading only single sequences at a time. However, these techniques 
did not promise to be very amenable to routine diagnostics, with complex and 
time-consuming workflows. 
Therefore we shifted our focus to fragment analysis techniques. DGGE and 
TGGE were no realistic candidates, as their notoriously low between-run 
reproducibility disqualified them for use in clinical diagnostics. T-RFLP seemed 
promising, but in a number of experiments we performed prior to the work of 
this thesis, we found that T-RFLP would be difficult to fully standardize because 
of the restriction step needed to split the 16S fragments. Therefore we focused 
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on the little-explored 16S-23S interspace region. 
We saw a possibility to exploit the length based bacterial signatures of the 
16S-23S IS region and to harness them to create a novel rapid catch-all bacterial 
detection and classification tool. However, we found that the tool would need 
some adaptations. The first thing that needed to be done was increase the 
resolution and deal with the fact that the IS region was little explored, thus not 
much information was available to link IS-polymorphisms to the underlying 
bacterial taxonomy. These issues were addressed by adding color labels to IS 
fragments, based on phylum specific signatures in the microbial DNA: we 
assigned different labels to the bacterial phyla that were found to be dominant 
in the human gut by the 2005 Science paper. While the addition of color as an 
extra dimension may seem trivial, its impact on the applicability of the IS-pro 
technique were tremendous.
The power of color
By adding the extra dimension of color to IS-fragment analysis, we were able 
to multiply the resolution of the technique by the number of color channels 
employed. Furthermore, adding color dramatically decreased the number of 
combinatorial possibilities* of fragments in complex microbiota: as bacteria 
generally have more than one IS-fragment, different fragments must be 
combined to identify the organism they derive from. In profiles of complex 
microbiota, the number of possible combinations can become extremely large, 
which limits identification of individual bacteria. By adding color, the number of 
possible combinations decreases dramatically as only fragments with the same 
color may be combined. Finally, the addition of phylum specific color labels 
allowed instant taxonomic classification to the phylum level of each fragment, 
which is very useful in assessing the overall structure of microbial populations 
and for classifying unknown bacteria.
Next, we decided to harness the immense possibilities of the field of computing. 
We wanted to create a reference database, containing information on IS-
profiles of all bacteria we were likely to encounter and build a translation 
algorithm that could successfully translate IS-profiles to the names and relative 
abundances of the associated species. In this way, we would need to perform 
the cumbersome task of sequencing thousands of bacterial species only once. 
For all subsequent analyses it would suffice to only generate an IS-profile and 
automatically translate it with the associated database. Finally, we needed a 
method to populate this reference database and therefore a method to unite 
the length information of Barry and Jensen’s 16S-23S IS region to Woeses 16S 
rDNA sequence information, so that the taxonomical classification provided by 
the latter could be conveyed to the former. 
* the number of possible combinations of fragments is in the order of 2f/n , where f represents the 
number of fragments and n the number of color channels.
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Of course, besides these technical developments, the technique needed to be 
validated for use in clinical routine. For classical clinical microbiology this could 
be done by comparing IS-pro results to culture results. For the novel field of 
complex microbiota-based diagnostics, we had to first set standards, define 
what is normal and perform a lot of work on stability and reproducibility of the 
technique. 
This thesis describes the development, validation and application of the IS-
pro technique, which was developed as a culture-free approach to detect and 
identify all bacteria in clinical samples.
Outline of this thesis
The thesis is divided in three parts. 
The first part consists of three chapters, which describe different aspects of the 
technical validation of the IS-pro technique. 
The first chapter describes the in-silico, in vitro and in vivo validation of the IS-
pro technique. It concerns all basic aspects, such as bacterial detection limits, 
differential potential of IS-pro to identify individual bacterial species, and the 
basic parameters of gut microbiota detection with IS-pro.
The second chapter highlights a specific case of bacteria that can be discriminated 
up to strain level instead of species level with IS-pro. This is only the case for a 
limited number of bacteria, and here we demonstrate how this may augment the 
possibilities of IS-pro towards clinical epidemiology for Staphylococcus aureus.
In the third chapter, we compare the culture-free IS-pro technique to culture. This 
is done with patient derived samples sent in for routine culture to the clinical 
microbiology laboratory. For straightforward comparison, we selected samples 
that were taken from locations that are normally sterile, with no resident 
microbiota. Also in this chapter, a universal technique is demonstrated to link 
IS-length information to 16S sequence information. 
The second part consists of three chapters, which validate IS-pro for application 
on the most complex microbial samples from the human body: the intestinal 
microbiota.
The first chapter investigates different ways to sample the intestinal microbiota 
and the impact of these different techniques on the outcomes of IS-pro. A most 
optimal sampling strategy is suggested.
The second chapter describes the neonatal gut microbiota and the effects of birth 
mode and feeding on its acquisition and development. 
The third chapter explores the intestinal microbiota of older children (> 2 
years). Its composition and stability through time are measured. This study 
was intended to set a healthy reference to which diseased states and unstable 
microbiota compositions can be compared.
The third part consists of five chapters, in which the application of IS-pro is 
demonstrated in various microbial ecosystems on the human body. Clinical 
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applications of complex microbiota analysis by IS-pro are demonstrated, as is 
an instance in which this was not possible.
In the first chapter IS-pro is applied to studying the nasopharyngeal microbiota. 
Changes in the nasopharyngeal microbiota caused by viruses are analyzed and 
linked to the development of asthma. 
The second chapter demonstrates the application of IS-pro to diagnose 
parodontitis, a disease of the oral cavity in which the gums surrounding teeth 
are inflamed, potentially leading to tooth loss.
The third chapter describes the application of IS-pro on an upcoming oral disease: 
peri-implantitis. The very quick increase in popularity of dental implants has 
also led to a rapid increase in incidence of infections of these implants. In this 
study we demonstrate that IS-pro can clearly distinguish microbiota of infected 
implants from that of healthy implants and normal dentition. 
The fourth chapter describes the microbiota associated with diverticulosis: a 
common condition in which diverticulas -outward bulges in the large intestine- 
have formed. We show that microbiota does not seem to play a role in this 
condition as it is does not differ significantly from healthy controls.
The fifth and final chapter demonstrates the application of IS-pro to diagnose 
diverticulitis, a disease in which diverticulas become inflamed. We show that, in 
contrast to diverticulosis, diverticulitis does have a specific microbial signature 
and can be quite accurately diagnosed with IS-pro. This study was unique in the 
sense that the control population was not a healthy population, but a random 
selection of people presenting to a gastroenterological practice with other 
diseases than diverticulitis. This study demonstrates the applicability of IS-pro 
in a true clinical setting.
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Abstract
The human intestinal microbiota is known to play an important role in human 
health and disease, and with the advent of novel molecular techniques, disease-
specific variations in its composition have been found. However, analysis of the 
intestinal microbiota has not yet been applicable in large scale clinical research 
or routine diagnostics because of the complex and expensive nature of the 
techniques needed.
Here we describe a new PCR-based profiling technique for high-throughput 
analysis of the human intestinal microbiota, which we have coined IS-pro. 
This technique combines bacterial species differentiation by the length of 
the 16S-23S rDNA interspace region with instant taxonomic classification by 
phylum-specific fluorescent labelling of PCR primers. We validated IS-pro in 
silico, in vitro and in vivo, on human colonic biopsies and faeces, and introduced 
a standardized protocol for data analysis. IS-pro is easy to implement in general 
clinical microbiological laboratories with access to capillary gel electrophoresis, 
and the high-throughput nature of the test makes analysis of large numbers 
of samples feasible. This combination renders IS-pro ideally suited for use in 
clinical research and routine diagnostics. 
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Introduction
The unravelling of the human intestinal microbiota and its role in health and 
disease has enjoyed much interest of recent, now modern techniques enable 
comprehensive characterization of microbial communities, including not 
yet cultivable organisms (1). Up till the late 1990s, examination of the gut 
bacteria was performed almost exclusively by means of culture, thus restricting 
inventarisation to the small fraction of organisms viable under the unnatural 
circumstances of the microbiology laboratory. With the advent of PCR in 
1983, a range of new DNA-based techniques became available, some of which 
have been applied to the investigation of the human intestinal microbiota. 
The picture that has emerged since the advent of these molecular techniques 
shows a complex bacterial community that consists almost entirely (>95%) 
of two bacterial phyla, the Bacteroidetes and the Firmicutes  (2). Well-known 
genera from the Bacteroidetes include Bacteroides and Prevotella. The Firmicutes, 
‘firmi-cute’ translating as ‘hard skin’, include almost all Gram-positive bacteria, 
members of the class of anaerobic Clostridia being the most abundant in the 
gut (2). At the level of the individual, the composition of the microbiota seems 
to be relatively stable in time (3) and is more or less conserved throughout 
the colonic tract (2,4). Between individuals, however, the composition of the 
microbiota is highly variable (5,4,2). Whether there is an ecological core, a 
set of species common to the majority of humans, and of how many species 
such a postulated set would consist, remains uncertain. Similarities between 
individuals have been found however. A known stable factor is species diversity, 
with Firmicutes having been described to typically harbour a greater variety of 
species than Bacteroidetes (6,2). Changes in the relative abundance of these two 
phyla have been associated with pathological conditions: obesity is typically 
characterized by an increase of Firmicutes diversity with concomitant reduction 
of Bacteroidetes (7) whereas Crohn’s disease has been associated with reduced 
diversity of Firmicutes (8).
Identification of the composition of the colonic microbiota, in particular of 
the phyla Firmicutes and Bacteroidetes, could be of great clinical value, amongst 
others in diagnosing, monitoring progress of disease or the effect of therapy. 
Additionally, the phylum Actinobacteria is of interest as some of its members 
are implied as beneficial ‘probiotic’ species (9) and others may be involved in 
gastrointestinal disease (10). Currently, in-depth analysis of the intestinal 
microbiota and identification of species is largely performed with sequencing-
based techniques. While these techniques have provided a wealth of information, 
they are typically laborious, expensive or both. Profiling techniques can provide 
a cheap alternative. None of the currently available techniques, however, have 
been specifically designed with the complexity of the intestinal microbiota 
in mind. What is more, there are no standard protocols for analysis in these 
profiling techniques, resulting in poor comparability between different research 
efforts.
Here we present IS-pro, a novel 16S-23S rDNA interspace (IS) region based 
profiling method. We have chosen for the IS region above the 16S region as 
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the 16S sequence, in spite of having hyper variable and extremely informative 
regions, shows little variation in length and is sometimes not divergent 
enough to give good separation in close relationships, e.g. species of the same 
genus  (11,12,13,14). The 16S-23S rDNA IS region, in contrast, is extremely 
variable in size and sequence even within closely related taxonomic groups (15), 
making it more suitable for analysis of complex communities.
In IS-pro, profiling is based upon species-specific length polymorphisms of 
the IS region and phylum-specific sequence polymorphisms of 16S rDNA. 
Amplification of the IS region with fluorescently labelled phylum-specific 
primers in the adjacent 16S rDNA yields peak profiles that provide two levels of 
information: colour of peaks sorts species into the phyla Firmicutes /Actinobacteria 
or Bacteroidetes and product lengths can be used to further identify bacteria at 
the species level. We investigated the theoretical and practical potential of this 
method in silico, in vitro and in vivo, with a diverse array of human samples. We 
further developed a standardised data analysis procedure to optimise profile 
comparability and allow for database construction. We have coined the method 
IS-profiling (IS-pro) and found that IS-pro is highly reproducible, fast and easy 
to perform and suitable for high-throughput profiling of the human intestinal 
microbiota in clinical labs with access to capillary gel electrophoresis.
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Materials & Methods
In silico analysis
An in silico library was created by performing virtual multiplex PCR on 491 
completed bacterial genomes derived from 342 species present in Genbank 
with a module built within the Kodon software package (Applied Maths, Sint-
Martens-Latem, Belgium). Generation of virtual IS-pro profiles from this 
database was done with the same module. Comparison of in silico profiles to 
equivalent in vitro profiles was done with the BioNumerics software package 
(Applied Maths, Sint-Martens-Latem, Belgium).
Discriminatory power was calculated with a generalized version of Simpson’s 
index of diversity 
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as described by Hunter et all (16), where aj is the number of strains in the 
population which are indistinguishable from the jth strain and N is the number 
of species in the population. In our model N was 342.
Cultured strains
Thirty strains were used throughout the experiments, consisting of 16 clinical 
isolates and 14 type strains, eight of which were sequenced strains (Supplemental 
Table 1). Aerobic species were cultured in shaking Luria broth (10g/l peptone, 
5g/l yeast extract, 10g/l NaCl) (LB) at 37°C for 18 h. Anaerobic species were 
cultured under anaerobic conditions in shaking LB for 48 h. DNA was isolated 
from 1 ml monoculture suspensions after which PCR was either performed 
directly or on mixes. For the species A. parvulum, C. coccoides, C. leptum and F. 
prausnitzii, DNA isolation was performed directly on freeze dried monocultures 
obtained from the German Collection of Micro-organisms and Cell Cultures 
(DSMZ, Braunschweig, Germany).
Human samples
A total of 100 mucosal colon biopsies from 20 healthy individuals were tested. 
The harvest of biopsy specimens for this study was approved by the institutional 
ethical review board of the VU University medical centre in Amsterdam, and 
all individuals provided written informed consent. Inclusion criteria were age 
between 18 and 80 years, no established disease and normal endoscopic and 
histopathologic findings of colonic mucosal samples harvested during the 
endoscopic procedure concomitant with the study biopsies. Exclusion criteria 
were bacterial or viral gastroenteritis (during the past half year), malignancy, 
severely immunocompromised patients, celiac disease, Crohn’s disease (CD), 
ulcerative colitis (UC), diverticulitis and use of antibiotics or probiotics (during 
the past half year). None of the individuals had any specific dietary regimen.
All human subjects were prepped with a standardized generally used laxative 
preparation consisting of high-volume polyethylene glycol (PEG) solution. 
Mucosal biopsy specimens were collected with a flexible video endoscope 
(Olympus, GmbH, Hamburg, Germany) and a flexible biopsy forceps (Wilson-
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Cook, European Endoscopy Group, Fujinon Medical Holland, Veenendaal, 
the Netherlands). Mucosal biopsy specimens were harvested from caecum / 
ascending colon, hepatic flexure, splenic flexure, sigmoid colon and rectum. The 
samples were washed twice in 500 µl PBS (pH 7) before DNA isolation to remove 
residual faecal material and non-adherent bacteria, followed by immediate 
snap freezing in liquid nitrogen and storage at -20 °C. One mucosal sample 
was excluded based on inhibition of the PCR. All faecal samples were gathered 
one week before harvesting of biopsies in sterile containers and were stored at 
-20 °C within 2 hours of collection.
DNA isolation
For DNA isolation, two protocols were employed. For mucosal samples and 
bacterial cultures, the first step consisted of lysis of tissue and bacteria. 360 
µl ATL buffer from the QIAamp DNA mini Kit (QIAGEN, Hilden, Germany) 
and 40 µl proteinase K were added to samples in an Eppendorf container. This 
mixture was vortexed and incubated at 56 °C whilst shaking at 100 RPM for 
1 h. Subsequently the mixture was centrifuged at 16,200 g for 10 s to remove 
droplets from the inside of the container. 400 µl of AL buffer (QIAGEN) was 
added, and the mixture was incubated at 70 °C whilst shaking at 100 RPM for 
10 min. An easyMAG automated DNA isolation machine (Biomérieux, Marcy 
l’Etoile, France) was used for further DNA extraction. The entire mixture 
(approximately 800 µl) was used and DNA was eluted in 110 µl NucliSens 
easyMAG extraction buffer 3 as provided by the manufacturer (Biomérieux), 
choosing the machine’s regular program with internal lysis, according to the 
manufacturer’s instruction.
To isolate DNA from faeces, 100-400 mg of faeces was placed in an Eppendorf 
container and weighed. Then, a 50 % w/v suspension was made in nucliSENS 
lysis buffer as provided with the easyMAG machine. This suspension was 
vortexed for 5 minutes and subsequently centrifuged at 16.200 g for 2 min. 
100 µl of supernatant was transferred to an eight-welled easyMAG container 
as provided by the manufacturer and 2 ml nucliSENS lysis buffer added. After 
incubation at room temperature for at least 10 minutes, 140 µl of magnetic 
silica beads were added as provided with the easyMAG machine. Afterwards, 
the mixture was inserted in the easyMAG machine and the ‘specific A’ protocol 
chosen, selecting the off board workflow and eluting DNA in 110 µl of buffer. 
Faecal DNA was diluted 10-fold before use in PCR. All DNA was stored at -20 °C.
DNA amplification
We designed five primers for amplification of IS-regions. Two phylum specific, 
fluorescently labelled forward primers were designed, both corresponding to 
conserved regions within the 16S rDNA: one FAM labelled primer, specific 
for Firmicutes and Actinobacteria, FirISf: 5’- CTGGATCACCTCCTTTCTAWG 
-3’ and one HEX labelled primer specific for Bacteroidetes, BacISf: 5’- 
CTGGAACACCTCCTTTCTGGA -3’. Three unlabelled reverse primers were 
constructed within the 23S rDNA region, the combination of which provided 
very broad coverage for Firmicutes, Actinobacteria and Bacteroidetes: DUISr1: 
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5’-AGGCATCCACCGTGCGCCCT -3’, DUISr2: 5’- AGGCATTCACCRTGCGCCCT 
-3’ and DUISr3: 5’- AGGCATCCRCCATGCGCCCT -3’. Unlabelled versions of 
the phylum specific forward primers were used in amplifications from which 
fragments were isolated for sequencing.
Amplifications were carried out on a GeneAmp PCR system 9700 (Applied 
Biosystems, Foster City, CA, USA). Cycling conditions for PCR were: 72 ºC for 
2 min, 35 cycles of 94 ºC for 30 s, 56 ºC for 45 s, 72 ºC for 1 min and a final 
extension at 72 ºC for 5 min. Each PCR mixture, with a final volume of 25 µl, 
contained 10 µl of buffered DNA, 1x superTaq buffer (Applied Biosystems), 
200 µM deoxynucleoside triphosphate, 0.04 % bovine serum albumin, 1 U of 
superTaq (Applied Biosystems) and 0.13 µM of each of the five primers.
Electrophoresis
PCR products were purified with the QIAquick PCR purification kit (Qiagen) 
according to the instructions supplied by the manufacturer. Subsequently, 5 µl 
of purified PCR product was mixed with 19.9 µl formamide and 0.1 µl Mapmaker 
1000 ROX labelled size marker (BioVentures, Murfreesboro, TN, USA). DNA 
fragment analysis was performed on an ABI Prism 3130XL Genetic Analyzer 
(Applied Biosystems). Data were further analyzed with the BioNumerics 
software package (Applied Maths). 
For cultured species, area under the curve (AUC) was measured for all peaks and 
log2 transformed. For complex profiles, all data points were log2 transformed. 
Data analysis
IS-profiles consist of a set of peaks with a specific length, measured in nucleotides 
(nt), reflecting lengths of IS-fragments, and a specific height, measured in 
relative fluorescence units (RFU), reflecting quantity of PCR product (Figure 
1). Where correlation or variance between profiles was determined, a log2 
transformation was performed on area under curve (logAUC) for cultured 
species and on peak heights (logRFU) in complex profiles from human samples 
(see below). This transformation was performed for two reasons. Firstly, log2 
transformation corrects for magnifications of small fluctuations in DNA input 
or in experimental circumstances resulting from the exponential nature of 
PCR. A log2 transformation compensates for this and enables analysis of 
variation in baseline levels irrespective of the number of duplication rounds. 
7000
6000
5000
4000
3000
2000
1000
200 400 600 800 1000
0
Length (nt)
H
ei
gh
t (
RF
U
)
Figure 1: IS-profile of colonic mucosa. Peak length, expressed in nucleotides, corresponds to 
IS-fragment length. Peak height, expressed in RFU, reflects quantity of fragments. Blue peaks 
represent Firmicutes/Actinobacteria, green peaks represent Bacteroidetes.
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Figure 2: Correlation of 2 mucosal profiles (caecum and splenic flexure) obtained from a single 
subject. 2A: Correlation of non transformed data is largely defined by a minority of high peaks. 
2B: Log2 transformation of data enables a large range of peak heights to contribute significantly 
to correlation of profiles. 2C: With variance analysis of log2 transformed data, a standard devi-
ation (SD) applicable to all peaks above a lower cut-off level can be identified. Below this cut-off 
level (area shown in red), variance is largely determined by background noise and peaks are dis-
carded when peaks in both profiles are lower. Above this level, SD is identical for all peaks and 
significant variations can be identified. All peaks in the light green area diverge >2 SD from the 
mean, all peaks in the darker green area deviate >3 SD from the mean. Peaks that differ signifi-
cantly between 2 profiles can be linked to their corresponding fragment lengths, which can then 
be retraced to a specific micro-organism (yellow outlined data points are shown as example). Note 
that the data points outlined in yellow are both <10 log2 (and thus <1000 RFU), and would not 
have been identified as varying significantly in non-transformed data.
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Secondly, log2 transformation of complex profiles compacts the range of 
variation in peak heights, reducing the dominance of high peaks and including 
less abundant species of the microbiota in correlation analyses. This results in 
improved consistency of estimated correlation coefficient, lower impact of inter-
run variation and improved detection of variation in less prominent species 
(Figures 2A and B). Correlations were calculated with Pearson’s product-moment 
correlation coefficient on log2 transformed data.
Sequencing of common IS-pro peaks
We isolated and sequenced a selection of 21 dominant IS fragments that were 
present in the profiles of five or more subjects (see Supplemental Table 4). To 
facilitate fragment isolation, amplification of Firmicutes/Actinobacteria and 
Bacteroidetes was performed in separate PCR reactions. Reaction conditions 
were identical as described above, with the exception that unlabelled phylum 
specific forward primers were used in separate amplifications.
To isolate IS fragments, profiles were separated on a 1.2% agarose gel and 
visualized with ethidium bromide. Fragment size was determined by correlating 
the distance of the band to the GenerRuler100 bp marker (Fermentas, 
Burlington, Canada). IS fragments of interest were isolated from the agarose 
gel by the “bandstab” method described by Wilton et al (17). The fragments 
were “stabbed” with a sterile wooden toothpick/stick and were retrieved after 
one minute. The sticks were placed in the amplification mix for one minute 
and swirled afterwards. A PCR was performed on the retrieved DNA under the 
same conditions as described above after which samples were stored at 4°C 
before ligation. After purification, the IS fragments were re-amplified, cloned 
and sequenced as described in supplemental methods. Per cloned fragment, 
five clones were sequenced to detect multiple sequences in one band. Sequence 
data was analyzed with the software package Kodon (Applied Maths). A BLAST 
algorithm was used to determine the origin of all sequenced fragments (18).
Results
In silico validation and theoretical considerations
We evaluated the general potential of IS-fragment length for species 
identification in silico with a database of 863 unique IS sequences from 491 
completed bacterial genomes belonging to 342 species of sixteen different phyla.
Fragment lengths varied from 125 to 1344 nucleotides (nt), with a median 
length of 495. The majority of species tested (75 %) harboured multiple copies of 
the IS-region (range 2-15), reflecting the number of 16S copies in their genome. 
In species that harbored multiple copies, lengths of the individual IS-regions 
commonly (55 %) varied within a single genome (range of varying fragments 
2-11). Species could thus be assigned an IS-profile consisting of one or more 
fragment lengths (Figure 3). 
Discriminatory power (D) of IS-profiles was calculated for a set of representatives 
of each of the 342 species. D is determined by the fraction of species that 
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can be discriminated within a set of unique species and can vary from 0 (all 
species are indistinguishable) to 1 (all species can be discriminated). When all 
fragments were taken into account, D was calculated to be 0.9992. Intra species 
conservation of profiles (ISC) was evaluated for a subset of 188 genomes derived 
from 55 species of which more than one completed genome was available. ISC 
was defined as the average fraction of strains within a species yielding identical 
profiles. When all variation in all fragments was taken into account, ISC was 
0.62. Allowing for small variations in fragment length greatly affected ISC, 
whilst only marginally affecting D. An optimal trade-off between D and ISC was 
found for a variation tolerance of plus or minus 2 nucleotides and yielded an 
ISC of 0.7825 (Supplemental Figure 2). This level of ISC reflects the potential 
to discriminate strains beyond the species level based on IS-profiles and is not 
significantly affected by a further increase in tolerance for fragment length 
variation. 
To further improve species identification, interpretation schemes of profiles 
can be devised to sort bacteria into their appropriate species. As an example, we 
evaluated the most basic scheme, in which only one band is used to identify a 
species. For this scheme, an ISC value of 0.9169 was found with a corresponding 
D value of 0.9793. Optimal parameters for classification schemes are dependent 
on the specific application of IS-pro and exhaustive analysis of all schemes falls 
beyond the scope of this work.
In vitro validation
We evaluated in vitro characteristics of IS-pro with 30 cultured type strains and 
clinical isolates belonging to the phyla Bacteroidetes, Firmicutes, Actinobacteria 
and Proteobacteria (Supplemental Table 1). These strains were chosen as they are 
representatives of groups common to the human gut. DNA was isolated from 
pure cultures after which PCR was performed either on DNA of a single species 
or on DNA mixtures.
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Figure 3: A bacterial chromosome (red ring) can contain >1 IS region. These regions can have 
different lengths. 3A: E. faecalis, for example, has two regions of 377 nucleotides (nt) and two 
regions of 275 nt. Amplification of these regions will result in a profile consisting of two distinct 
bands. 3B: In silico profiling of a range of bacterial species illustrates diversity of band patterns. 
Note that most band lengths are between 200 nt and 1000 nt. Because of the small scale of the 
figure, bands lying closely together may appear as a single thick band. 
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Evaluation of reproducibility and correlation to in silico patterns
In series of duplicate analyses, band lengths and areas were found to be highly 
reproducible over the entire fragment length range. The median deviation 
from average band length was 0.16 nt, with 99 % of deviations < 1 nt (107 
measurements on ten species of Bacteroidetes, Firmicutes and Actinobacteria 
yielding 21 bands). Duplicate analysis of 33 peaks derived from 14 species of 
Bacteroidetes and Firmicutes gave a standard deviation (SD) of 0.20 logAUC for 
random peak area variation in a range of 0 – 18 logAUC.
Sensitivity of IS-pro for the different phyla was measured with a series of 
dilutions of members of each of these three phyla. Species used were Bacteroides 
vulgatus, Bacteroides fragilis, Bacteroides thetaiotaomicron, Enterococcus faecalis, 
Bacillus cereus and Bifidobacterium adolescentis. The lower limit of detection for 
all species was 10 cfu/l. Mixtures of these species had a similar cut-off, and no 
intra- or inter phylum bias in PCR efficiency was found. Finally, correspondence 
of in vitro generated profiles with in silico predictions was found to be high in 
eight sequenced strains, with a median peak length deviation of 0.5 nt and a 
maximum of 2 nt. This value coincides with the earlier described allowance of 
peak length variation optimized for trade-off between D and ISC.
Evaluation of primer specificity and potential biases
In all 30 species tested, including non-sequenced and strict anaerobic species 
common to the human gut, colour labelled primers were specific for their 
respective phylum. This held true both for pure cultures as well as for mixtures 
of species. Potential intra- and inter phylum PCR biases were quantitatively 
investigated in a number of experiments:
Inter-phylum biases:
DNA of Enterococcus faecalis and Bacteroides fragilis, both at a starting 
concentration of approximately 10 cfu/l, was mixed in nine different ratios. 
The total AUC of the profiles was measured and linear regression analysis was 
performed. In this assay, observed ratios did not differ significantly from the 
expected mixing ratio (see Supplemental Methods) implying an absence of PCR 
bias towards either species.
IS-pro was further performed on DNA of seven different species within the 
genus Bacteroides and eight species of Clostridium. Possible inter-phylum biases 
were evaluated by comparing profiles obtained from a Bacteroides mixture and 
a Clostridium mixture to a profile obtained from a mixture of all 15 species. 
Median difference between peak areas found in monophyletic mixtures and 
their equivalent in multiphyletic mixtures was 0.34 logAUC for Clostridium 
peaks (range -0.7 - 1.19) and 0.65 logAUC for Bacteroides peaks (range -0.23 
- 1.50). Peak variation was not attributable to a selective bias for one or more 
specific species or to one of their phyla.
Intra-phylum biases
To check for the presence of intra-phylum biases, the same set of Bacteroides 
and Clostridium species was used. Profiles were generated from separate strains, 
from a mixture of all Bacteroides species and from a mixture of all Clostridium 
species. When species harboured one or more identical bands, the sum of pure 
culture AUCs was used in the comparison. The eight Firmicutes species yielded 
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23 distinct peaks, the seven Bacteroidetes yielded eight distinct peaks. Median 
difference between mixture and pure culture was 0.50 logAUC for Firmicutes 
(range -0.83 - 1.88) and 0.03 logAUC for Bacteroidetes (range -1.68 – 1.07). For 
both genera no concerted variation of peaks belonging to a single species was 
found (Figure 4).
In vivo validation
To evaluate performance of IS-pro on typical clinical samples, we analyzed the 
characteristics of profiles obtained from colonic mucosal biopsies and faecal 
samples. Mucosal profiles were generated from 100 colonic biopsies from 20 
healthy subjects taken from five locations along the colonic tract, ranging 
from caecum, ascending colon, transverse colon and sigmoid colon to rectum. 
Performance of IS-pro on these samples was evaluated separately for Firmicutes/
Actinobacteria and Bacteroidetes. 
Intra- and inter-subject correlation of profiles was assessed to determine 
reproducibility of profiles obtained from different sampling locations. 
Correlation of mucosal samples along the colonic tract within subjects was high. 
Mean Pearson correlation of samples was 90 % for Firmicutes/Actinobacteria and 
92 % for Bacteroidetes with respective standard deviations of 4.6 % and 4.0 %. 
Inter subject correlation was much lower, with an average of 58 % for Firmicutes/
Actinobacteria and 66 % for Bacteroidetes with respective standard deviations of 
7.6 % and 8.8 %. These two levels of correlation, intra- and inter-individual, are 
distinctly identifiable in figure 5.
The high level of correlation found in same-subject profiles indicates that these 
profiles consist mainly of fragments of similar length (similar bacterial species 
present). Dissimilarity between these profiles was mainly attributable to 
Clostridium & Bacteroides separately and mixed
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Figure 4A: Log2 transformed area under curve (AUC) of 23 Clostridium peaks. Blue bars are 
AUCs as measured in a mixture of only Clostridium species, red bars represent AUCs of these 
same peaks as found in a mixture of Clostridium and Bacteroides species. 4B: Same as 3a, now 
for 8 Bacteroides peaks. Blue bars represent AUCs in a mixture of only Bacteroides, red bars in 
a mixture of both genera. No significant change is observed between the two series. This implies 
that the amplification of Clostridium and Bacteroides IS fragments is not influenced by the pre-
sence of species of the other phylum.
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Figure 5: Correlation of profiles of Firmicutes/Actinobacteria (top) and Bacteroidetes (bottom) 
in colonic mucosal samples of 20 healthy subjects. Radial axis represents correlation. Colours and 
numbers on circular axis represent subjects, letters represent biopsy location. C=caecum, H=he-
patic flexure, L=splenic flexure, S=sigmoid, R=rectum. Line colours correspond to subject colours. 
Each line represents average correlation of the profile obtained at the location indicated on the 
circular axis to all profiles of the subject represented on the circular axis. Profiles are subject spe-
cific and highly similar throughout the colon. Average intra subject correlation of profiles is 90% 
(st.dev 5%) for Firmicutes/Actinobacteria and 92% (st.dev 4%) for Bacteroidetes. Average inter 
subject correlations are 58% (st.dev 8%) for Firmicutes/Actinobacteria and 66% (st.dev 9%) for 
Bacteroidetes. Clear outliers are subject 9, whose profiles correlate markedly less with other sub-
jects, and subject 15, whose Firmicutes/Actinobacteria profiles are not stable along the colon.
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variations in peak heights (relative quantity of species present). To identify the 
factors contributing to this variation and their relative impact we performed a 
threshold analysis and a variance components analysis on a subset of samples 
that were analyzed in duplicate (Supplemental Methods).
Threshold analysis showed that random variation was stable for all peaks higher 
than 6 logRFU within a range of 0-14. This means that large peaks are equally 
reproducible as small ones above a background noise level of 6 logRFU. Above this 
level, random sampling variance was 0.25 logRFU for Firmicutes/Actinobacteria 
and 0.18 logRFU for Bacteroidetes. Sample location  was responsible for the 
remainder of variance. Total variance, combining random sampling variance 
and location variance was 0.86 logRFU for Firmicutes/Actinobacteria and 0.87 
logRFU for Bacteroidetes (Supplemental Methods). Quantification of sampling 
variance enables determination of outliers: less than 5% of samples will randomly 
diverge >2 SD and less than 0.3% will randomly diverge >3 SD. IS-pro has a 
normal standard error of sqrt(0.86) » sqrt(0.87) = 0.93 logRFU for Firmicutes/
Actinobacteria and Bacteroidetes in mucosal samples. When comparing multiple 
profiles, fragments with significantly higher or lower peaks can thus be isolated 
and the organisms to which the peak(s) belong can be identified (Figure 2C).
To ascertain reproducibility and noise threshold in faecal samples, the same 
analyses as employed for mucosal samples were used. To evaluate reproducibility 
of profiles in faeces, correlation of profiles from 14 duplicate faecal samples, in 
which both samples were collected from the same excrement, was performed. 
This analysis showed profiles to be generally stable, with an average correlation 
of 96 % for Bacteroidetes and 90 % for Firmicutes/Actinobacteria with standard 
deviations of 1.5 % and 3.1 % respectively.
For faecal samples, threshold analysis showed a background noise level similar to 
that of mucosal samples. Peaks higher than 6 logRFU were equally reproducible. 
Random sampling variance was 0.18 logRFU for Firmicutes/Actinobacteria and 
0.23 logRFU for Bacteroidetes. Location variation added 0.65 logRFU and 0.34 
logRFU for Firmicutes/Actinobacteria and Bacteroidetes, amounting to a standard 
error of 0.91 and 0.75 respectively.
Correlation of faecal samples to mucosal samples could not be accurately 
assessed in our data set. Variability in this correlation is large and sample 
numbers need to be adjusted accordingly to properly assess the distribution of 
these subject-specific correlations. 
Sequencing of common peaks
To confirm the origin of IS-pro peaks, we isolated and sequenced a selection 
of 21 common IS fragments that were present in the profiles of five or more 
subjects from the colonic biopsy series (Supplemental Table 4). Three fragments 
were selected based on their in-silico predicted length of the common gut 
bacteria Faecalibacterium prausnitzii, Bacteroides fragilis and Bacteroides vulgatus. 
After sequencing these three fragments were identified as F. prausnitzii, B. 
fragilis and B. vulgatus. For 15 of the 21 fragments, the phylum from which they 
derived could be identified. For 14 of these, the species could be determined. 
These species were all common gut bacteria from the phyla Firmicutes and 
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Bacteroidetes and one Fusobacterium species. Notably, all 15 sequences that 
could be phylogenetically classified had been sorted into the correct phylum by 
IS-pro. Five of the six fragments that could not be identified to the phylum level 
matched with sequences derived from human gut metagenomes in the NCBI 
env_nt database. For one fragment no matches were found. Four fragments 
were sequenced in >1 individuals. Fragments of identical length had identical 
sequences in the different individuals. Only one fragment contained two 
different sequences. These sequences belonged to Prevotella copri and Alistipes 
putredinis with a length of 396 nt. Alistipes putredinis, however, was found to 
have a second fragment of 237 nt, enabling differentiation of the two species in 
the IS-pro procedure.
Discussion
With the advent of advanced molecular techniques for analysis of the human 
intestinal microbiota, a beginning has been made towards understanding 
its role in health and disease. Now specific variations in composition of the 
intestinal microbiota have been linked to well defined disease states (8,7), a role 
for its analysis as a clinical application is emerging. IS-pro is an uncomplicated 
PCR-based profiling method enabling high-throughput analysis of complex 
microbiota with equipment commonly available in general microbiological 
laboratories. We demonstrate that species-specific polymorphisms of the 
16S-23S rDNA interspace (IS) region provide sufficient variation to permit 
discrimination of bacterial species. Phylum specific colour labelling further 
provides a straightforward means of classifying species into dominant phyla 
and enables identification of variation within these phyla. Peak heights reflect 
quantity, without an apparent bias towards species or fragment length and 
profiles thus yield information not only on the presence of species, but also 
on their relative abundance. We demonstrate that profiles are reproducible 
and show that log2 transformation enables both the identification of slight 
variations between related profiles as well as correlation analysis of large sets 
of profiles.
Our in silico observations of species specificity of IS-lengths for a broad array of 
bacteria fit well with previous reports which analyzed this phenomenon in Bacteria 
(19,20) and identified this same phenomenon in a diverse array of organisms 
springing from all domains of life (21,22). Because of this conservation, the IS 
region is analyzed for taxonomic typing of prokaryotes either by sequencing, 
restriction fragment analysis or by direct analysis of length polymorphisms 
(23,19). The high level of correlation of mucosal samples throughout the colon 
as identified by IS-pro corresponds well with current knowledge (2,4) and 
underlines the high reproducibility of the technique. Dissimilarity between 
subjects is also in accordance with analyses by other techniques, including clone 
bank analysis (24). Finally, sequence data confirmed specificity of IS-pro in 15 
common peaks, underlining the validity of the technique. In-silico predictions 
corresponded to sequence results and in a random sample collection of 21 peaks, 
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all classifiable Bacteroidete and Firmicute sequences were sorted into the correct 
phylum. This latter finding confirms phylum specificity of the IS-pro primers 
beyond the sequenced species on which they were tested.
IS-pro cannot achieve the same level of detail as clone bank analysis or second 
generation sequencing techniques. The latter approaches are however typically 
restricted to small sample numbers due to high price and labour intensiveness. 
At this point, these techniques are therefore restricted to experimental 
endeavours, and very far from application in clinical routine. Micro array 
techniques can be applied as a high-throughput tool in microbiota analysis 
(25), but lack quantitation, are restricted to a predetermined set of species and 
remain expensive.
In comparison with the three currently most popular profiling techniques, DGE, 
T-RFLP and ARISA, IS-pro offers a number of advantages for analysis of the gut 
microbiota. Denaturing gel electrophoresis (DGE) based techniques are typically 
laborious and hard to standardise (26) making them unsuitable for high-
throughput use. Terminal Restriction Fragment Length Polymorphism (T-RFLP) 
forms an improvement over DGE in terms of standardisation and complexity of 
the technique. However, discriminatory potential of T-RFLP has been shown 
to be limited, rendering the technique primarily suited for use in communities 
with low or intermediate species richness and thus not for analysis of the human 
gut microbiota (27,28,29). Finally, Automated Ribosomal Intergenic Spacer 
Analysis (ARISA), an IS-region based profiling application, has been shown to 
be effective for analysis of complex bacterial consortia (30,31). This technique 
has however seldom been used in gut microbiota analysis and described primer 
sets are not optimized for use in human samples. Furthermore, paucity of IS 
sequence data prevents straightforward identification of fragments.
In IS-pro, colour labelling of IS fragments enables straightforward sorting 
of all fragments into clinically relevant groups and at the same time doubles 
the theoretical discriminatory potential as compared to ARISA. Besides 
providing a novel way of fragment differentiation, IS-pro is a tool optimized for 
investigating the human gut microbiota with a standardized analysis protocol, 
making the technique well suited for high-throughput implementation and 
database construction. 
In conclusion, the whole process of IS-pro, from sample collection to data 
analysis, is easy to implement in general microbiological laboratories with 
access to capillary gel electrophoresis. We believe that the accessibility and high-
throughput potential of IS-pro should enable the technique to find application 
not only as a clinical tool, but also as a research tool in analysis of large data sets.
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SUPPLEMENTAL INFORMATION
Supplemental methods
Variance components analysis
Consider the following model for log2 transformed peak values within a one 
nucleotide (nt) interval:
Here, the response variable Y is the log2 transformed peak value within a one nt 
interval for a particular fragment i as measured in a sample taken from patient 
j on intestinal location k and analysed in l repeats.
Because the number of fragments is limited by the nature of the assay, Fi is 
modelled as a fixed effect and μ + Fi denotes the average overall response for a 
particular fragment. All other terms are modelled as random effects: Pj is the 
average overall deviation for the jth patient, FiPj is the additional deviation on 
the ith fragment for the jth patient, Lijk is the deviation from the jth patient mean 
for the ith fragment on the kth intestinal location. Finally, εijkl is the deviation 
that results from repeated testing of a given sample. We only incorporated those 
fragments that yielded a meaningful response (defined as a peak value within a 
one nt interval above or equal to 128 RFU, see below) in both duplicates.
Reproducibility on the sample level is related to the last term. Reproducibility 
on the level of the patient incorporates variability between locations. Variability 
between patients is composed of main effects as well as interaction effects. 
The various sources of variation can be separated and quantified by means of 
variance components analysis. Computations were performed with the ML 
method using the SAS© procedure VARCOMP. 
The variability between samples within a single patient can be estimated with 
satisfactory precision. For Firmicutes/Actinobacteria, approx. 70% of the total 
variance in measurements within a single patient is due to variability between 
locations (0.86/0.61), whereas approx. 30% is due to repeated testing of a sample 
taken on a single location. The latter figure is approx. 20% for Bacteroidetes. The 
normal standard error of IS-pro can be calculated to be sqrt(0.86) » sqrt(0.87) = 
0.93 logRFU for Firmicutes/Actinobacteria and Bacteroidetes in mucosal samples 
(Supplemental Table 2).
Threshold analysis
Threshold analysis was performed by application of the variance components 
model to the dataset of duplicate samples. Data were selected for inclusion if 
both duplicate measurements yielded a peak signal above the threshold value. 
The focus of the analysis was on the estimate of the error term, i.e. the variation 
of the log2 transformed peak value for a given fragment that results from 
repeated testing of a sample after correction for differences between patients 
and between locations.
From the results, it can be inferred that: (i) the absolute error estimate decreases 
by using a higher threshold; and (ii) the relative error estimate increases by using 
a higher threshold. These findings can be interpreted as follows. First, the error 
ijklijkjijiijkl εLPFPFμY +++++=  
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term decreases in an absolute sense because irrelevant peaks, i.e. “noise”, are 
less reproducible than relevant peaks, i.e. “true signals”. Second, the error term 
increases in a relative sense because differences in background noise between 
patients and between locations are (to some extent) removed, especially if 
background noise acts in an additive (instead of multiplicative) manner, e.g. by 
modification of baseline values.
The reduction of the absolute error estimate with increasing threshold is 
stronger in Firmicutes/Actinobacteria than in Bacteroidetes, but the latter already 
have comparatively low absolute error estimates at relatively low thresholds. 
Note that selected patients differ more with respect to Bacteroidetes, i.e. the 
“true signals” are less variable in repeated testing but differ more between 
patients, as compared to Firmicutes/Actinobacteria. Nevertheless, for both 
Firmicutes/Actinobacteria and Bacteroidetes the preferred threshold would have 
to be between 100 and 200 RFU (Supplemental Figure 1). Setting a precise 
threshold requires differential valuation of the error term in an absolute and a 
relative sense, considering the trade-off between these two.
Linear regression of mixing experiment
Linear regression of log10 (observed ratio) vs log10 (mixing ratio) was performed 
(Supplemental Table 3). From these results we can infer the following. First, at 
a mixing ratio of 1:1 the observed ratio is 100.015 = 1.035 with a 95% confidence 
interval (CI) of [0.760–1.409]. Hence, the observed ratio is not significantly 
different from expectation. Second, if the mixing ratio increases tenfold then 
the observed ratio increases 100.941 = 8.730 with a 95% CI of [5.058–15.07]. 
Likewise, if the mixing ratio decreases tenfold then the observed ratio decreases 
10-0.941 = 0.115 with a 95% CI of [0.066–0.198]. Thus, the observed ratio responds 
not significantly different as expected. 
Additional Bacteroidetes strains
64 additional strains belonging to the 10 species within the genus Bacteroides 
were cultured for sensitivity analysis of the BacISf primer. These species were 
B.caccae, B.capillosis, B.distasonis, B.eggerthii, B.fragilis, B.melaninogenicus, 
B.thetaiotaomicron, B.uniformis, B.ureolyticus and B.vulgatus. Four strains were 
type strains, the other 60 strains were clinical isolates identified by API RAPID 
ID 32A (BioMérieux, Marcy l’Etoile, France). Culturing, DNA isolation and DNA 
amplification were performed as described in the methods section of the main 
manuscript.
DNA Sequencing
Sequence PCR was performed using the BigDye® Terminator Kit v3.1 cycle 
sequencing kit (Applied Biosystems, California, USA) and M13 primers 
(Forward, reverse: gtaaaacgacggccag, caggaaacagctatgac). The reaction mix was 
prepared according to the protocol of the kit. The reaction was carried out under 
the following conditions:  1 min at 96°C; 25 cycles of 10 sec at 96°C, 5 sec at 
55°C, and 4 min at 60°C. 
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   46 21-9-2016   15:09:06
IS-pro for intestinal microbiotaa
47
Ethanol precipitation
To remove unincorporated dye terminators, an ethanol precipitation was 
conducted directly after the sequence reaction. 12 µl Milli Q and 2 µl NaAc 
(3 M, pH 5.2) were added to each sample and vortexed. After this step, 50 µl 
ethanol (100%) was added and incubated for 15 minutes at room temperature. 
The samples were centrifuged for 20 minutes at 16.200 g after which the 
supernatant was discarded.  The pellet was washed with 250 µl ethanol (70%) 
and centrifuged for 5 minutes (16.200 g) to obtain the pellet. After repeating 
these last 2 steps, the samples were placed on the bench to evaporate remaining 
alcohol. 25 µl of Hi-Di-Formamide was added to each pellet and vortexed 
thoroughly. The samples were incubated for 3 min at 95°C to convert the DNA 
fragment to its linear form. The samples were analysed on the ABI prism. 
Sequence analysis 
Sequences were analyzed on the ABI 3730xl sequencer (Applied Biosystems) and 
trimmed to remove vector sequence with the software package Kodon (Applied 
Maths, Saint-Martens-Latem, Belgium). Sequences that did not include original 
forward and reverse primer binding sites were excluded. Homologs to the 
obtained sequences were searched for in the NCBI databases Human G+T, nr/
nt, wgs and env_nt. Positive identification was based on > 95% homology. 
Supplemental Results
Additional analysis of  sensitivity and specificity of primers
In our In-silico database that consisted of 863 IS sequences obtained from 
491 completed bacterial genomes, sensitivity and specificity of all primers was 
analyzed. Sensitivity of the Firmicute/Actinobacteria primer for Firmicute and 
Actinobacteria sequences in this database was 100% (349 of 349 sequences 
derived from 156 Firmicutes and Actinobacteria genomes). Specificity was 84% 
(matching sequence in 88 of 555 non-Firmicute/Actinobacteria sequences). 
Specificity reached a significance level of 98% when the Firmicute/Actinobacteria 
forward primer was combined with reverse primers DUISr1-r3. 
For Bacteroidetes, sensitivity was 96% (24 of 25 sequences derived from 
11 genomes) and specificity was 99% (matching sequence in 6 of 873 non-
Bacteroidete sequences). Confirmation of sensitivity by screening of our 
forward primers against the RDP database was not possible, as the position of 
the primers (E.coli ref. pos. 1528-1549) fall beyond the sequence data in this 
database. However, as the number of sequenced Bacteroidetes strains was low, 
we felt it was necessary to confirm the measured sensitivity by some other 
means. To this end we tested 64 strains derived from 10 different species from 
the genus Bacteroides in vitro. These strains were all amplified by IS-pro with an 
efficiency similar to the sequenced type strains. This finding strengthened our 
confidence in the sensitivity as found in the in-silico analysis.
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Supplemental Table 2: Variance components analysis for Firmicutes/Actinobacteria and Bacteroi-
detes
Supplemental Table 3: Linear regression of mixing experiment
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Supplemental Table 4: List of 21 common IS fragments that were isolated and sequenced from 
human colon biopsies with references to sequence data. Fragments for which matches were only 
found in human gut metagenomes (NCBI env_nt database) could not be identified to the phylum 
level. These fragments were classified as ‘uncultured human gut bacterium’.  For one fragment 
(GU332543) no match was found.
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Supplementary Figure 1: Threshold analysis for Firmicutes/Actinobacteria (left) and Bacteroidetes 
(right) in mucosal profiles. Shown are random sampling variance (in logRFU) and upper and lower 
95% confidence intervals. Contribution of background noise to variance stabilizes between 100 
and 200 RFU.
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Supplementary Figure 2: Effect of bandwidth (BW) on discriminatory power (D) and intra spe-
cies conservation (ISC) of profiles for 188 genomes derived from 55 species. Left: The increase in 
ISC per extra nucleotide bandwidth stabilizes at a low level for BW >2. Right: the increase in the 
ratio D/ISC declines markedly for BW > 2.
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Abstract
Background. We present an easily applicable test for rapid binary typing of 
Staphylococcus aureus: binary interspace (IS) typing. This test is a further 
development of a previously described molecular typing technique that is based 
on length polymorphisms of the 16S-23S rDNA interspace region of S. aureus. 
Methodology/Principal Findings. A novel approach of IS-typing was 
performed in which binary profiles are created. 424 human and animal derived 
MRSA and MSSA isolates were tested and a subset of these isolates was 
compared with multi locus sequence typing (MLST) and Amplified Fragment 
Length Polymorphism (AFLP). Binary IS typing had a high discriminatory 
potential and a good correlation with MLST and AFLP.
Conclusions/Significance. Binary IS typing is easy to perform and binary 
profiles can be generated in a standardized fashion. These two features, 
combined with the high correlation with MLST clonal complexes, make the 
technique applicable for large-scale inter-laboratory molecular epidemiological 
comparisons.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a growing cause of 
concern world-wide, not only because of the high incidence of infections with 
these resistant micro-organisms in hospitals, but also because of the increasing 
incidence of infections with MRSA acquired in the community [1]. Control 
measures to halt this rise, or to lower the prevalence of MRSA have been 
implemented in many countries. Important components of control strategies 
are detection of resistant strains and tracking of transmission of strains in 
hospitals and the community by molecular typing.
Several different molecular typing methods are available, these have recently 
been reviewed by Struelens et al [2]. Each method has its own strengths and 
weaknesses, but no single method yet combines high discriminatory power, full 
inter-laboratory portability, ease of performance and low cost. 
We have further developed a previously described molecular typing technique 
that is based on length polymorphisms of the 16S-23S rDNA interspace 
region (IS) of S. aureus [3]. S. aureus strains typically have 5 or 6 IS regions of 
different sizes. Amplification of these IS regions and gel electrophoresis of the 
PCR products yields banding patterns that are characteristic for individual 
strains. Typing methods based on these IS patterns correlate well with the 
more mainstream molecular typing methods [4]. We adapted IS-based typing 
for analysis on an automated capillary gel electrophoresis machine, translated 
banding patterns to binary profiles to provide inter-laboratory portability, 
and created a digital database. The method was tested on a collection of 424 
MRSA and methicillin-susceptible S. aureus (MSSA) isolates of human and 
animal origin and compared with MLST and AFLP. Finally, performance of the 
method was evaluated in a real world epidemiological problem: identification of 
pig farming-associated MRSA isolates belonging to MLST clonal complex 398 
collected throughout the Netherlands. IS typing proved so practical in this last 
test that we developed a simple version of the test, to make it applicable in 
laboratories with no capillary gel electrophoresis facilities.
Results
In silico analysis
Unique band patterns were obtained with virtual PCR performed on the whole 
genome sequences of the two reference strains. The patterns were clearly 
distinguishable from each other. In vitro analysis of the cultured reference 
strains with the automatic sequencer as well as with agarose gel, showed banding 
patterns identical to the predicted in silico banding patterns. Some vague bands 
of less than 10% intensity were present. According to protocol, these bands 
were excluded from the analysis. 
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Figure 1. Common IS fragments in S. aureus  A: Representation of IS profiles of 9 strains of S. 
aureus. In this subset, 11 of 16 common bands are represented. B: Superposition of all 424 S. 
aureus profiles. Every data point represents a peak (>10% of average peak height within a profile). 
X-axis represents fragment length, Y-axis represents peak height in relative fluorescence units 
(RFU). The 16 distinct fragment lengths are clearly visible in this representation. C: Total number 
of peaks for all fragment lengths. The 16 common fragment lengths are marked by the grey lines. 
Not all fragment lengths are equally common, especially fragments of 538 and 615 nt length are 
rare.  Peaks of which <10 representatives were found were not included in the set of 16 common 
peaks.
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Patterns obtained with capillary gel electrophoresis
Capillary gel electrophoresis yielded clear patterns (figure 1A). Bands showed 
some variation in intensity, but were clearly distinct from background noise. 
Among the 424 isolates tested, 134 unique patterns were observed. Every 
pattern was composed of three to seven fragments of different length. Over all 
different patterns, the total number of different fragment lengths that we found 
was 16. This became especially apparent when all profiles were superimposed 
over one another as shown in figure 1B and C. Each band pattern could thus 
be assigned a binary code of 16 digits reflecting presence or absence of each 
defined band category. We calculated discriminatory potential of this binary 
typing system based on presence and absence of the 16 common bands. To 
this end, we assessed the number of peaks present in each profile. This number 
was normally distributed around five, with three and seven bands as minimum 
and maximum, respectively. The theoretical discriminatory potential is equal 
to the number of possible band patterns, which can be calculated by the sum 
of possible combinations of 3, 4, 5, 6 or 7 bands = 16!/13! + 16!/12! + 16!/11! 
+ 16!/10! + 16!/9! ≈ 64 x 106. To evaluate the in vitro discriminatory power of 
binary IS-typing, we compared it to MLST and AFLP in a sub selection of 89 
isolates.
Comparison with MLST and AFLP
To compare IS-typing to MLST and AFLP, a cluster analysis based on IS-typing 
was performed on a sub selection of 89 S. aureus isolates that had previously 
been assigned 30 unique multi locus sequence types [5]. Of these isolates, 
79 could be clustered into 11 MLST clonal complexes. Ten isolates were not 
classifiable in this sense. AFLP analysis identified 6 major S. aureus lineages. The 
major AFLP clusters could be subdivided in 17 subclusters. AFLP major clusters 
2, 3, 4, 5 and 6 correspond with MLST clonal complex 30, 45, 22, 121 and 398, 
respectively. Apparently, these clusters are genetically very homogeneous, but 
significant genetic heterogeneity could still be found with AFLP. AFLP cluster 1 
was very diverse and comprised six MLST clonal complexes.
In this analysis 33 unique IS types were found belonging to 13 clusters. These 
clusters were defined as isolates with identical binary profiles or with profiles 
differing no more than one digit from the most common profile within that 
group. IS clustering was found to have a high correlation with MLST clonal 
complex clustering and with major AFLP clusters (figure 2). Of the 79 isolates, 
correlation between CC and IS-typing was not consistent in four isolates, of 
CC types 1, 15 and 121. CC types 1 and 15 both fell within the genetically 
heterogeneous AFLP cluster 1.
Cluster analysis of binary IS typing data
Cluster analysis of the binary coded IS typing profiles showed that almost all pig-
farming-associated isolates formed one large homogenous cluster very distinct 
from all other isolates (figure 3). It consisted of a main group of identical types 
and a few small subgroups, which differed from the main cluster and from each 
other by no more than one band. Typically, pig-farming associated MRSA isolates 
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Figure 2. Correlation of digital IS profiles with MLST and AFLP. Thirty-three unique IS types 
were found belonging to 13 clusters. These clusters were defined as strains with identical binary 
profiles (connected by a vertical line) or as profiles differing no more than one digit from the most 
common profile within that group (connected by grey triangles).
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were characterized by the presence of fragments of length 369, 386, 399, 520, 
539 and 601nt. One pig farming-associated MRSA isolate fell entirely outside 
the cluster, but clustered with a number of MSSA isolates obtained from pigs. 
This was the isolate of the aberrant MLST 9. Remarkably, one MSSA derived 
from a monkey clustered with the pig farming-associated MRSA isolates. Within 
the isolates originating from animals, only small clusters were observed, one of 
which consisted of three porcine MSSA isolates and the pig farming-associated 
MRSA strain with MLST 9. No clear association was found between S. aureus IS 
type and host animal species. Beside the pig farming-associated MRSA cluster, 
only 7 of 33 animal IS types were found among the IS types found in humans. 
These strains mainly derived from cats (seven of ten feline strains had an IS 
type that was also found in humans). Thus, spread of S .aureus between humans 
and animals is not only common between humans and pigs, but also between 
humans and cats. 
Agarose protocol
With the agarose protocol, optimised for minimal effort, machinery and time, 
discrimination of all fragment lengths was not possible. Discrimination of pig 
farming-associated MRSA strains from other strains, however, appeared easy 
and straightforward. Total time needed from cultured strain to IS pattern on 
agarose gel was about 4 hours.
Discussion
The invariable presence of a set of IS fragments with differing lengths in each S. 
aureus type,  offers an opportunity for simple strain-level typing for this micro-
organism. Different strains of S. aureus harbour IS fragments of various length 
and number. The total number of IS fragments of different lengths found in a 
collection of nearly 500 strains was 16; the number of different IS fragments 
per strain varied between 3 and 7. Based on the presence and number of these 
16 defined band classes, we translated band patterns into digital profiles. 
Translation was performed with an automated protocol without manual 
interference. This eliminated subjective interpretation of band patterns.
Clustering of strains based on the resulting digital IS-profiles showed a very 
high correlation to MLST and AFLP based clustering.  For two of the four strains 
where we found no correlation between MLST, AFLP and digital IS-profiles – 
of CC type 1 and 15 – it is known that there is no correlation between MLST 
and pulsed field gel electrophoresis (PFGE) [5].  For the strains that could not 
be classified into clonal complexes, cluster partitioning was fully consistent 
between IS-typing , MLST and AFLP (data not shown). The good correlation 
between MLST, AFLP and IS-typing confirmed the value of digital IS-typing.
Conventional slab-gel IS typing for S. aureus has been described before [3,6,7,8], 
and when we corrected for primer positions, we found that ten of the sixteen 
characteristic IS fragments that we found have previously been described by 
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Figure 3. Minimal spanning tree of S.aureus isolates of human and animal origin. Nodes 
represent binary IS types. Node colour corresponds to the source of the strains, pig farming-as-
sociated, human or other animal. Node size corresponds to the number of strains of identical IS 
type within that node. When isolates of different sources have identical profiles, the node is de-
picted as a pie chart, the size of individual parts indicating relative abundance of different sources 
in that node. The pig farming-associated MRSA isolates (in pink) clearly form a distinct cluster. 
Only one of the pig farming-associated MRSA isolates (with ST 9) fell outside of this cluster and 
instead clustered with MSSA isolates obtained from pigs. This strain is marked with an asterisk 
(*) in the figure. Besides the pig farming-associated MRSA isolates, not many IS types are found in 
both humans and animals. Within the central node of the pig farming-associated MRSA cluster, 
one isolate derived from another animal can be found. This is the MSSA isolated from a monkey.
Gurtler et al [9].  Conventional IS-typing has been reported to be well suited 
for inter-laboratory comparison of data [6], and IS profiles have been shown to 
be stable over time [10]. Stability of profiles was confirmed by our finding that 
IS-profiles of pig-farming associated strains were highly conserved in strains 
collected from many different locations across the Netherlands. 
Agreement of conventional IS-typing with AFLP and PFGE has previously 
been reported to be good, albeit with somewhat less discriminatory power 
[4,5,11]. This implies that IS-typing may be best suited for determining deeper 
evolutionary relationships, a notion that is supported by our comparison with 
MLST and AFLP.
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As an example of the application of IS typing, we have used this technique to 
quickly analyze pig farming-associated MRSA strains collected from different 
regions in The Netherlands. Although initially thought to be a problem 
confined mainly to the Netherlands, several reports now illustrate that spread 
of pig farming-associated MRSA is an international issue affecting numerous 
European countries and the US [12,13,14,15]. This cluster analysis showed that 
pig-farming associated MRSA strains are clonally related and clearly distinct 
from other human strains or even all animal strains that we analyzed, with the 
exception of one MSSA strain derived from a monkey. The distance between the 
pig farming-associated strains and all other strains is remarkable and intriguing 
and warrants further investigation into the evolutionary origins of these strains. 
The sensitivity and specificity of IS typing as a tool for identification of pig 
farming-associated MRSA strains was 100% when MLST clonal cluster 398 was 
regarded as gold standard for identification. With the agarose gel based protocol 
too, identification of pig farming-associated MRSA was very straightforward. 
In conclusion, we find digital IS-typing to be a simple tool for strain level typing 
of S. aureus. IS-typing correlated  well with MLST and AFLP. As has been shown 
for MLST, the discriminatory potential of IS-typing appears lower than that 
of AFLP This level of discrimination, combined with the binary character of IS 
typing data, permitting easy inter-laboratory exchange of typing information, 
renders IS typing very well suited for epidemiological investigation of S. aureus 
on a national or global level.  
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   61 21-9-2016   15:09:13
Chapter 2
62
Methods
Strains: The strain collection comprised 424 isolates, consisting of 125 human 
MRSA isolates, 144 human MSSA isolates, 42 pig farming-associated MRSA 
isolates obtained from humans, 10 MSSA isolates obtained from pigs, 101 
other MSSA isolates obtained from other animal species and two reference 
MRSA strains (Mu50 and COL), whose full sequences are available in the public 
databases. A subset of 89 of these strains was also typed by MLST and AFLP 
as described by Melles et al [5]. The human strains were clinical isolates from 
patients admitted between 2005 and 2008 at the VU university medical center 
and the Erasmus university medical center; the pig farming-associated strains 
were obtained from the strain collection of the National Institute of Public Health 
and the Environment, the isolates derived from animals were clinical isolates 
from horses, sheep, dogs, cats, pigs, ferrets, chinchilla’s and monkeys and were 
obtained from the Faculty of Veterinary Medicine of Utrecht University. The 
pig farming-associated strains were isolated from different sources across the 
Netherlands and were previously typed by MLST [16] and AFLP. All these pig 
farming-associated strains, except for one, were of MLST 398 or of the closely 
related type 752 or 753; the exception was a strain with MLST type 9. 
Strain culture and DNA isolation
All strains were cultured overnight on sheep blood agar (Oxoid, Cambridge, 
UK). A 1.0 McFarland suspension was made in tryptic soy broth (Oxoid). From 
this suspension, aliquots of 200µl or 500µl were centrifuged at 16000g for 3 
minutes in a 1 ml Eppendorf vial. The 200µl supernatant was removed and 
the pellet suspended in 200µl Tris EDTA (TE) buffer (pH 8.3). This suspension 
was centrifuged at 16000g for 3 minutes. The supernatant was diluted tenfold 
with milliQ water and used for PCR amplification and subsequent analysis in 
an automated sequencer.  The 500µl aliquot of supernatant was used without 
further processing for PCR amplification and subsequent analysis by agarose gel 
electrophoresis.
DNA amplification and analysis
For amplification of the 16S-23S rDNA spacer regions, two primers were 
constructed in conserved regions of 16S and 23S rDNA, respectively. The 
primers sequences were FirISf: CTGGATCACCTCCTTTCTAAG and DUISr1: 
AGGCATCCACCGTGCGCCCT. For use in capillary gel electrophoresis, a FAM 
labelled version of forward primer FirISf was made. The amplifications were 
carried out on a GeneAmp PCR system 9700 (Applied Biosystems, Foster City, 
CA, USA). Cycling conditions for PCR were: 94ºC for 5 min, 35 cycles of 94ºC for 
30s, 56ºC for 45s, 72ºC for 1 min and a final extension at 72ºC for 5 min. Each 
PCR mixture, with a final volume of 15µl, contained 1µl of DNA, 1x PCR buffer 
gold (Applied Biosystems), 1.5mM MgCl2, 67µM deoxynucleoside
 triphosphate 
(Applied Biosystems), 0.5µl of 1.25% bovine serum albumin, 0.5U of AmpliTaq 
Gold (Applied Biosystems) and 1µM of each primer.
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PCR products were analyzed either on a fully automated sequencer or by agarose 
gel electrophoresis. For processing on the automated sequencer, labelled 
PCR products were purified using the Qiagen PCR purification kit (Qiagen, 
Hilden, Germany) according to the instructions supplied by the manufacturer. 
Subsequently, 5µl of purified PCR products were mixed with 19.9µl formamide 
and 0.1µl MAPmarker 1000 ROX-labelled size marker (BioVentures, 
Murfreesboro, TN, USA). DNA fragment electrophoresis was performed on an 
ABI Prism 3130XL Genetic Analyzer. For agarose gel electrophoresis, the PCR 
products (10 µl) were mixed with 1µl loading buffer, and separated on a 1.5% 
agarose gel. Electrophoresis was performed at 90V during 1.5 hours. 
Data analysis
Data were further analysed with the BioNumerics software package (Applied 
Maths, Sint-Martens-Latem, Belgium). Only bands with a peak height of more 
than 10% of the average peak height within a profile were included in analyses. 
Binary profiles were created for all strains based upon the presence of 16 IS 
fragments of distinct lengths. These fragment lengths were 353, 368, 386, 399, 
415, 431, 475, 480, 492, 510, 521, 526, 538, 599, 604 and 615 nucleotides (nt). 
Bands were included in one of sixteen defined band classes if deviation from the 
defined length of that band class was no more than +/- 2nt. All identification 
and classification of bands was automated according to abovementioned 
parameters. No manual adjustments were made afterwards. 
Cluster analysis was performed on binary profiles with the Dice binary 
similarity coefficient in combination with the Unweighted Pair Group Method 
with Arithmatic mean (UPGMA). Minimum spanning trees were created from 
binary profiles with the BioNumerics software package (Applied Maths).
Agarose gel band patterns were digitalized using the Gel Doc XR system (BioRad, 
Hercules, CA, USA) and interpreted visually.
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Abstract
Molecular methods such as qPCR have found their way into clinical microbiology 
laboratories for the detection of an array of pathogens. Most routinely used 
methods, however, are directed at specific species. Thus, anything that is not 
explicitly searched for will be missed. This greatly limits the flexibility and 
universal application of these techniques. We investigated the application of 
a rapid universal bacterial molecular identification method, IS-pro, to routine 
patient samples received in a clinical microbiology laboratory. IS-pro is a 
eubacterial technique based on the detection and categorization of Interspace 
regions length between 16S and 23s ribosomal DNA, that are specific for each 
microbial species. As this is an open technique, clinicians do not need to decide 
in advance what to look for.  We compared routine culture to IS-pro in 66 samples 
sent in for routine bacterial diagnostics. The samples derived from patients with 
infections of normally sterile sites (without a resident microbiota). Results were 
identical in 20 (30%) of samples, IS-pro detected more bacterial species than 
culture in 31 (47%)  of samples, and five of the ten culture negative samples 
were positive with IS-pro. The case histories of the five patients from which 
these culture negative / IS-pro positive samples derived, suggest that the IS-
pro findings were highly clinically relevant. Our findings indicate that an open 
molecular approach such as IS-pro may have a high added value for clinical 
practice. 
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Introduction
For a long time, clinical bacterial diagnostics has been performed almost 
exclusively by cultivation-based techniques. Over time, these techniques have 
been highly optimized for efficient cultivation of known clinically relevant 
species. Currently, almost all information we have on clinical microbiology has 
been generated by cultivation-based techniques. Like all techniques, cultivation 
has its advantages and its drawbacks. Advantages include the ability to detect 
multiple species simultaneously and the universal nature of the system: while 
selective media may be employed to single out specific species, non-selective 
media, incubated under different conditions, can sustain a very broad range of 
bacteria, which obviates deciding in advance which specific microbe should be 
sought. The most notable drawbacks of culture for clinical application are the 
long time needed for bacteria to grow (10), the inability to culture bacteria after 
patients have received antibiotics and the inability to detect bacterial species 
that are refractory to cultivation.
With the advent of PCR, molecular techniques and particularly qPCR, were 
introduced into the field of bacterial diagnostics as an alternative to culture. 
While qPCR overcomes some of the limitations of culture, it introduces its own 
limitations. QPCR needs no cultivation, so it is faster than culture, it can detect 
bacteria even in samples obtained from patients receiving antibiotic treatment 
and in it can be used to detect cultivation-refractory species. However, qPCR 
is typically a selective technique, with which only the species at which it is 
specifically directed can be detected. Eubacterial PCRs and qPCRs have been 
described, but these methods typically require an additional sequencing step 
to classify PCR products (24).  Current diagnostic schemes based on qPCR 
thereforeoften require either the application of multiple qPCRs, performed 
simultaneously or sequentially or an additional sequencing step, which makes 
these schemes expensive, slow or both. Finally, because most qPCRs are built 
upon knowledge gained by cultivation techniques, they are generally aimed at 
known cultivable species. 
This latter issue, which thus applies to culture as well as qPCR, has become highly 
relevant in recent years, as it has become clear that our indigenous microbiota 
consists for a very large part of bacteria that are refractory to routine cultivation 
techniques (6). As many infections are caused by our indigenous microbiota 
(3,12,19), it is very well possible that with standard bacterial diagnostics we 
have been missing many pathogens (20).
Amplification and Sanger sequencing of 16S RNA with universal bacterial 
primers is a common solution to this issue, as this approach allows for detection 
of uncultivable bacterial species. However, this approach is only applicable 
to samples containing one or two bacterial species. When multiple species 
are present, the different Sanger reads will be superimposed and cannot be 
interpreted (5). 
Next generation sequencing approaches are able to identify multiple sequences 
simultaneously. However, large batch sizes are necessary to reduce costs and 
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workflows are typically complex: while it is has been described to be theoretically 
possible to process a sample within 24 hours (18), a working system has yet to 
be described.
Moreover, the 16S sequence composition is often not divergent enough to 
distinguish between individual bacterial species (8), which is essential for 
clinical diagnostics, as only specific species within a genus may be pathogenic, 
and the presence and expression of chromosomal antibiotic resistance  genes 
may vary largely between species within the same genus (e.g. AmpC which is 
expressed in Citrobacter freundii, but not in other Citrobacter species) (14).
We developed a PCR-based method, IS-pro, that combines rapid and cultivation-
independent detection of bacterial DNA, irrespective of bacterial species, and, 
by a careful choice of target and primers, capable of identifying all bacteria in 
a sample. IS-pro includes the advantages of qPCR over cultivation techniques 
like limited sample processing steps, fast results, detection of bacteria after 
antibiotic administration and detection of uncultivable species. IS-relies on 
length and sequence polymorphisms of the 16S-23S ribosomal interspace 
regions. As these regions are present in all bacteria and their polymorphisms are 
highly species specific, IS-pro is a universal system that can detect all bacterial 
species within a sample. Furthermore, as the technique has been set up to 
minimize inter-species PCR competition, IS-pro can detect and identify many 
species simultaneously, rendering the technique applicable to single-species 
detection and complex microbiota analysis alike (2). In this study we applied 
the IS-pro technique to samples from infections of normally sterile body sites 
and fluids commonly caused by indigenous microbiota as routinely received in 
a clinical microbiology laboratory. We found that IS-pro generally detected not 
only the species found by culture, but also many additional bacterial species . 
We confirmed these findings with a next-generation sequencing approach and 
clinical data.
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Material & Methods
Design
The study was set up as a comparative study of culture techniques as used in 
daily routine in our laboratory compared to IS-pro. Discrepancies between the 
results of culture and IS-pro were further investigated by analysis of the samples 
by next-generation sequencing and clinical information.
Samples
Samples were collected between October 2012 and May 2013 at the department 
of medical microbiology of the VU university medical center, Amsterdam, the 
Netherlands. Sequential samples from normally sterile body sites and fluids 
sent for routine bacterial culture were included. For this study, we selected 
samples from abscesses and empyema’s. Ethical board consent was not needed 
for this study.
Sample processing and cultivation
Samples were sent by routine transport to the microbiological laboratory of 
the VU University medical center, and processed immediately. For routine 
bacteriological culture, all samples were processed according to the standard 
operating procedures of the VUmc laboratory. This encompassed: a Gram stain, 
and inoculation and incubation at 37°C of the following media:  Chocolate agar 
(Biomerieux, Marcy l’Étoile, France), incubated for 2 days in CO2, sheep blood 
agar (BioMerieux),  incubated for 2 days aerobically, CAP agar (sheep blood agar 
with colistin and aztreonam, Oxoid, Landsmeer, the Netherlands), incubated 
for 2 days aerobically, MacConkey 3 Agar (BioMerieux), incubated for 2 days 
aerobically, Brain Heart infusion (BHI) broth (Mediaproducts b.v., Groningen, 
the Netherlands), incubated for 2 days aerobically, Schaedler agar (Oxoid), 
incubated for 3 days anaerobically, Schaedler agar supplemented with phenyl 
ethyl alcohol (Oxoid), incubated for 3 days anaerobically.  If the BHI broth 
did not show growth after two days, it was subcultured on sheep blood agar 
and Schaedler agar; these were incubated as described above. Identification of 
bacterial colonies was done by MALDI-TOF (VITEK MS system, Biomérieux).
DNA isolation
DNA was isolated directly from all specimens according to routine molecular 
diagnostic protocols. Briefly, 200µl of sample (pus or other) was added to 400µl 
AL buffer (Qiagen, Hilden, Germany) and 40µl proteinase K in an Eppendorf 
container. This mixture was centrifuged for 10 seconds at 9000 g, then vortexed 
and incubated at 56°C while shaking at 1400 rpm for 1h. An easyMAG automated 
DNA isolation machine (Biomérieux) was used for further DNA extraction. 
Sample mixtures (each 640 µl) were transported to an 8-welled easyMAG 
container, and suspended in 2 ml nucliSENS lysis buffer as provided by the 
manufacturer. After incubation at room temperature for 1h, 70 µl of magnetic 
silica beads was added, as provided with the easyMAG machine. Afterward, the 
mixture was inserted in the easyMAG machine, and the “specific A” protocol was 
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chosen, selecting the off-board workflow and eluting DNA in 110µl of NucliSens 
easyMAG extraction buffer 3 as provided by the manufacturer (Biomérieux). All 
DNA was stored at -20°C. For all separate DNA isolation runs, negative controls 
were included that were analyzed with IS-pro. The same DNA isolate was used 
for IS-pro and PacBio analyses.
IS-pro
Amplification of IS-regions was performed with the IS-pro assay (IS-
diagnostics, Amsterdam, the Netherlands) according to the protocol provided 
by the manufacturer. IS-pro differentiates bacterial species by the length of the 
16S–23S rDNA intergenic spacer (IS) region with taxonomic classification by 
phylum-specific fluorescently labelled PCR primers (2) (figure 1). The procedure 
consists of two separate standard PCRs: the first PCR contains two different 
fluorescently labeled forward primers targeting different bacterial groups and 
three reverse primers providing universal coverage for those groups. The first 
forward primer is specific for the phyla Firmicutes, Actinobacteria, Fusobacteria 
and Verrucomicrobia (FAFV) and the second labeled forward primer is specific 
for the phylum Bacteroidetes. A separate PCR with a labeled forward primer 
combined with seven reverse primers is specific for the phylum Proteobacteria. 
Amplifications were carried out on a GeneAmp PCR system9700 (Applied 
Biosystems, Foster City, CA). After PCR, 5µl of PCR product was mixed with 
20µl formamide and 0.2µl custom size marker (IS-diagnostics). DNA fragment 
analysis was performed on an ABI Prism 3500 Genetic Analyzer (Applied 
Biosystems). Data were analyzed with the IS-Pro proprietary software suite (IS-
Diagnostics, Amsterdam, the Netherlands) and results presented as microbial 
profiles. Automated species calling of IS-pro peaks was done with the dedicated 
IS-pro software suite (IS-Diagnostics) in which peaks are linked to a database 
containing IS-profile information of >500 microbial species.
Peaks lower than 128RFU were regarded as background noise and were discarded 
from further analysis. The whole procedure, from DNA isolation to analyzed 
data could be done within five hours.
Next Generation sequencing
All samples were further analyzed by Circular Consensus Sequencing 
with a SMRTbell template on the Pacific Biosciences (PacBio) RS 
II machine (Pacific Biosciences, CA, USA). For Circular Consensus 
PacBio sequencing, a forward primer was selected in a conserved 
region of the 16S rDNA (5’-GGATTAGATACCCBGGTAGTCC- 3’, 
E.coli reference position ~810). Four reverse primers were selected 
in the 23S rDNA (5’-CCATCCTTTTCACCTTTCCTTCACAGTAC- 3’, 
5’-CCATCCTTTTCGCCTTTCCTTCACAGTAC- 3’, CCATCCTTTTCGCCTTTCCC 
TCACGGTAC- 3’, and 5’-CCATCCTTTTCACCTTTCCCTCACGGTAC- 3’) together 
providing very broad coverage of bacterial species. Amplicons consisted of the 
V6-V9 regions of the 16S rDNA, the 16S-23S interspace region (IS1) and a part 
of the 23S rDNA region (figure 2).  Forward primers were barcoded at the 5’ side 
for multiplexing on the PacBio SMRT cell. To ensure optimal SMRT cell ligation, 
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padding sequences of 5 nucleotides were added to the primer sequences at 
the 5’ side. The PCR mixture for amplification consisted of 10.325µl HPLC 
water, 2.5 µl SuperTaq Buffer (SphaeroQ, Gorinchem, the Netherlands), 0.8 µl 
BSA (0.04%, Sigma), 16S-23S reverse primers 0.975 µl (10 µm), 0.2 µl dNTP 
(0.20 mM, Invitrogen, Carlsbad, CA, USA), and 0.2 µl SuperTaq enzyme (1 U, 
SphaeroQ), 10 µl DNA and 1 µl forward primer (10 µm). The GeneAmp PCR 
system 9700 (Applied Biosystems, Foster City, CA) was used for amplification 
with 35 cycles of 30s melting at 94°C, 45s annealing at 60°C, 140s elongation 
at 72°C followed by a final elongation for 11 minutes at 72°C. Sequencing was 
performed on the PacBio RS II instrument.  The data collected from the PacBio 
RS II  instrument were processed and filtered using the SMRT Analysis software 
suite. The Continuous Long Read (CLR) data were filtered by read-length (>50), 
subread-length (>50) and read quality (>0.75). Quality analysis of the filtered 
FASTQ reads was performed with CLC Genomics Workbench version 6.0.4. 
The resulting fragments were again filtered by length (>1000 and <3000). 
Sequences, in which no tag was found, were discarded and remaining sequences 
were oriented in the same direction by using the tag orientation as a reference. 
Virtual IS-pro was performed on resulting sequences with an in-house built 
algorithm. This algorithm identified best-matching IS-pro primers and their 
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Figure 1:  Schematic representation of the concept behind IS-pro procedure. a: all bacterial spe-
cies contain at least one IS-region in their chromosome. However, many species contain multi-
ple alleles of the IS-region. These regions may vary between different alleles. Depicted here is 
the schematic situation in Enterococcus faecalis that contains four alleles of the IS-region. Two 
have a length of 275 nucleotides, the other two of 377 nc. When amplified a profile specific for 
E.faecalis is obtained. b: IS-profiles are highly diverse between different species. The fact that 
species commonly have multiple alleles with different lengths dramatically increases the differen-
tial potential between species. c: By amplifying IS-fragments with phylum specific fluorescently 
labeled primers, a next layer of information is added. d: When an IS-profile is made of a sample 
containing multiple species from different phyla, peaks with different lengths, height and color 
are found. These correspond to species, abundance and phylum. A peak profiles may be translated 
to a list of bacterial species by a software algorithm linked to a database of IS-profiles of known 
bacterial species. The whole IS-pro procedure from unprocessed sample to analyzed data can be 
performed in 5 hours.
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   73 21-9-2016   15:09:14
Chapter 3
74
binding sites. Thus, color label and length of corresponding IS-fragments could 
be predicted. These virtual IS-pro fragments were used to match to actual IS-pro 
data. Subsequently, the first 50 nucleotides were trimmed off all sequences and 
the following 700 nucleotides were aligned and taxonomically classified with the 
Silva Incremental Aligner (SINA) version 1.2.11 (16). Settings for taxonomical 
classification were as follows: minimal identity with query sequence 0.9, 
number of neighbors per query sequence 10, reject sequences below identity 
70%. Comparisons were made against five different databases (GreenGenes, 
RDP, EMBL, LTP and SLV) to identify ambiguous classifications. 
All downstream data analyses, visualizations and comparisons of resulting data 
from culture, IS-pro and PacBio analyses were done with the Spotfire software 
package (TIBCO, Palo Alto, CA, USA).
Figure 2: Schematic representation of the PacBio sequencing approach. A bacterial chromosome 
always consists of one or more ribosomal regions (top left). These regions each consist of a 16S, 
a 23S and a 5S region and two interspace regions (IS1 and IS2). Identity of the bacterial species 
can be assessed either by the sequence of the 16S fragment or by the length of the IS1 region 
(top right). Amplification primers were chosen to cover a large part (~700 nucleotides) of the 
16S region, containing four variable regions (V6-V9) for sequence-based species identification. 
Each amplicon thus consists of both the 16S region and the IS1 region, enabling comparison of 
identifications. Forward primers had sequence tags for multiplexing in the PacBio run. Padding 
sequences were added to prevent damage to the sequence tags and for optimal SMRTbell ligation 
(bottom). By performing a virtual IS-pro on full-length sequences, best matching (labelled) IS-pro 
primers and predicted length of resulting IS-fragments could be determined. The resulting virtual 
IS-fragments could be matched to actual IS-fragments. In this fashion, bacterial identifications by 
16S sequence analysis could be directly matched to corresponding IS-fragments.
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Results
Culture vs IS-pro
In total, 66 samples were included from different bodily locations falling in nine 
distinct categories (Table 1). Of these samples, 56 were culture positive and ten 
were culture negative. All samples that yielded a positive culture result were also 
positive by IS-pro. Of the ten culture negative samples, five were also negative 
with IS-pro. However, the other five culture negative samples were positive with 
IS-pro (table 1). For 20 samples, outcomes at species level were identical between 
culture and IS-pro (table 2). For 31 samples, more species were found with IS-
pro than with culture. For two samples, less species were found with IS-pro than 
with culture. Finally, for thirteen samples, comparisons could not be made for 
all species, because some species were not identified by culture, either because 
species did not have final identifications or, more commonly, because species 
were deemed to be clinically irrelevant in the context of the presence of known 
pathogens that could alone account for the clinical picture. In twelve of these 
thirteen samples, the dominant species that were identified by culture were all 
confirmed by IS-pro. Because results were identical as far as was analyzable, we 
displayed these samples as identical in table 2. For one sample in this subset, 
none of the cultured species were identified, making a comparison impossible.
In total, 76 species were identified by culture. 72 of these (95%) were also 
found with IS-pro. The four cultured strains that were not found by IS-pro 
came from two samples, which harbored multiple species. The first sample came 
Table 1: Sample categories and outcomes of culture and IS-pro. No culture positive samples were 
negative by IS-pro. Five culture negative samples were positive by IS-pro. In four of these sam-
ples, the same species that was identified by IS-pro was detected with PacBio sequencing. The 
two remaining culture negative and IS-pro positive samples showed a very low load (<500 RFU).
Sample Category Total 
Sample # 
Only Culture 
positive 
Culture neg  
IS-pro pos 
Both 
negative 
Both 
Positive 
intraperitoneal 
abscess 
18 0 1 1 16 
abscess head/neck 11 0 3 1 7 
abscess mamma 4 0 0 0 4 
septic arthritis 2 0 0 0 2 
lymph node 1 0 0 1 0 
osteomyelitis/ 
spondylodiscitis 
9 0 1 0 8 
perianal abscess 1 0 0 0 1 
pulmonary abscess 1 0 0 0 1 
urogenital abscess 5 0 0 0 5 
wound/subcutaneous 
infection 
14 0 0 2 12 
Total 66 0 5 5 56 
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from a thoracical abscess post esophagus surgery and contained Enterococcus 
faecium and in lesser abundance Staphylococcus aureus, Serratia marcescens and 
Alcaligenes denitrificans (all in a single sample). IS-pro detected E. faecium, and 
in lesser abundance E.faecalis and S.anginosus, but not the additional three 
species found by culture. The second sample derived from a subcutaneous 
infection and contained Aggregatibacter actinomycetemcomitans and in lesser 
abundance Actinomyces israelii and multiple anaerobic species. With IS-pro, A. 
actinomycetemcomitans and multiple anaerobic species were found, but not the 
A. israelii. The presence of these strains additionally found by culture in these 
two samples could not be confirmed by sequencing.  
Overall, common pathogens were found in samples in which they could be 
expected, such as Escherichia coli in abdominal and urogenital abscesses and 
Staphylococcus aureus in subcutaneous infections. For all abscess-derived 
samples, IS-pro found significantly more species than culture, including bacterial 
species less familiar as pathogens, such as Akkermansia muciniphila and Alistipes 
putredinis which are well known gut commensals that are refractory to standard 
culture techniques. Species considered to be normal commensals were generally 
found in locations close to their normal niche, such as abdominal abscesses for 
intestinal species. However, sometimes these species were also found in less 
expected locations, such as an Aggregatibacter in a subcutaneous infection or 
Bacteroides fragilis in an osteomyelitis sample. A clustered heat map of all IS-pro 
results is given in figure 3.
PacBio sequencing
To aid in the interpretation of discrepancies between culture and IS-pro, 
PacBio sequencing data was used as a third unrelated comparator technique. 
Because error rates are known to be high in PacBio sequence data (7), even when 
performing circular consensus sequencing, this data was only interpreted in 
the context of culture and IS-pro. In practice, this meant that PacBio data were 
only used as a confirmatory technique: when species were found with IS-pro 
Table 2: Comparison of identified species between culture and IS-pro. More species were general-
ly found with IS-pro for samples where a more complex microbiota could be expected.
Sample Category Total Sample # Identical More in Culture More in IS-pro 
intraperitoneal abscess 18 10 0 8 
abscess head/neck 11 5 0 6 
abscess mamma 4 1 0 3 
septic arthritis 2 2 0 0 
lymph node 1 1 0 0 
osteomyelitis/spondylodiscitis 9 3 1 5 
perianal abscess 1 0 0 1 
pulmonary abscess 1 0 1 0 
urogenital abscess 5 4 0 1 
wound/subcutaneous 
infection 
14 7 0 7 
Total 66 33 2 31 
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that were not found with culture, the presence of those species in the PacBio 
data was determined. The basis of this approach lies in the negligible chance 
that a series of sequencing errors would lead to exactly the same species as was 
found with an unrelated technique (IS-pro). We chose for the PacBio platform, 
as we wanted to be certain that species identification by sequence analysis truly 
matched IS-pro data. Therefore we needed to sequence the 16S and the adjacent 
IS region (figure 3). From these long sequences (1500-2000 nc), we could match 
sequence identification by 16S V6-V9 regions to predicted IS-fragments by 
virtual IS-pro. These predicted IS-fragments could subsequently be used to 
match against actual IS-pro data. 
For all but one of the samples that were identical in culture and IS-pro, presence 
of all species was also confirmed by PacBio data at least to the family level. A 
Mycobacterium tuberculosis isolate present in a sample from a spondylodiscitis 
was found by culture and IS-pro, but was not identified by PacBio. For the 
samples that were positive in culture and IS-pro, of the total of 129 species 
found with IS-pro, 94 (73%) were also found by PacBio. The two samples in 
which more species were found by culture than by IS-pro, have been discussed 
above (under IS-pro results). 
Three of the five samples that were negative in culture and positive in IS-pro 
were also positive with PacBio sequencing. The two IS-pro-positive samples that 
were not positive with PacBio showed a very low bacterial load in IS-pro (<500 
relative fluorescence units (RFU).
For samples with the most relevant discrepancies (discrepant in positivity 
between culture and IS-pro or less species found in IS-pro than culture), outcome 
compared to PacBio results and clinical records (see below) are given in table 3.
Clinical cases
As it can be difficult to assess the value of a new technique against a gold 
standard to which it is potentially superior, we focused on the five cases that 
were culture negative and IS-pro positive (table 3). The case reports are briefly 
discussed below.
A first case was of a child with an infected thoraco-lumbar osteosynthesis device, 
which had been placed for correction of a scoliosis. The infection was treated 
with intravenous broad-spectrum antibiotics and the osteosynthesis device 
was surgically cleaned. A sample was taken during surgery for microbiological 
analysis. This sample was culture negative but showed presence of Bacteroides 
fragilis by IS-pro (reproduced by PacBio data). The child was discharged with 
oral antibiotics (not directed specifically towards Bacteroides fragilis as IS-
pro analysis was not performed in the acute setting).  However, the child did 
not recover and returned for further surgical cleaning of the osteosynthesis 
device two months later. During this procedure, two samples were taken for 
microbiological analysis. These samples were analyzed by culture only and 
both showed a high load of Bacteroides fragilis. 
The second case was of a 63 year old female who had undergone a modified 
radical neck dissection for an adenoid carcinoma. She had received 
perioperative gentamycin and clindamycin. However, infection parameters 
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osteomyelitis/spondylodiscitis
intraperitoneal abscess
mammary abscessabscess head/neck
septic arthritis
wound/subcutaneous infection
perianal abscess
pulmonary abscess
urogenital abscess
SAMPLE TYPE Heat Map Intensity
maximum
average
minimum
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Bacteroides finegoldii
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Lactobacillus reuteri
Lactobacillus spp.
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Morganella morganii
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Mycoplasma spp.
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Streptococcus infantarius
Streptococcus intermedius
Streptococcus mis group
Streptococcus pyogenes
Streptococcus salivarius group
Unknown Acnobacteria
Unknown Bacteroidete
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SPECIES
Figure 3: IS-pro results of all positive samples depicted as a clustered heat map. Common patho-
gens known from culture, clearly play an important role when considering all species found by 
IS-pro. In intraperitoneal abscesses and abscesses in the urogenital region, gut microbiota clearly 
play an important role as can be seen by the high presence of Bacteroides and other anaerobic 
species in the rightmost cluster.
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rose postoperatively (Leucocytes (L) 15,9x10e9/L, C-reactive Protein (CRP) 
119) and a fluid collection was found in the operated region of the neck. This 
collection was aspirated after which the aspirate was sent in for microbiological 
analysis. Culture was negative, but IS-pro showed the presence of multiple 
bacterial species, all typical residents of the pharyngeal mucosa: Streptococcus 
mitis group, Streptococcus salivarius group, Haemophilus parainfluenzae, 
Pseudomonas aeruginosa and a Bacteroidetes species. Presence of Streptococci 
and Bacteroidetes species was also found by PacBio sequencing. The patient 
recovered following aspiration of the fluid and a course of amoxicillin-
clavulanate.
The third case was of a patient who had undergone an operation for a laryngeal 
carcinoma. Post-operatively the patient developed aspiration pneumonia. 
In a sputum sample, Staphylococcus aureus, Haemophilus parainfluenzae and 
Streptococcus mitis group were found by culture. The patient was treated 
with a seven-day course of flucloxacillin intravenously. After an initial good 
response to the antibiotic therapy, infection parameters rose again after five 
days during flucloxacillin treatment (L 20,1, CRP 269). A course of ceftriaxone 
combined with amoxicillin-clavulanate was subsequently initiated after which 
Infection parameters decreased only slowly. A fluid collection was found in the 
operated area. This was punctured and drained. The punctate was sent in for 
microbiological analysis. Culture results were negative while IS-pro showed 
Haemophilus parainfluenzae. This finding was confirmed by PacBio analysis. 
The infection subsided after drainage of the fluid collection and continuation 
of the antibiotic therapy.
The fourth case was of a patient with a colonic carcinoma who underwent 
a left-sided hemicolectomy. The operation was complicated by leakage of 
the intestinal anastomosis followed by a septicemia for which admission to 
the intensive care was necessary. Here the patient was treated with a broad-
spectrum antibiotic regimen, consisting of metronidazole, ceftazidim and 
fluconazole. While the infection subsided under this regimen, the patient 
underwent another abdominal operation to correct a fascial dehiscence. 
Peroperatively, a remnant of a paracolic abscess was found. The contents were 
aspirated and sent in for microbiological analysis. Culture was negative. IS-pro 
showed a low signal of an unidentified Firmicutes species, PacBio was negative. 
The patient recovered slowly and was discharged two months later.
The fifth case was of a patient who developed a persisting delirium after 
recurrent episodes of otitis media. On MRI a soft-tissue mass was seen close 
to the jugular foramen. A punctate was taken from this lesion and sent in for 
cytological and microbiological examination. By cytology an infectious process 
was suspected. However, microbiological culture was negative. IS-pro showed 
low-level presence of a Bacteroidetes species and an Enterobacter species (not 
found by PacBio). While IS-pro results were not available at the time of the 
decision, the cytology results combined with elevated infection parameters 
(L 13,6 CRP 113) prompted the attending physician to initiate a course of 
penicillin based on a suspicion of Actinomyces infection. However, the patient 
did not respond to this treatment. Subsequently, a course of voriconazole 
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was given for a suspected fungal infection and a course of ceftazidim because 
Pseudomonas aeruginosa was found in culture of a sputum sample. The patient 
did not respond to any of these treatments and died seven weeks after 
initial admission. It should be noted here that both Enterobacter species and 
Bacteroides species are generally insensitive to penicillin and ceftazidim.
Discussion
In this study we demonstrate the application of IS-pro, an open molecular 
approach that can be performed rapidly on clinical samples and we compare it 
to culture. IS-pro was able to reproduce the results of culture, and additionally 
found many species that were not detected by culture, possibly reflecting the 
actual in vivo microbial situation more accurately. Not only did IS-pro detect 
additional bacteria in culture positive samples, but bacteria were also found in 
culture negative samples. These additional IS-pro findings were largely (73% 
of strains found by IS-pro) confirmed by an independent sequencing approach 
and the case records further underline that they may be highly relevant for 
clinical diagnosis and appropriate treatment.
We are not the first to find that molecular techniques can detect bacteria that 
have not been detected by culture (24) and that these additional species are 
not necessarily uncultivable species (23). However, studies performed to date 
did not include a third –unrelated- comparator technique to further evaluate 
discrepancies. Moreover, while various approaches have been explored to 
detect microorganisms by an open molecular approach, no suitable means of 
doing this in a clinical setting has been demonstrated to date: amplification 
and detection of 16S fragments does not give species identification (13), 
Sanger sequencing is restricted to one or maximally two species being present 
in a sample and next generation sequencing approaches –while the first system 
was described 25 years ago (1)- have still not led to applications that may be 
performed in a clinical routine setting in a microbiological laboratory.
As IS-pro is straightforward to implement and fast to execute (<5 hours from 
sample to result), we here demonstrate a fully molecular approach, which 
performs better than culture with a turnaround time of less than a day directly 
on clinical specimens without the need for sequencing. We confirm the accuracy 
of this approach with an independent sequencing approach.
An issue with this study was that not all peaks could be identified to species 
level by IS-pro yet, nor could all sequences be identified to species or genus level 
with PacBio sequencing. Comparisons were therefore sometimes necessarily 
made on higher taxonomic levels, which may have lead to incorrect matching 
of species. When IS-pro peaks could not be identified to the species level, they 
could still be classified to phylum level. Therefore, results of unknown species 
could be given as a molecular Gram stain, which could still guide antibiotic 
choice, as discussed previously by Kobayashi (9). We designed this study to 
demonstrate the possibilities and results of a broad range bacterial PCR with 
direct species identification to clinical practice on a wide range of clinical 
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specimens. We decided not to include samples from locations that harbor a 
resident microbiota, such as sputum or faeces. While it is of course technically 
feasible to perform IS-pro on these sample types, our goal was to perform a 
head-on comparison between IS-pro and culture. This would not have been 
feasible for samples that contain many species that are difficult to detect by 
routine culture. Moreover, comparison of sequence-based techniques to highly 
selective culture approaches as are applied routinely in fecal diagnostics, is a 
wholly different issue altogether, which falls outside the scope of this study.
Furthermore, in this study we did not examine all human sample types; 
important omissions were blood and CSF, both of which sample types typically 
harbor low bacterial loads. We did not perform analyses on blood as it has been 
shown that the sensitivity of molecular assays to detect pathogens in blood 
is largely dependent on the volume of blood from which DNA is isolated and 
requires specialized DNA extraction methods (11). CSF was not included in 
this study as sample volumes are often low and are used in total for culture. In 
the period of sample collection of this study, no samples with enough excess 
CSF were collected. However, another sample type that typically harbors a low 
bacterial load is joint aspirate. The two joint aspirates that were included in this 
study showed a full concurrence between culture and IS-pro (both positive, 
same species identified).
This choice, however also precluded an accurate estimation of analytical 
performance characteristics per sample type. Furthermore, this study 
highlights one of the most important issues of an open molecular approach in 
routine diagnostics: the interpretation of species that have not been found by 
culture. To assess whether these additional species are truly present in the site 
of pathology in the patient and may have a clinical implication, the possibility of 
contamination of samples should first be ruled out. Contamination of reagents 
of DNA isolation or PCR mix was ruled out by the negative controls, which 
were taken along with each DNA isolation run throughout the whole process 
and were all negative. Contamination of the samples themselves was more 
difficult to rule out. However, a number of ways to make contamination very 
unlikely is demonstrated in the case reports: in the first case an initial finding 
of Bacteroides fragilis was confirmed in a completely independent follow-up 
sample taken from the same patient two months later, making contamination 
very unlikely. In the second case report, laboratory contamination was unlikely, 
as all bacteria found were common residents of the pharyngeal mucosa. The 
abscess from which the punctate was taken was situated adjacent to the 
pharynx, making pharyngeal mucosa residents the most likely causative agents. 
In the fifth case report, the clinical relevance of the species found was made 
likely because the patient did not respond to antibiotics to which the species 
found by IS-pro were intrinsically resistant. The third case report makes clinical 
relevance of the species found likely by a combination of the factors at play in 
the first and fifth case report: in a first sample  Haemophilus parainfluenzae, 
Staphylococcus aureus and Streptococcus mitis were found while an unrelated 
second sample confirmed the presence of Haemophilus parainfluenzae after a 
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course of flucloxacilline, to which it is generally resistant, while the other two 
species are generally sensitive. The culture media used for both samples were 
identical.
Of course, contamination of samples from the patient’s own microbiota is more 
difficult to assess. However, this issue is not new at all; it is has always been a 
known factor in culture-based microbiology, most notably a factor that clinical 
microbiologists have successfully learnt to deal with. Here, extensive experience 
of bacterial cultures in a clinical situation has led to understanding and correct 
interpretation of results. It is to be expected that this will also happen for 
open-molecular techniques as microbiologists gain more experience with this 
approach in clinical routine.
Many studies have now confirmed that routine culture techniques cannot 
detect many species that are common in endogenous complex microbial niches 
such as the gut, the oral cavity or the urogenital tract (4,17,21). It is also well 
established that bacteria deriving from the endogenous microbiota are common 
causative agents of infections of normally sterile body sites (12,19,22,23). In 
addition, this study and previous studies show that cultivable organisms too 
can be missed by routine culture (23,24)
The importance of a fast open molecular approach for clinical practice thus 
seems evident. Examples of clinical situations in which such an approach may 
be of added value include situations in which a rapid diagnosis is required (eg 
septic arthritis), in hard to diagnose clinical syndromes (e.g. fever of unknown 
origin), when patients have already received antibiotics prior to sampling, for 
samples with a high false-negative rate in culture (e.g. joint aspirates (15)) and 
diseases caused by fastidious or uncultivable organisms (e.g. strict anaerobes). 
In addition, an open molecular technique can detect unknown novel pathogens 
and has great potential for the promising field of complex microbiota-based 
diagnostics.
We conclude that an open molecular approach that can be performed in a 
clinical routine setting, such as IS-pro, may have a high added value for clinical 
practice. It outperforms culture in terms of speed and detection of bacteria, and 
has the advantage over current PCR-based approaches that it is not limited to a 
predefined set of bacteria that has to be decided on in advance.
Of course microbiologists will need to gain experience with such a novel approach 
to optimally interpret results for clinical decision-making, but it is very likely 
that this will happen just as it has done for culture-based microbiology.  
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Evaluation and validation of IS-pro 
for intestinal microbiota analysis
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Abstract
The composition of the gut microbiota is associated with various disease states, 
most notably inflammatory bowel disease, obesity and malnutrition. This 
underlines that analysis of intestinal microbiota is potentially an interesting 
target for clinical diagnostics. Currently, the most commonly used sample types 
are feces and mucosal biopsy specimens. Because sampling method, storage and 
processing of samples impact microbiota analysis, each sample type has its own 
limitations. An ideal sample type for use in routine diagnostics should be easy to 
obtain in a standardized fashion without perturbation of the microbiota. Rectal 
swabs may satisfy these criteria, but little is known about microbiota analysis 
on these sample types. 
In this study we investigated the characteristics and applicability of rectal swabs 
for gut microbiota profiling in a clinical routine setting in patients presenting 
with various gastro-intestinal disorders. We found that rectal swabs appeared 
to be a convenient means of sampling the human gut microbiota. Swabs can be 
performed ‘on demand’, whenever a patient presents; swab-derived microbiota 
profiles are reproducible, whether they are gathered at home by patients or by 
medical professionals in an outpatient setting and may be ideally suited for 
clinical diagnostics and large-scale studies.
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   90 21-9-2016   15:09:18
Rectal swabs for microbiota analysis
91
Introduction
Research into the composition of the gut microbiota in health and disease has 
bloomed since the advent of molecular approaches of its characterization. From 
the many investigations conducted in this field, evidence is accumulating that 
the composition of the gut microbiota may be related to disease states, most 
notably in inflammatory bowel diseases (IBD)[1], obesity[2] and malnutrition[3]. 
A prerequisite for using microbiota analysis as a clinical tool is efficient and 
consistent sampling and sample preservation [4–6]. An important factor in this 
regard is the influence of sample handling and the effect of intestinal preparation 
by bowel cleansing on composition of microbiota in stools and intestines [7,8].
Currently, the most commonly used sample type for analysis of intestinal 
microbiota is feces. Classical microbial diagnostics on feces focuses on infectious 
gastroenteritis. For this purpose, current fecal sampling seems satisfactory. 
However, for a more comprehensive analysis of the intestinal microbiota, 
sampling, storage and processing of samples have a significant impact on the 
resulting composition analysis. The ideal sample should be easy to obtain in 
a standardized fashion with no preceding perturbation of the microbiota. 
Currently, fecal samples are usually collected by patients themselves at home. 
This introduces potential contamination during collection, time-lag before 
freezing, freezing above -20°C and thawing during transport to the laboratory. 
Evidence is compelling that these factors may introduce variation large enough 
to thwart microbial diagnostics [5].
An alternative is direct sampling of the intestinal mucosa by taking biopsies 
during endoscopy. While these samples can be gathered in a highly standardized 
fashion, the invasive nature of the sampling procedure precludes large-
scale implementation as a screening or follow-up tool. In addition, prior to 
colonoscopy, patients are to be prepped with stringent laxative schemes, which 
have been shown to perturb the intestinal microbiota [8].
A third approach is to obtain samples by rectal swabbing. Rectal swabs can be 
easily obtained and can be stored immediately in a standardized fashion without 
previous perturbation of the microbiota. Rectal swabs are already regularly used 
for screening for resistant microbes and have shown to be very effective for that 
purpose [9].
In the present study we investigated the applicability of rectal swabs for gut 
microbiota analysis in a clinical routine setting. We analysed the effect of storage 
and processing conditions on reproducibility and compared microbial profiles 
by rectal swabbing to those from fecal and mucosal samples. Our results showed 
that rectal swabs are well suited for consistent and efficient routine sampling of 
the intestinal microbiota.
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Methods
Design
This study was set up as a descriptive study to evaluate applicability and 
reproducibility of rectal swabs and to compare resulting bacterial profiles with 
those from feces specimens and mucosal biopsies. Two rounds of investigations 
were held. First, patients who underwent an elective colonoscopy were asked 
to bring in feces one week before the procedure and rectal swabs and biopsies 
were taken during the procedure. Because colonoscopy involves intestinal 
preparation, in a second round patients with inflammatory bowel disease who 
did not undergo intestinal preparation were asked to sample feces and to obtain 
one rectal swab at home; a second rectal swab was obtained on the day they 
brought in the feces (figure 1). 
The study was approved by the institutional ethical review board of the VU 
University Medical Center in Amsterdam, NL, and all individuals provided 
written informed consent. Subjects were included who either underwent an 
elective colonoscopy between February and June 2011,or who presented 
for commonly scheduled control at the inflammatory bowel disease (IBD) 
outpatient clinic in October 2012. In the first group, the only exclusion criterion 
was a contraindication for taking mucosal biopsies. 
Samples
All patients who underwent colonoscopy were prepped according to a 
standardized protocol with a laxative preparation consisting of high-volume 
polyethylene glycol (PEG) solution (Moviprep, Norgine B.V., Amsterdam, 
The Netherlands). Mucosal biopsy specimens were collected with a flexible 
video endoscope (Olympus GmbH, Hamburg, Germany) and a flexible biopsy 
forceps (Wilson-Cook; European Endoscopy Group, Fujinon Medical Holland, 
Veenendaal, The Netherlands). Mucosal biopsy specimens were harvested 
from sigmoid colon at 20-30 cm from the anal verge. Per subject, one mucosal 
sample was washed twice in 500µl PBS (pH 7) before snap-freezing in liquid 
nitrogen and a second sample was deposited in a container filled with 500µl 
PBS and snap frozen in liquid nitrogen. All samples were stored at −20°C. In 
the colonoscopy group, rectal swabs were collected at the time of colonoscopy, 
just prior to the endoscopic procedure. Rectal swabs (FLOQSwabs 552C, Copan, 
CA, USA) were inserted into the anal canal, beyond the anal verge (±3cm). For 
home swabbing, patients were instructed to do the same. Two rectal swabs were 
deposited in a container with 500 µl Reduced Transport Fluid (RTF) buffer[10] 
and kept at room temperature for 2 hours prior to storage at −20°C. One swab 
was immediately snap frozen in liquid nitrogen.  
In the IBD outpatient group, two rectal swabs were gathered. One by the 
patients themselves at home, a day prior to presentation, the other was taken 
at the outpatient clinic. Both swabs were stored in a container with 500µl RTF 
buffer at −20°C.
In both the colonoscopy as well as the IBD outpatient group, fecal samples were 
gathered within five days before presentation at the outpatient clinic. Samples 
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were gathered in sterile containers and were stored at −20°C within 2 h after 
collection and kept frozen until further analysis.
DNA isolation
DNA was isolated from feces or mucosal biopsies as described previously [11]. 
In short, for mucosal samples, the first step consisted of lysis of tissue and 
bacteria with the QIAamp DNA mini Kit (Qiagen, Hilden, Germany) followed 
by DNA extraction with the NucliSENS® easyMag® automated DNA isolation 
machine (Biomérieux, Marcy l’Etoile, France). For fecal samples, 100-400mg of 
feces was used as input for the fecal DNA extraction protocol of the easyMag 
machine as described by the manufacturer. For DNA isolation from swabs, one 
ml of nucliSENS® lysisbuffer, containing guanidine thiocyanate, was added 
to each vial containing a swab tip and the mixture was shaken at 1400rpm 
(Thermomixer comfort, Eppendorf, Hamburg, Germany) for five minutes. For a 
subset of 14 snap frozen swabs, an additional bead-beating step was evaluated. 
For these swabs, after five minutes of shaking at 1400 rpm, the mixture was 
divided into two parts. To one part, approximately 100µg of Zirconia 0.1 silica 
fecal sample
rectal swab
10 Subjects (buff er) -20°C buff er -20°C-5 to -2 days presenta on outpa ent clinic
B
rectal swab
A
fecal sample
38 Subjects -20°C buff er -20°C snap frozen-5 to -2 days day of colonoscopy
2 rectal swabs
rectal swab
mucosal biopsy
Figure 1: Two subject groups were sampled. Group A: 38 subjects who underwent an elective 
colonoscopy. Feces was collected at home two to five days before. Rectal swabs and biopsies were 
taken during the procedure. Two swabs were stored for two hours at room temperature and at 
-20°C afterwards, one swab was immediately snap frozen. The mucosal biopsy was washed in PBS 
and snap frozen.
Group B: 10 patients with IBD. This group collected feces and one rectal swab at home. Feces was 
stored in a sterile container and the rectal swab in RTF buffer, both at  at -20°C. A second rectal 
swab was obtained at the outpatient clinic and stored in the same fashion as the first swab.
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beads were added and bead-beating was performed for 60 seconds. Afterwards, 
all samples were centrifuged for four minutes at 12.000g and added to the 
easyMag container. DNA extraction was performed on the easyMag machine 
with the Specific A protocol as described by the manufacturer.
IS-profiling of the intestinal microbiota
The intestinal microbiota analysis was performed by IS-pro as described 
previously [11]. IS-pro involves bacterial species differentiation by the length of 
the 16S–23S rDNA interspace region with taxonomic classification by phylum-
specific fluorescent labelling of PCR primers. 
Amplification of IS regions - Five primers were used for amplification of 
IS regions. Two fluorescently labelled forward primers were phylum-specific, 
for the 16S rDNA region: one FAM-labelled primer, specific for Firmicutes, 
Actinobacteria, Fusobacteria and Verrucomicrobia (for efficiency this group 
will further be referred to as AFFV) and one HEX-labelled primer specific for 
Bacteroidetes. Three unlabelled reverse primers were specific for the 23S rDNA 
region. The combination of these primers provided very broad coverage for 
Firmicutes, Actinobacteria, Fusobacteria, Verrucomicrobia, and Bacteroidetes. 
The primers were used in a multiplex PCR, which amplified the 16S-23S IS 
region.  The length of this IS region and its PCR product is species-specific. The 
fluorescent label provides identification of all fragments at the phylum level.
Amplifications were carried out on a GeneAmp PCR system9700 (Applied 
Biosystems, Foster City, CA). Cycling conditions for PCR were 72°C for 2 min; 
35 cycles of 94°C for 30 s, 56°C for 45 s, and 72°C for 1 min; and a final extension 
at72°C for 5 min. Each PCR mixture, with a final volume of 25µl, contained 10µl 
of buffered DNA, 1x superTaq buffer (SphaeroQ, Gorinchem, the Netherlands), 
200µM deoxynucleoside triphosphate, 0.04% BSA, 1 U of superTaq, and 0.13µM 
of each of the 5 primers.
IS-Fragment analysis - After PCR, 5µl of PCR product was mixed with 19.8µl 
formamide and 0.2µl Mapmaker 1000 ROX-labeled size marker (BioVentures, 
Murfreesboro, TN, USA). DNA fragment analysis was performed on an ABI 
Prism 3130XL Genetic Analyzer (Applied Biosystems). Results are presented as 
color-labeled peak profiles (figure 2). These peaks can be regarded as operational 
taxonomical units (OTU’s). All data were further analyzed with the Spotfire 
software package (TIBCO, Palo Alto, CA, USA).
Statistical analysis
Repeatability and reproducibility
Variations in peak heights by repeated testing, repeated sampling or different 
storage methods were quantified by means of a variance components analysis. 
For twelve rectal swabs, the lysis buffer that was added to the swab tip was 
split into two aliquots and processed separately. From the resulting profiles, 
repeatability ε was estimated according to the model:
The variation introduced by repeated sampling was estimated from 29 x 2 
rectal swab profiles from the two rectal swabs that were taken just prior to the 
ijkjijiijk PFPFY  
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   94 21-9-2016   15:09:20
Rectal swabs for microbiota analysis
95
endoscopic procedure and stored in RTF at room temperature for two hours. 
Sampling variation σ was estimated according to the model:
Variation introduced by storage at room temperature was estimated from 29 x 2 
rectal swabs of which one was stored in RTF at room temperature for two hours 
and the other was directly snap frozen in liquid nitrogen. Storage variation τ 
was estimated according to the model:
In all cases, the response variable Y is the log2 transformed peak value within a 
one nucleotide interval for a particular fragment i as measured in a rectal swab 
profile taken from patient j. Furthermore, μ + Fi denotes the average overall 
response in the study population for a particular fragment i, Pj is the average 
overall deviation for the jth patient and FiPj is the additional deviation on the ith 
fragment for the jth patient. Finally, the factors εijk, σijl and τijm are the deviation 
from the jth patient mean for the ith fragment on the kth repeated sample, the 
lth duplicate sample and the mth storage method, respectively.
We only incorporated those fragments that yielded a meaningful response 
(defined as a peak value within a one nucleotide interval above or equal to 128 
relative fluorescence units (RFU)) in both duplicates [11]. Because the number 
of fragments is limited by the nature of the assay, Fi  was modelled as a fixed 
effect. All other terms were modelled as random effects. Computations were 
performed with the ML method using the SAS© procedure VARCOMP.
Correlation of profiles
Correlation analyses were performed as described previously [11]. Comparisons 
between all samples were made by calculating squared correlation coefficients 
for all possible pairs of samples. When duplicate swabs stored in RTF from the 
colonoscopy group were compared to other samples, averaged profiles of the 
duplicate swabs were used.
ijljijiijl PFPFY    
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Figure 2: Sample IS-profile. The x-axis represents IS fragment length, the y-axis represents rela-
tive abundance of fragments. Colours of fragments correspond to bacterial phyla. Blue peaks rep-
resent AFFV group, red peaks represent Bacteroidetes. Each peak may be regarded as an operational 
taxonomic unit (OTU).
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Comparisons were grouped in intra and inter individual comparisons, the former 
group comprising all comparisons between samples from the same individual, 
the latter group comprising all other comparisons. Median and inter quartile 
range (IQR) were calculated for each group. 
Diversity analysis
Diversity was calculated per phylum and for the overall microbial composition by 
pooling all phyla together. Within-sample (alpha) diversity was calculated as the 
Shannon index, which was recently shown to be a robust estimate of microbial 
diversity [12]. Diversity indices were calculated for all sample types from both 
the colonoscopy and the IBD outpatient group. Dissimilarities between samples, 
or between-sample diversity, were represented in a dissimilarity matrix that 
was built using the cosine distance measure. Given two  vectors  of attributes 
(two profiles in our case), A and B, the cosine dissimilarity is represented using 
a dot product and magnitude as:
 dissimilarity = 
The resulting dissimilarity matrix was summarized and visualized in a low-
dimensional space using principal coordinate analysis (PCoA). Diversity analysis 
was performed using the vegan software package in R.
Results
Study population
A total of 38 subjects were included in the colonoscopy group, 23 male and fifteen 
female. The indications for colonoscopy were suspected neoplasm (8), screening 
for familial tumours (5), IBD (5), and general gastrointestinal complaints (13), 
of which diverticulosis was the most common diagnosis (6 out of 13). Not all 
sample types could be harvested from all subjects and in a few samples the PCR 
reaction was inhibited. The total number of samples obtained was:  35 snap 
frozen rectal swabs, 37 sets of rectal swabs in RTF, 33 dry mucosal biopsies, 35 
mucosal biopsies in sodium chloride 0.9% and 19 fecal samples.
Ten subjects were included in the IBD outpatient group, two male (both with 
ulcerative colitis) and eight female (four with ulcerative colitis, four with 
Crohn’s disease). Two subjects presented with active disease, eight with disease 
in remission. The total number of samples was: ten swabs and ten fecal samples 
taken at home by the patients themselves and ten swabs taken at the outpatient 
clinic by their physician.
Effect of bead-beating for DNA isolation
As it has been described that DNA isolation protocols for fecal samples that 
include bead-beating give higher DNA yields of certain groups of bacteria [13], 
we compared this procedure to automated DNA isolation for swab samples. 
With a mixed effects model, accounting for both fixed and random effects, we 
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found bead-beating to have a significant negative impact on DNA recovery from 
Bacteroidetes. Bacteroidetes peaks in DNA isolated without a bead beating step 
were on average 1.85 times higher than the equivalent peaks in DNA isolated 
with a bead beating step (p=0.015). For the AFFV group there was also a trend 
towards a negative impact of bead beating. Peaks from DNA without bead 
beating were on average 1.45 times higher than equivalent peaks generated 
from DNA with a bead beating step (p=0.051). Furthermore, bead beating also 
showed a negative impact on the estimated diversity both for Bacteroidetes and 
the AFFV group (figure 3).
Effect of storage and processing of rectal swabs
To evaluate the effect of a non-stringent sample storage protocol, we compared 
microbiota profiles of snap-frozen rectal swabs to profiles of rectal swabs that 
had been stored at room temperature in RTF for two hours before freezing 
at −20°C. As storage conditions may affect Gram-positive and Gram-negative 
bacteria differently, we analyzed data separately for AFFV and Bacteroidetes. 
Correlations were calculated for profiles derived from snap frozen swab samples 
versus the averaged profiles of duplicate swab samples stored in RTF at room 
temperature before freezing. For both AFFV and Bacteroidetes, intra-individual 
comparisons showed high similarities as measured by a high median R2. Inter 
individual comparisons were low, as was expected (figure 4B). For all measured 
values in the above and subsequent sections, we refer to table 1.
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Figure 3: Diversity analysis of samples that were either directly lysed or underwent bead-beating 
prior to DNA isolation. Shannon diversity indices are generally lower for bead-beated samples for 
the phylum Bacteroidetes (pink), the AFFV group (blue) and consequently for all phyla combined 
(green).
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Repeatability and reproducbility
The estimated variance for repeated testing of same samples was 0.25 log2RFU 
for Bacteroidetes and 0.37 log2RFU for AFFV. Total sampling variance, which 
includes variance introduced by repeated sampling as well as repeated testing, 
was estimated to be 0.78 log2RFU for Bacteroidetes and 1.16log2RFU for AFFV. 
Storage variance, introduced by storing swabs at room temperature in RTF 
buffer instead of direct snap freezing, was estimated to be 0.79 for Bacteroidetes 
and 1.14 for AFFV. Thus, additional variance was introduced by taking multiple 
samples as compared to repeated testing of the same sample. However, no 
additional variance was introduced by storing swabs at room temperature in 
RTF for two hours as compared to directly snap freezing them in liquid nitrogen.
Correlation of swab derived profiles
To further evaluate the reproducibility of the swabbing procedure, we performed 
a correlation analysis on swabs taken from the same patient (n=37). We compared 
the duplicate swabs that were stored in RTF buffer at room temperature for 
2 hours with each other and with the swabs that were directly snap frozen. 
Log 2 transformed profiles were compared pairwise intra- and inter individually 
with Pearson correlation and results were analyzed separately for Bacteroidetes 
and AFFV. For the duplicate swabs stored in RTF, intra-subject correlations were 
high for both AFFV and Bacteroidetes, whereas inter individual correlations 
were low. Correlations between RTF-stored swabs and snap frozen swabs were 
also very high for both Bacteroidetes and AFFV (Figure 4A and 4B).These data 
underline the reproducibility of rectal swabs within the same patient, regardless 
whether samples are stored in RTF buffer at room temperature for two hours or 
are directly snap frozen in liquid nitrogen.
Group Comparator 1 Comparator 2   AFFV Bacteroidetes 
A 
(c
ol
on
os
co
py
) 
Swab Snap frozen swab A 0,73 (0,23) 0,81 (0,24) 
  B 0,12 (0,16) 0,13 (0,20) 
Duplicate swab A 0,70 (0,38) 0,72 (0,31) 
  B 0,13 (0,15) 0,12 (0,17) 
Faeces A 0,17 (0,18) 0,36 (0,35) 
  B 0,10 (0,12) 0,16 (0,20) 
Mucosal biopsy A 0,15 (0,21) 0,32 (0,44) 
  B 0,10 (0,11) 0,13 (0,19) 
Faeces   A 0,12 (0,28) 0,33 (0,35) 
    B 0,12 (0,14) 0,18 (0,16) 
B 
(I
BD
) 
Swab at home Swab (hostpital) A 0,55 (0,26) 0,82 (0,23) 
  B 0,14 (0,03) 0,03 (0,14) 
Faeces A 0,23 (0,52) 0,75 (0,39) 
  B 0,10 (0,12) 0,05 (0,20) 
 
Table 1: Median R squared and Inter Quartile Range (IQR) values for all comparisons. IQR values 
are indicated in brackets. Rows A and B indicate either intra-individual comparisons (A) or inter-
individual comparisons (B).
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Figure 4: Comparisons of microbiota profiles of the colonoscopy group expressed as R squared. 
All comparisons have been done separately for AFFV group (left) and Bacteroidetes (right). Figures 
show comparisons of all profiles. Red dots represent comparisons of samples of the same subject 
(intra-subject correlation). Yellow box plots are based on all correlations, red box plot on intra-
subject correlations only. A: Duplicate swab profiles stored in RTF buffer. B: Swab stored in RTF 
buffer vs. snap frozen swabs. C: Swabs stored in buffer vs. mucosal biopsies. D: Swabs stored in 
buffer vs. fecal samples. E: fecal samples vs. mucosal biopsies.
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To test whether self-sampling by patients at home would yield comparable results 
to swabs taken at the outpatient clinic, we compared these in ten individuals. 
Again, profiles were compared pair wise and results were analyzed separately for 
AFFV and Bacteroidetes. This analysis too showed high intra-subject correlations 
and low inter-subject correlations (Figure 5A). This showed that self-collected 
swabs were highly comparable to clinically collected swabs when stored in the 
same fashion.
Correlation of different sample types
Finally, rectal swabs, fecal samples and mucosal biopsies were compared by 
correlation of profiles. First, we compared swab samples to mucosal biopsy 
samples taken by colonoscopy in 32 subjects. These correlations were generally 
low, especially for the AFFV group. Bacteroidetes profiles showed a somewhat 
higher similarity with a large distribution of values for R2 (Figure 4C). Next, 
rectal swab profiles were compared to fecal profiles in nineteen subjects of the 
colonoscopy group and in all ten subjects of the IBD outpatient group. In the 
colonoscopy group, correlations between swab and fecal profiles were generally 
low, similar to the correlation of swab samples to mucosal biopsy samples 
in this prepped patient group. Bacteroidetes generally had a slightly higher 
correlation than AFFV (Figure 4D). In the IBD outpatient group, correlations 
were markedly higher, especially for the Bacteroidetes, which had a median R2 
similar to that found for duplicate swab profiles (Figure 5B). As expected, inter 
subject correlations were low in both groups. These data showed that fecal 
profiles resembled swab profiles, in particular for the phylum Bacteroidetes, but 
not in people who underwent bowel prepping.
Finally, as we found rectal swab microbiota profiles to be distinct from mucosal 
and fecal microbiota profiles in the colonoscopy group, we were interested in the 
similarity between fecal microbiota and mucosal microbiota. To compare these, 
we used the same analysis as above. We found that correlations between fecal 
samples and mucosal biopsies were as low as the correlations of swab samples to 
both these sample types. Again, a higher correlation was found for Bacteroidetes 
than for AFFV (figure 4E). 
Diversity analysis
Shannon diversity indices were highly similar between duplicate swabs and 
snap frozen swabs for all phyla. The most pronounced difference in diversity 
indices for the various sample types was in the AFFV group. Here, diversity was 
markedly lower in mucosal biopsies and fecal samples than in rectal swabs. For 
the phylum Bacteroidetes, diversity was similar for the different sample types 
(figure 6). Furthermore, we compared microbial diversity in prepped versus 
unprepped individuals for rectal swabs and fecal samples. As fecal samples were 
taken before bowel prepping, we did not expect to find differences in diversity in 
this sample type between the two groups. Indeed, diversity in fecal samples was 
very similar in both groups. For the rectal swab samples, diversity seemed to be 
somewhat higher in the unprepped group, and distribution of diversity indices 
appeared smaller than in the prepped group. Moreover, the higher diversity in 
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rectal swabs as compared to fecal samples held true for both the prepped as well 
as the unprepped group (figure 7).A comparison between all sample types was 
made with a cosine dissimilarity matrix and visualized by principal coordinate 
analysis. From this analysis it becomes apparent that rectal swabs, fecal samples 
and mucosal biopsies may sometimes be very similar, but that on a whole, these 
three sample types seem to harbor more or less distinct microbiota (figure 8).
Discussion
In this study we showed that rectal swabs provide a good method to produce 
highly reproducible microbiota profiles. Profiles are similar to those of fecal 
samples in unprepped patients, especially for the phylum Bacteroidetes. We 
suggest that rectal swabs may be ideally suited for large-scale studies and for 
routine clinical applications of microbiota profiling.
Whereas correlation of swab profiles to fecal profiles was quite high in patients 
who did not undergo extensive intestinal preparation for colonoscopy, 
the similarity between different sample types was markedly lower in the 
colonoscopy group. Most likely, this was due to the preparatory bowel lavage, 
which obviously affected the intestinal content. Therefore, we suggest that 
sampling of the intestinal microbiota with feces or by rectal swabbing, without 
previous bowel preparation, is probably the preferred method if analyzing 
genuine, undisturbed microbiota.
Rectal swabs are an attractive means of sampling the intestinal microbiota in a 
clinical setting without the drawbacks of feces collection or mucosal sampling. 
Subjects do not need to collect fecal samples at home and do not need to be 
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Figure 5: Comparisons of microbiota profiles in the IBD outpatient group expressed as R squared. 
All comparisons have been done separately for AFFV group (left) and Bacteroidetes (right). Figures 
show comparisons of all profiles. Red dots represent comparisons of samples of the same subject 
(intra-subject correlation). Yellow box plots are based on all correlations, red box plots on intra-
subject correlations only. A: Swabs taken by patients at home vs. swabs taken by the physician at 
the polyclinic. B: Swabs vs. fecal samples.
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prepped or undergo invasive procedures. The applicability of rectal swabs is 
highlighted by the fact that they are already commonly used in clinical routine 
and can be taken at every visit. 
We further showed that short-term storage of rectal swabs in RTF buffer at 
room temperature had no impact on the composition of the microbiota, thus 
relaxing requirements for sample collection and storage and making the method 
applicable in almost any (clinical) setting. The effects of various storage protocols 
on microbiota composition have been investigated previously. Prolonged 
storage of feces at room temperature as well as thawing of feces >1 hour before 
DNA isolation has been shown to impact the microbiota composition [5]. It has 
also been found that storage at room temperature impacts microbiota analysis 
on feces [4,6]. In contrast, it has also been reported that storage of feces has 
no significant effect on microbiota composition [14]. This lack of effect seems 
improbable, since analysis by classic culture has amply shown that storage of 
feces at room temperature leads to marked changes in microbial composition. 
Regardless of these discrepancies, we here demonstrated that storage of rectal 
swabs at room temperature for 2 hours in a stabilizing buffer (RTF buffer), did 
not impact microbiota composition.
As bead beating has been described to be of added value in DNA extraction 
especially for bacteria in the phylum Firmicutes [7,15], we evaluated this for swab 
samples. In these samples it did not contribute to the DNA yield.  In contrast, 
bead beating diminished the yield of Bacteroidetes DNA. This was an unexpected, 
yet reproducible outcome in the context of what has been described for isolation 
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Figure 6: Diversity analysis of the different sample types. Shannon diversity indices are highly 
similar between duplicate swabs and snap frozen swabs for all phyla. Diversity is lower for the 
AFFV group in mucosal biopsies and fecal samples compared to rectal swabs.
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of bacterial DNA from feces. As composition of microbiota in rectal swabs does 
not differ markedly from that in fecal samples –especially in Bacteroidetes-, 
composition cannot have been a factor. We hypothesize that the effect may be 
due to the large differences in bacterial loads in fecal and swab samples. With 
lower loads, bead beating may damage DNA, instead of contributing to DNA 
yield. For clinical routine, in which speed and ease is essential, omission of bead 
beating is favorable.
We have performed repeatability and reproducibility analysis previously on 
mucosal biopsies and fecal samples [11]. The values as measured here for rectal 
swabs are highly similar to those previously reported findings. The practical 
implication of this is that sampling variation in microbiota profiles introduced 
by the swabbing procedure itself is no larger than that introduced by taking 
multiple mucosal biopsies or by analyzing different sub samples of the same 
fecal sample. Reproducibility of rectal swab samples was further underlined by 
high total profile correlations and similarity of diversity indices.
It has been shown that the microbiota composition of rectal swab samples is 
similar to that of fecal samples and less similar to the microbiota composition 
of mucosal biopsies in a group of patients with colorectal carcinoma [16]. This 
similarity was believed to be due to adherence of feces to swab samples, since 
they harvested the swabs from patients that were not prepped for colonoscopy. 
In these series, we showed that swab profiles are indeed similar to feces profiles 
obtained from unprepped subjects -in particular for the phylum Bacteroidetes-, 
but decidedly distinct in prepped patients. In these prepped subjects, microbiota 
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Figure 7: Comparisons of microbial diversity in prepped versus uprepped subjects. Diversity in 
fecal samples is similar in both groups. For rectal swab samples, diversity seems to be somewhat 
higher in the unprepped group, and distribution of diversity indices are somewhat smaller than in 
the prepped group. AFFV diversity can be seen to be higher in rectal swabs than in fecal samples.
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profiles in swab samples were also distinct from profiles in mucosal biopsies. 
Rectal swabs were taken just prior to colonic mucosal biopsies, both after 
prepping of the subject. The difference in composition between these samples 
thus seemed to represent a true difference in composition between the proctum, 
which was sampled by rectal swabs, and more proximal in the (distal) sigmoid 
colon, as sampled by sigmoidal mucosal biopsies. The higher diversity of the AFFV 
group in rectal swab profiles may be caused by the presence of a different array 
of species characteristic for the transitional zone of a strict anaerobic to a more 
aerobic environment. Also, the stratified squamous epithelium characteristic 
for the lower part of the anal canal may support different microbial species than 
the columnar epithelium of the more proximal parts of the colon. In this context 
it is interesting to note that ulcerative colitis always commences at exactly this 
transitional zone from whereon the disease proceeds inward. 
The study presented here has been specifically set up to evaluate feasibility 
and reproducibility of a convenient sampling method for intestinal microbiota 
profiling that can easily be used in a routine clinical setting.  Rectal swabs indeed 
proved very convenient. However, there are some potential drawbacks of rectal 
swabs, such as unwillingness of patients to undergo the swabbing procedure 
because of discomfort, a potential lack of biomass captured by the swab and 
the potential of contamination of the sample with skin bacteria. Concerning 
patient compliance, we found that patients were generally willing to undergo 
the procedure after a brief explanation. As of the lack of biomass, we did not find 
evidence of this theoretical problem in our study. Also, we did not find evidence 
PC2
PC3 PC1
Mucosal biopsy Faeces Rectal swab
Figure 8: Principal coordinate analysis depicting the different sample types. Rectal swabs, fecal 
samples and mucosal biopsies may sometimes be very similar, but on a whole, these three sample 
types seem to harbor more or less distinct microbiota.
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of contamination by skin bacteria. We hypothesize that extent of this potential 
problem is limited, as bacterial load in the rectum is orders of magnitude higher 
than on the skin.
We applied strict per protocol execution for all procedures in this study to be 
able to evaluate the impact of isolated effects on microbiota analysis. There 
are yet some additional aspects that would have been interesting to evaluate, 
like evaluating more storage regimens or different DNA isolation methods. 
However, this would have required taking more swabs than the three that were 
harvested for this study. Moreover, the EasyMag system for DNA isolation as 
was employed here, has been described to be very suitable for extraction of DNA 
from fecal samples. Therefore only preprocessing with bead-beating was tested 
as a variable, as this has been described to be of added value in fecal samples. 
In conclusion, it is important to define standards for reproducible and accurate 
sampling of gut microbiota that can be implemented in clinical routine.We 
found that rectal swabs were a convenient means of sampling the human gut 
microbiota. Swabs can be taken ‘on demand’, whenever a subject presents. The 
acquired samples resembled fecal microbiota and showed a highly reproducible 
profile, whether they were gathered at home by patients or by medical 
professionals in an outpatient setting.
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Neonatal microbiota can be classified into two distinct 
settler types with different development over time
Chapter 5
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Abstract
Background Intestinal microbiota development of newborns is very much 
dependent on delivery mode and feeding type. We have recently shown that 
neonatal microbial profiles can be separated into two distinct compositional 
clusters, coined settler types. These two settler types are characterized by a 
high abundance of either  Bacteroidetes (settler type B) or  Firmicutes (settler 
type F). In the present study, we investigate the relation of settler types with 
delivery mode and maternal microbiota composition. We further investigate 
the development of these settler types in relation to feeding (breast-fed versus 
formula-fed).  
Methods Fecal samples were collected from  neonates at three time points: 
one, four and twelve weeks after birth. A fecal sample of all mothers was taken 
during the first week after delivery. 32 children were exclusively breast-fed and 
45 were exclusively bottle fed. All analyses were done with IS-pro, a clinically 
validated microbiota analysis tool, based on length and sequence variation of 
the 16S-23S interspace (IS) region.
Results In total, 45 vaginally delivered (VD) infants and 32 infants born 
by cesarean section (CS) were included in this study. At week one,  the 
Bacteroidetes  dominant cluster was found only in VD infants (n=27), while 
the  Firmicutes  dominant cluster was present in 18 VD and all CS infants. 
Microbiota of children in settler type B showed a high similarity to gut 
microbiota of their mothers at all time points, while those in settler type F 
showed a low similarity to that of their mothers at all time points. We could show 
that many Bacteroidetes species were transferred from mother to child in settler 
type B, but Alistipes species, present in all mothers, were never acquired by a 
child. Microbiota in settler type F showed a clear effect of feeding type (breast-
fed vs formula-fed), with breast-fed children harboring more  Staphylococcus 
epidermidis than formula-fed children.
Conclusion The neonatal microbiome can be separated into two distinct settler 
types: a Bacteroidetes  and a Firmicutes dominant type. Vaginally delivered 
children can have either settler type, while children delivered by caesarean 
section almost exclusively have settler type F. By classifying children into settler 
types instead of delivery mode, group effects may become clear and associations 
with disease later in life might prove easier to establish.
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Introduction
After birth, the neonatal human intestine rapidly obtains large numbers of 
facultative anaerobes or aerobes, such as Staphylococcus, Enterobacteriaceae, and 
Streptococcus. These microbes are transient and are replaced by a wide variety 
of obligate anaerobes, such as Bifidobacterium, Bacteroides, and Clostridium, in 
a matter of days.1 During the first few months, the diet of the infant almost 
exclusively consists of milk, thereby enabling milk oligosaccharide fermenters, 
such as Bifidobacterium to thrive. Initially, the intestinal microbiota of an 
infant has a low diversity and complexity, but it develops and matures slowly, 
reaching an adult state at around 3 years of age or perhaps somewhat later in 
childhood.2,3 There is  high variability in the profiles of fecal microbiota among 
the infants, being generally dominated by Actinobacteria (mainly the genus 
Bifidobacterium) and Firmicutes (with diverse representation from numerous 
genera).4 The development of intestinal microbiota in neonates is critical, 
since initially present bacteria can modulate the expression of genes in host 
epithelial cells. Furthermore, as has been reviewed extensively, the composition 
of the microbiota is important for the development of the immune system and 
immunological tolerance.1,5–7
Probably the most influential external factor for the development of the infant’s 
microbiome is the mother’s microbiome, due to intimate contacts during 
birth, nursing, and early feeding.2,8,9 The microbes from mother’s mouth and 
skin transfer horizontally to the newborn through several processes from the 
beginning of life.2,8,10,11 During delivery, transmission of microbiota from the 
birth canal and anus occurs from mother to the offspring, but to what extent this 
happens is not clear. In vaginally delivered infants, colonization with maternal 
vaginal and fecal microbes, including lactobacilli and group B streptococci, strongly 
suggests a maternal signature and successful transmission of specific gut 
microbes has been demonstrated in a limited number of bifidobacterial species, 
which were obtained from the feces of both mothers and (vaginally delivered) 
infants.12–14 Gut microbiota of infants delivered by caesarean section strongly 
resembles maternal skin microbes (staphylococci).11,15,16 Moreover, caesarean 
born infants harbor less Bifidobacterium, Escherichia–Shigella and Bacteroides 
species compared to children born vaginally.4,13 Differences in the postnatal 
microbial colonization may explain the higher incidence of immune mediated 
diseases such as allergy in children born by caesarean section as compared with 
those born vaginally.1,17 
Type of feeding after birth also seems to play a role in the colonization process, 
although only minor differences have been noted between breast- and formula-
fed infants over the past years.8 The microbiota of breast-fed neonates is 
dominated by the genera Bifidobacterium and Ruminococcus and low presence of 
clostridia.18 There is evidence for direct inoculation of the infant gut microbiota 
by bacteria present in breast milk (lactobacilli, enterococci and staphylococci), 
while exclusively formula-fed infants have an increased richness of species 
compared with breast-fed neonates and harbor a diverse microbiota including 
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Enterobacteriaceae, Enterococcus and Bacteroides, as well as Bifidobacterium and 
Atopobium18–20 and overrepresentation of Clostridium difficile.4
In our previous study we showed a clear clustering of vaginally born, breast-fed 
infants into two so-called settler types at one week of age: one group of infants 
was Bacteroidetes dominant in their feces, and the other groups microbiota 
consisted mainly of bacteria from the phylum Firmicutes [Chapter 4 of this 
thesis]. The origin of such a clustering, of which Bacteroides dominance has also 
been shown in another study,21 with a small study population, remains to be 
explained. The aim of this study is to further investigate these settler types, 
by comparing gut microbiota composition in term infants, born vaginally (VD) 
or by caesarean section (CS) and who received breast-feeding (BF) or formula 
feeding (FF) during the first 3 months of life. Moreover, a possible relation 
between settler type and maternal microbiota is investigated. 
Patients and Methods
Study design
The women and children included in this study were part of a larger prospective 
cohort study investigating the potential clinical and microbial consequences 
of empiric antibiotic use in early life.22 Study subjects were recruited from the 
maternity wards of four teaching hospitals in the Netherlands. Patients were 
enrolled between January 2012 and March 2014. Parents of term-born infants 
(≥ 36 weeks of gestational age) that stayed in the hospital for at least 24 hours 
were approached for participation in the study. Exclusion criteria were 1. 
Congenital illness or malformations; 2. Severe perinatal infections for which 
transfer to the neonatal intensive care unit was needed; 3. Maternal probiotic 
use ≤ six weeks before delivery and 4. Insufficient knowledge of the Dutch 
language. 
The selected study group comprised 77 healthy women and their infants, divided 
into four groups: 
group A] 24 infants, born by vaginal delivery, breast-fed, 
group B] 21 infants, born by vaginal delivery, formula-fed,  
group C] 24 infants, born by caesarean section, formula-fed, and 
group D] 8 infants born by caesarean section, breast-fed.  
Informed consent was obtained from parents at enrollment. This study was 
approved by the joint Medical Ethics Committee (VCMO, nowadays MEC-U: 
Medical Research Ethics Committees United (Nieuwegein)) and proof of local 
feasibility was given for all participating centers. The study has been performed 
in accordance with the ethical standards laid down in the 1964 Declaration of 
Helsinki and its later amendments. 
Stool sample collection
One stool sample from mother (M), collected within the first week after the 
delivery, was obtained as well as stool samples from the infants at day seven 
(T1), at the end of the first month (T2) and third month (T3). Mother’s stool 
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sample was caught in a tray and infant stool samples were collected from diapers, 
transferred to stool collection vials and immediately frozen in the hospital or 
home freezers (-20 o C). Frozen samples collected at home were transported on 
ice to the hospital and immediately stored upon arrival at -20 o C until further 
analysis. 
Isolation and identification of bacteria
As starting point for DNA isolation from feces, a pea-sized fecal sample (100–
400 mg) was placed in an Eppendorf container. Then, a 500 µl suspension was 
made in nucliSENS lysis buffer, as provided with the easyMAG, an automated 
system for total nucleic acid isolation (bioMérieux Clinical Diagnostics, Marcy 
l’Etoile, France). This suspension was vortexed for 1 minute, shaken for 5 
minutes and subsequently centrifuged at 16,200 g for 2 minutes at room 
temperature. Supernatant (100 μl) was transferred to an 8-welled easyMAG 
container, and 2 ml nucliSENS lysis buffer was added. After incubation at 
room temperature for ≥10 min, 70 μl of magnetic silica beads was added, as 
provided with the easyMAG machine. Afterwards, the mixture was inserted in 
the easyMAG machine and the “specific A” protocol was chosen, selecting the 
off-board workflow and eluting DNA in 110 μl of buffer. Fecal DNA was diluted 
10-fold before use in PCR. All DNA was stored at -20°C. 
16S-23S IS profiling of gut microbiota
Amplification of interspace regions (IS-regions) was performed with the IS-
pro technique (IS-diagnostics, Amsterdam, The Netherlands). This technique 
combines bacterial species differentiation by the length of 16S-23S rDNA 
interspace region with instant taxonomic classification by phylum-specific 
fluorescent labeling of PCR-primers. As described previously, for amplification 
of IS regions  phylum-specific, fluorescent labeled primers were designed, 
corresponding to conserved regions within the 16S rDNA and 23S rDNA.23 The 
procedure consists of two multiplex PCRs: a first PCR has two different fluorescent 
color labeling: one for the phyla Firmicutes, Actinobacteria, Fusobacteria and 
Verrucomicrobia (FAFV) and a second color for the phylum Bacteroidetes. A 
separate PCR is performed for the phylum Proteobacteria. Amplifications were 
carried out on a GeneAmp PCR system 9700 (Applied Biosystems, Foster City, 
CA). Cycling conditions for PCR were 10 cycles of 94°C for 30 s, 67°C to 57°C 
(‘touch down’) for 45 s, 72°C for 1 min; 25 cycles of 94°C for 30 s, 57°C for 
45 s, and 72°C for 1 min; 72°C for 11 min and a final extension at 4°C. Each 
PCR mixture, with a final volume of 25μl, contained 10 μl of buffered DNA, 1x 
superTaq buffer (Applied Biosystems), 200 μM deoxynucleoside triphosphates, 
0.04% BSA, 1 U of superTaq (Applied Biosystems), and 0.13 μM of each of the 
primers.
Data analysis
After pre-processing (IS-pro software suite, IS-diagnostics, Amsterdam, The 
Netherlands), each sample was represented by a microbial profile, consisting 
of color-labeled peaks. Each peak was characterized by a specific IS fragment 
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(measured as nucleotide length) and a color related to a specific phylum group. 
The intensity of peaks reflected the quantity of PCR product (measured in 
relative fluorescence units). We further considered each peak as an operational 
taxonomic unit (OTU) and its corresponding intensity as abundance. Intensity 
values were log2 transformed in order to compact the range of variation in peak 
heights, to reduce the impact of dominant peaks and include less abundant 
species of the microbiota in downstream analyses. This transformation results 
in improved consistency of the estimated correlation coefficient, lower impact 
of inter-run variation, and improved detection of less prominent species. This 
conversion was used in all downstream analyses, such as calculating within-
sample and between-sample microbial diversity. A clustered heat map was 
made by generating a correlation matrix based on cosine correlations of all log2 
transformed profile data followed by clustering with the unweighted pair group 
method with arithmetic mean (UPGMA).24
Diversity analysis and discriminative features selection
Diversity was calculated using the Shannon index25 and differences in this index 
were tested with Mann-Whitney U test. Dissimilarities between samples, or 
between-sample diversity, were calculated using the cosine distance measure 
between each pair of samples’ profiles. Diversity analysis was performed using 
the vegan software package in R (Foundation for Statistical Computing, Vienna, 
Austria) and SPSS (SPSS for Mac release 22.0; SPSS Inc. Chicago, IL, USA). 
Data are shown as median (interquartile range) for continuous variables as 
appropriate. Differences were considered to be significant for p < 0.05.
1 
 
Table 1. Study cohort characteristics
# data available for n=23 mothers. *antibiotic treatment shortly before 3th month stool sample; 
this sample was excluded from the analysis.
BF: breast-fed ;CS: caesarean section; FF: formula fed; VD: vaginally delivered.
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Results
Fecal samples of 77 term infants and their mothers were obtained. 45 infants 
were vaginally born and 32 were born by caesarean section. 32 children were 
exclusively breast-fed and 45 were exclusively bottle-fed. One mother in group 
A received antibiotics during labor (more than four hours before the child was 
born), but antibiotics during labor was not designated an exclusion criterion.  
Participant characteristics are shown in Table 1. Baseline characteristics were not 
statistically different between the groups (groups were compared by ANOVA).
At one week of age, a clear separation into two clusters of neonatal microbiota 
profiles could be made (Figure 1). One cluster was characterized by a high 
abundance of the Bacteroidetes phylum; the other cluster by a high abundance 
of species from the Firmicutes, Actinobacteria, Fusobacteria and Verrucomicrobia 
(FAFV) group. The clusters were coined ‘settler types’ B and F respectively, 
representing the preponderant bacterial phylum. A cutoff at a relative 
abundance of Bacteroidetes at 0.3 (total load of Bacteroidetes/ total bacterial 
load) was used to discriminate between the Bacteroidetes and Firmicutes 
settler type. With only a single exception, Bacteroidetes dominant samples came 
from children who were delivered vaginally. All children who were delivered 
by caesarean section harbored a Firmicutes dominant microbiota. However, a 
significant proportion (40%) of children delivered vaginally also had a Firmicutes 
dominated microbiota, similar to children delivered by caesarean section.
To investigate whether children with different settler types differed in microbiota 
development over time, the microbial composition at the three time points were 
explored per settler type (Figure 2 and 3). 
In this analysis it became apparent that settler types were the main driving force 
of separation of microbial samples in a principal coordinate analysis (PCoA). 
This effect was most outspoken at week 1, but remained evident at 1 month 
and 3 months of age. At each time point, the abundance of Bacteroidetes and 
FAFV group differed significantly between the two settler types (p<0,005 at all 
time points), while abundance of Proteobacteria was the same for the two groups 
(figure 4). The Shannon diversity of Bacteroidetes and FAFV group also differed 
significantly between the settler types (p<0,005 at all time points). Bacteroidetes 
were most abundant and had highest diversity in settler type B, while FAFV 
group had  the highest abundance and diversity in settler type F.  Total diversity 
was significantly lower in settler type F at T=2 and T=3 (p<0,05). Proteobacteria 
diversity did not differ between groups. In settler type F, Bacteroidetes did 
increase in abundance and diversity over time, but they did not reach the levels 
of settler type B in three months of time. 
Thus, while some microbiota profiles of children with settler type F appeared 
more similar to microbiota profiles of children with settler type B after three 
months, in the PCoA analysis abundance and diversity analysis showed that at 
group level microbial compositions still differed significantly. However, there 
also appears to be some convergence of microbiota profiles on group level: 
abundance and diversity of Bacteroidetes increase over time in settler type F, 
while FAFV abundance and diversity decrease. At the same time FAFV diversity 
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Bacteroidetes FAFV
Vaginal delivery
min max
Cesarian section
Bacteroidetes settler type
Firmicutes settler type 
Bacteroidetes
FAFV
Figure 1. Heat map of samples of all children at T=1 (one week). A clear clustering of infant 
microbiota into a Bacteroidetes dominant (above) and Firmicutes dominant cluster (below) can 
be seen at one week of age.
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increases in settler type B, towards a value similar to that of settler type F. 
Hence, while microbiota composition is significantly different at all time points 
for settler type B and F, there does seem to be some convergence towards a 
similar microbiota over time.
Stability of the population, expressed as cosine distance, also differed per 
settler type (figure 4). Lower values in this respect mean higher stability of the 
population over time. Cosine values of all phyla combined, as well as cosine 
values of Bacteroidetes, were lower at all time points in settler type B compared 
to settler type F. This implies that settler type B microbiota is more stable in the 
first 3 months of life than settler type F at the level of Bacteroidetes as well as for 
the total microbial population.
Finally, maternal stool samples were analyzed to investigate the extent of vertical 
transmission of microbiota from mother to child and to explore whether the 
maternal gut microbiota has impact on the neonatal settler type. By performing 
a principal coordinate analysis (PCoA) of all maternal and infant samples, it 
became apparent that the most important drivers separating samples were 
origin (maternal vs infant) and settler type (Figure 5). Maternal samples all 
clustered together, regardless of the settler type of the child and infant samples 
clustered together per settler type. Clustering of infant samples per settler type 
remained apparent at all time points. 
By performing analyses per settler type, group effects become clear. Children 
in settler type B showed a higher similarity to gut microbiota of their mothers 
at all time points compared to children in settler type F, in particular for the 
phylum Bacteroidetes. However, similarity to other mothers than their own was 
correspondingly high for children in settler type B. Two reasons turned out 
to be responsible for this phenomenon: firstly, not all species from maternal 
microbiota are transferred successfully to infants. This is especially apparent 
for Alistipes spp, that are present in all mothers, but in none of the infants 
at one week of age. Secondly, some species are present in most mothers 
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Figure 2. PCoA analysis of intestinal microbiota of all children at week 1 (T=1), 
month 1 (T=2) and month 3 (T=3). Samples are colored by settler type. 
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and are particularly likely to be transferred from mother to child, such as 
Bacteroides vulgatus and Bacteroides fragilis (Figure 6). It can also be seen that 
children harbor some species that apparently are undetectable in the maternal 
microbiota. These may be species with low abundance in mothers that became 
successful settlers in the infant’s microbiota, or these species may derive from 
a different environmental source. Taken together, these effects render mothers 
and children distinct groups, with similarity between members of the two 
groups comparable for all individuals. However, when studying individual cases 
as shown in figure 6, it can be seen that children in settler type B often seem to 
inherit selected bacterial species from their mothers gut microbiota.
However, differences can be seen in the composition of the FAFV cluster in 
both settler types, when investigating dominant species. Settler type F is, at 
one week of age, dominated by Staphylococcus epidermidis, Streptococcus mitis 
and Streptococcus salivarius, common members of oropharyngeal and skin 
microbiota. With time, the predominance of these species decreases, and those 
are at the same time replaced by a diverse panel of bacterial species. 
The type of feeding, breast- or formula-feeding did not result in significant 
differences at the phylum level (vaginally delivered, breast- versus formula 
feeding (A-B) and caesarean section, formula versus breast-feeding (C-D)). This 
may have been due to the small group sizes and/or subtle differences that were 
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Figure 3. Abundance (left) and diversity (right) per phylum for all time points per settler type. 
1 week (T=1), 1 month (T=2) and 3 months (T=3) of age.
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not detected by the technique applied. Further analysis revealed that settler 
types were not determined by feeding type; the numbers of infants breast- and 
formula fed were distributed evenly between settler type B and F. However, 
in settler type F, an effect of feeding type was shown, with breast-fed children 
harboring more Staphylococcus epidermidis compared to formula fed children. 
Formula-fed children acquired higher numbers of Enterococcus faecalis over time. 
Discussion
In this study gut microbiota composition during the first 3 months of life of 
healthy term infants, receiving breast-feeding or formula-feeding who were 
born vaginally or by caesarean section, was characterized. At one week of age a 
clear separation into two clusters of neonatal microbiota profiles, as shown in 
our previous study [Chapter 4 of this thesis], could be confirmed. The emergence 
and development of the so-called settler types, in which Bacteroidetes (settler 
type B) or Firmicutes, Actinobacteria, Fusobacteria and Verrucomicrobia (FAFV) 
(settler type F) are highly abundant, was explored. Importantly, we found that 
only vaginally delivered children had settler type B. Children born by cesarean 
section all had settler type F. However, 40% of vaginally delivered children also 
had settler type F. 
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Figure 4. Stability analysis of neonatal gut microbiota per settler type. 
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Moreover, the potential relation between settler type and maternal microbiota 
was investigated. It was shown before that infants are rapidly colonized by 
microbes from different environments they are exposed to shortly after birth, 
and that the mode of delivery is very determinative in this context.21,26,27 In 
vaginal delivery, the child being born has an extensive opportunity to acquire 
its mother’s vaginal and fecal microbiota.12,14,18 Although there have been 
suggestions that the ingestion of amniotic fluid allows some colonization of 
the infant’s gut in utero, infants born by caesarean section have no access to 
the mother’s (vaginal and fecal) microbiota.11,14,29 Gut microbiota of caesarean 
delivered infants strongly resembles skin microbes, suggested to be derived from 
their mother and caregivers/hospital staff,11,15,16 but also from microbes coming 
from operating rooms: it was recently shown that bacterial content of operating 
room dust corresponded to human skin bacteria.30 Vertical transmission of 
microbes from mother to infant thus especially takes place during vaginal 
delivery. However, the data presented in this study indicate that a substantial 
number (40%) of vaginally delivered children have an initial microbiota very 
similar to that of children delivered by caesarean section. They share the 
underrepresentation of Bacteroides species. Literature shows that microbiota 
of infants delivered by caesarean section remains more heterogeneous over 
time compared to the vaginally born infants, and Bacteroides spp in particular 
are less prevalent or missing in the caesarean section-delivered newborns.14 
This study demonstrated that settler type was the main driver of separation 
of microbiota composition at one week of age, expressed as high versus low 
abundance and diversity of Bacteroidetes phylum members. Interestingly, 
settler type B (Bacteroidetes species dominant) consists exclusively of vaginally 
delivered children, while settler type F (mainly species of the Firmicutes phylum 
A B
Settler type F (infant) Settler type B (infant)Settler type F (mother) Settler type B (mother)
Figure 5. Principal Coordinate Analysis (PCoA) of samples from mothers and children colored by 
neonatal settler type. Main drivers of separation are origin of the samples (maternal or infant) and 
infant settler type. Maternal samples cluster together regardless of the child’s settler type. Settler 
types cluster together at T=1 (panel A), but also when all time points are compared (panel B).
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dominant) consists of children delivered vaginally and by caesarean section. 
Based on the present data, we hypothesize that not delivery mode per se has the 
greatest impact on initial development of the microbiota, but that exposition 
to maternal fecal microbiota during delivery is a prerequisite for acquisition of 
Bacteroidetes dominant microbiota. The importance of the mother’s intestine 
as source for the for the transmission of specific Bifidobacterium strains was 
shown before.12 Group effects became clear by classifying children according to 
the assigned settler types, and subsequent studies on development of disease 
later in life might turn out to be easier to establish by this classification. Next 
to exposure to maternal microbiota, other characteristics of and around the 
delivery process may play a role regarding settler type determination and/or the 
degree of mother-to-infant transmission of microbes. Because epidemiological 
evidence suggests that acquiring bacteria from the Bacteroidetes phylum (both 
abundance and diversity of these species) is associated with a lower risk of asthma 
and allergic diseases as well as type 1 diabetes,31-34 the specific conditions during 
labor and delivery may be important: duration of ruptured membranes, total 
duration of delivery, maternal bowel movements during labor, and environment 
(home versus hospital (delivery room, operating room), to name a few. At 
present we don’t have sufficient detailed data on those conditions for this group 
of vaginally delivered children, but are currently investigating those conditions. 
They could be part of an updated version of the original “hygiene hypothesis”, 
which associated increased proportion of people affected by allergic diseases 
with differences in diet or in childhood exposure to microbes and allergens.35 
Accordingly, it was shown that increased exposure to microbial compounds has 
to occur early in life to affect maturation of the immune system and thereby 
reduces risk for development of allergic diseases.36 The impact of the present 
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study for the hygiene hypothesis would be that not vaginal versus caesarean 
delivery as such, but exposure to vaginal, and particularly fecal microbiota 
during vaginal delivery would have far-reaching long-term consequences. 
Future investigations should elucidate this possibility. 
Over a course of three months the separation into clusters remained, though 
some children with settler type F moved towards settler type B children. This 
merging was caused by the acquisition of Bacteroidetes by settler type F children; 
Bacteroidetes did increase in abundance and diversity over time, but they did not 
reach the levels of settler type B in three months of time. The difference between 
an infantile versus adult-like microbial composition in general was confirmed 
in this study, as maternal samples cluster together regardless of the child’s 
microbiota (that clustered together based on settler type). The development of 
the gut microbiota continues during the first years of life and its composition 
is considered to resemble the adult gastrointestinal tract by the age of 3 or 
somewhat later in childhood.3,26   
When comparing microbiota composition of mothers and infants, transmission 
of Bacteroidetes from fecal microbiota from mother to child seems to determine 
infant settler type: when transmission takes place, children develop settler 
type B, but when transmission does not take place, children develop settler 
type F. Children in settler type B show a higher similarity to gut microbiota 
(Bacteroidetes) of their mothers at all time points, while those in settler type F 
show a lower similarity to that of their mothers at all time points. Interestingly, 
microbiota similarity was not significantly higher for mother-child pairs than 
for children compared to unrelated mothers. This effect was largely caused by 
the fact that only a limited number of Bacteroidetes species were transferred 
from mother to child; some species that were present in all mothers were never 
transferred to the child, such as Alistipes species, while other species that were 
commonly present in high abundance in mothers, such as B. vulgatus and B. 
fragilis, seemed to be transferred preferentially to children. Furthermore, 
infants also harbor species that were not detected in the maternal microbiota. 
These may be species with low abundance in mothers that became dominant in 
the infant’s microbiota, or they may possibly originate from other body sites 
or the environment. This was shown before and a decline over time may reflect 
reduced fitness to persist in the human gut.14
Results presented here confirm data from literature that demonstrated only 
minor differences in microbiota composition in breast- and formula-fed 
infants.8,37,38 Feeding type thus does not seem to be one of the dominating 
factors involved in gut microbiota maturation, at least of less importance than 
settler type. An effect of feeding type that could be shown in infants with 
settler type F was breast-fed children harboring more Staphylococcus epidermidis 
compared to formula fed children, who acquire higher amounts of Enterococcus 
faecalis over time. Our results are in accordance with literature showing typical 
inhabitants of the human skin to be dominant members with longer residence 
time in breast-fed infants,39 and with our own data describing Streptococcus 
and Enterococcus species being discriminatory signature taxa associated with 
formula feeding (chapter 2 of this thesis). Possibly the relatively less robust 
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microbiota of infants belonging to settler type F, compared to those of settler 
type B, was more susceptible to subtle changes caused by feeding type.
The fairly high number of healthy, term infants included in this study is a 
strength of the study as it allowed thorough analyses of the progression of 
bacterial colonization in the gastrointestinal tract during the first 3 months 
of life. Although the initial process of colonization is known to be dynamic 
and complex, clustering into settler types at one week of age could be clearly 
demonstrated. This study also has a few limitations. First, IS-pro consists of two 
separate PCRs. One for amplification of Bacteroidetes and FAFV and a second for 
Proteobacteria. This precludes direct comparison of abundances of Proteobacteria 
to Bacteroidetes and FAFV. Furthermore, IS-pro does not generate 16S sequence 
data but instead amplifies the 16S-23S IS region for bacterial identification. 
While IS-pro can generally differentiate bacterial taxa to species level, direct 
comparison to results of other studies performed with 16S sequencing may 
be less straightforward. However, the IS-pro technique has been extensively 
validated for reproducibility on fecal samples and has been shown to correlate 
well to sequence data.23,40 Secondly, there may have been differences in storage 
conditions between samples, because all samples were obtained by parents 
and stored in their home freezers. Parents, however, were clearly instructed on 
how to collect and store the samples, so we assume no major influence on fecal 
compositions.
Conclusion 
The neonatal microbiome can be separated into two distinct settler types: 
a Bacteroidetes  (settler type B) and a Firmicutes/ Actinobacteria/ Fusobacteria/ 
Verrucomicrobia (settler type F) dominant type. Vaginally delivered children can 
have either settler type, while children delivered by caesarean section almost 
exclusively have settler type F. By classifying children into settler types instead 
of delivery mode, group effects may become more clear and associations with 
disease later in life might prove easier to establish. Future studies should focus 
on establishing the presence of these settler types and factors associated with 
settler type development as long-term consequences remain unknown up to 
now. 
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Abstract
Numerous diseases linked to microbial imbalance can be traced back to 
childhood, illustrating the impact of the juvenile microbiota development from 
infancy toward adulthood. However, knowledge on this subject is currently 
very limited. The primary aim of this study was to characterize composition 
and short- and long-term stability of the intestinal microbiota in healthy 
children. Between November 2011 and June 2014, 61 children 2 to 18 yr of 
age from different areas in The Netherlands were included and instructed to 
collect fecal samples weekly, for 6 wk, and a follow up sample after 18 mo. The 
intergenic spacer profiling technique (IS-pro) was used to analyze all available 
fecal samples. Microbial diversity was calculated by the Shannon diversity index 
and individual compositional stability by comparing all collection time points. 
Microbial stability varied per phylum (P <  0.0005), declined rapidly in a short 
time period, and subsequently stabilized on the long run with very gradual 
variation, leading to an overall compositional stability of 70% on average over 
a period of 18 mo. Higher species diversity was correlated to a higher overall 
compositional stability (P <  0.001). We observed an age-independent bacterial 
shared core consisting of a limited number of species. In conclusion, in this 
study, we showed that microbial composition stability in children varied per 
phylum, at both short-term and long-term intervals. Healthy children seem to 
share a microbiome core consisting of a limited number of species.
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Introduction
The human body harbors trillions of microbes belonging to hundreds of 
different species, of which the vast majority reside in the gastrointestinal tract. 
Investigation into the pathophysiologic significance of our microbial symbionts 
has only recently been boosted by new DNA-based detection methods. It has 
become clear that the intestinal microbiota plays a crucial role in maintaining 
intestinal and overall health, including nutrient digestion and regulation of host 
metabolism and immune system 1– 4. Disruption of the homeostasis between 
the gut microbiota and host has been linked to gastrointestinal and systemic 
diseases, such as inflammatory bowel disease, necrotizing enterocolitis, atopy, 
autoimmune diseases, and obesity 5– 9. These observations have reinforced the 
potential of microbiota characterization as a diagnostic biomarker for health 
and disease, opening avenues toward development of novel, microbiota-
targeted preventative and therapeutic strategies. For recognition of disease-
specific microbial patterns and assessment of their role in (the course of) 
disease, detailed understanding of the intestinal microbiota in terms of 
composition and physiologic temporal variations is essential (10). Current 
knowledge on composition and dynamics of the human gut microbiota is 
limited, methodologically inconsistent, and largely based on studies in adults, 
describing a fairly stable composition over time. Studies on composition and 
temporal stability in children have almost exclusively focused on the first years 
of life, a period characterized by a highly dynamic and shifting intraindividual 
bacterial composition 11– 13. Information on the development and stability of the 
microbiota from infancy toward adulthood is yet very limited.
The fact that numerous diseases linked to microbial imbalance can be traced 
back to this specific period illustrates the importance and impact of the juvenile 
microbiota 14– 16. Characterization of the normal microbiota in children and its 
development from infancy toward adulthood is central to enlarge knowledge 
about microbiota-related pathology.
The primary aim of this study was to characterize composition and short-term 
and long-term stability of the intestinal microbiota in healthy childrenfrom2 to 
18 yr of age.
Materials and methods
Subjects and study design
A heterogeneous cohort of healthy Dutch children was included to form a fair 
presentation of the general (young) population. For this purpose, we invited 
children in the age of 2-18 years, visiting primary and secondary schools in both 
urban and rural areas in five different provinces of the Netherlands (Noord-
Holland, Zuid-Holland, Overijssel, Friesland, Flevoland) to participate. To focus 
exclusively on temporal gut microbiota dynamics during state of health, strict 
criteria for exclusion were applied: use of antibiotics or immune modulating 
agents within six months prior to the study, culture-proven infectious 
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gastroenteritis in the last six months prior to inclusion, history of surgery of 
the gastro-intestinal tract (except appendectomy), or a diagnosis of chronic 
gastro-intestinal disease, such as celiac disease, functional constipation, short 
bowel syndrome or inflammatory bowel disease. Subjects (or their parents) 
completed a questionnaire on the following items: age, length and weight, 
pregnancy duration, way of delivery, type of neonatal feeding (breastfeeding or 
formula feeding), use of antibiotics in first year of life, current medication, and 
defecation pattern. This study was approved by the Medical Ethics Committee 
of VU University Medical Center and was performed in accordance with the 
ethical standards laid down in the 1964 Declaration of Helsinki and its later 
amendments.
Sample size calculation
A formal power analysis could not be performed for this study since no previous 
data on microbiota stability in healthy children were available.
   
Sampling
Sterile plastic containers and an information letter were provided to parents 
and children, with instructions on procedure of collection and storage of 
the fecal samples. Children (or their parents) were instructed to collect fecal 
samples (approximately two grams) during six weeks at weekly sampling 
intervals, and a follow-up sample after eighteen months. Fresh fecal samples 
were immediately stored in the freezer at home at -20°C. For collection of 
the eighteen months follow up samples, parents were contacted by telephone 
or e-mail. Non-responders received a maximum of 2 reminders. At time of 
collection of the follow-up fecal sample, information was obtained on use of 
antibiotics and major changes in health status during the past 18 months, 
such as a diagnosis of (chronic) gastro-intestinal disease. DNA extraction was 
performed after collection of those frozen fecal samples collected at weekly 
intervals, DNA extraction of the follow-up samples was performed within three 
months following collection. 
DNA extraction and sample preparation
DNA was extracted from fecal samples with the easyMAG extraction kit 
according to the manufacturer’s instructions (Biomérieux, Marcy l’Etoile, 
France). One hundred to 400mg of feces was placed in an Eppendorf tube with 
200 ml of nucliSens lysis buffer and vortexed. Tubes were incubated while 
shaking for 5 min at room temperature. After centrifugation (13,000 rpm; 2 
min), 100 ml supernatant was transferred to an easyMAG isolation container 
containing 2 ml nucliSENS lysis buffer. This suspension was incubated for 10 
min at room temperature, after which 70 ml of magnetic silica beads were 
added. The easyMAG automated DNA isolation machine was used following 
the “specific A” protocol, eluting DNA in 110 ml buffer. All fecal samples were 
analyzed by intergenic spacer profiling (IS-pro), and the first samples collected 
(baseline samples) were also analyzed by 454-pyrosequencing 17.
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IS-Pro
For IS-pro, DNA samples were diluted 1:10. Amplification of IS regions was 
performed with the IS-pro assay (IS-Diagnostics, Amsterdam, The Netherlands) 
according to the protocol provided by the manufacturer. IS-pro differentiates 
bacterial species by the length of the 16S–23S rDNA IS region with taxonomic 
classification by phylum-specific fluorescently labeled PCR primers 17. 
The procedure consists of 2 PCR reactions, together covering the phyla 
Firmicutes, Actinobacteria, Fusobacteria, Verrucomicrobia, Bacteroidetes, 
and Proteobacteria. The first PCR reaction contains 2 different fluorescently 
labeled forward primers and 3 unlabeled reverse primers. The first forward 
primer is specific for the phyla Firmicutes, Actinobacteria, Fusobacteria, and 
Verrucomicrobia (FAFV), and the other labeled forward primer is specific for 
the phylum Bacteroidetes. The second PCR contains a forward-labeled primer 
specific for the phylum Proteobacteria and a combination of 7 reverse primers, 
together covering the phylum Proteobacteria. The IS-pro primers have been 
extensively evaluated for coverage of the various phyla included in the assay. An 
in silico analysis was performed on all 16S–23S sequences available at GenBank 
in April 2014 (8990 sequences). Here, matches for both forward and reverse 
primers were found in 95% of Firmicutes (3129/3303), 99% of Actinobacteria 
(814/815), 88% Bacteroidetes (245/280), and 98% of Proteobacteria sequences 
(3714/3803). Furthermore, to confirm in silico results and to evaluate 
reproducibility of IS profiles within species, IS-pro reactions were performed on 
588 cultured bacterial strains, belonging to 189 species from the phyla covered 
by the IS-pro primers. These findings confirmed in silico predictions. The data 
from the in silico and in vitro analyses were combined to form a database used 
in translation of profiles to species names. Amplifications were carried out on a 
GeneAmp PCR system9700 (Applied Biosystems, Foster City, CA, USA). After 
PCR, 5 ml PCR product was mixed with 20 ml formamide and 0.2 ml custom 
size marker (IS-Diagnostics). DNA fragment analysis was performed on an ABI 
Prism 3500GeneticAnalyzer (Applied Biosystems).
454 Pyrosequencing
Amplicon libraries for pyrosequencing of the 16S rDNA V1–V3 regions 
were generated using 2 primers: the first primer was a barcoded reverse 
primer consisting of the 454 Titanium platform A linker sequence 
(59-CCATCCCTGCGTGTCTCCGACTCAG-39), a key (barcode of 6–8 
nt as described by the HMP consortium in http://www.hmpdacc.org/
doc/16S_Sequencing_SOP_4.2.2.pdf) that was unique for each sample, 
and the 16S rRNA 534R primer sequence 59-ATTACCGCGGCTGCTGG-39. 
The second primer was a forward primer consisting of a 9:1 mixture 
of 2 oligonucleotides, 59-B AGAGTTTGATCMTGGCTCAG-39 and 
59-BAGGGTTCGATTCTGGCTCAG- 39, where B represents the B linker 
(59-CCTATCCCCTGTGTGCCTTGGCAGTCTCAG-39) followed by the 16S rRNA 
8F and 8F-Bif primers, respectively 18. 
PCR amplifications (in a volume of 50 mL) were performed using 13FastStart 
High Fidelity Reaction Buffer, 1.8mMMgCl2, 1 mM dNTP solution, 5 U 
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FastStart High Fidelity Blend Polymerase (from the High Fidelity PCR System; 
Roche, Indianapolis, IN, USA), 0.2mMreverse primer, 0.2 mM of the barcoded 
forward primer (unique for each sample), and 1 mL of template DNA. PCR cycle 
conditions were as follows: an initial denaturation at 94°C for 3 min, followed 
by 25 cycles of denaturation at 94°C for 30 s, annealing at 51°C for 45 s, and 
extension at 72°C for 5 min, and a final elongation step at 72°C for 10 min. 
Amplicons (20 mL) were purified using AMPure XP purification (Beckman 
Coulter, Beverly, MA, USA) according to the manufacturer’s instructions 
and eluted in 25ml TE buffer 13 solution, pH 8.0, and low EDTA. Amplicon 
concentrations were determined by the Quant-iT PicoGreen dsDNA reagent 
kit (Thermo Fisher Scientific, Grand Island NY, USA) using a Victor3 Multilabel 
Counter (Perkin Elmer, Waltham, MA, USA). Amplicons were mixed in equimolar 
concentrations. 454-Sequencing was performed on a GS FLX Titanium PicoTiter 
Plate with a GS FLX pyrosequencing system (Roche, Branford, CT, USA).
Data analysis
IS-pro
Preprocessing was carried out with the IS-Pro proprietary software suite (IS-
Diagnostics) and resulted in microbial profiles. Three levels of information were 
obtained: color of peaks sorts species into the phyla FAFV, Bacteroidetes, and 
Proteobacteria, which are the main phyla present in the human gastrointestinal 
tract. Length of the 16S–23S rDNA IS region, displayed by number of 
nucleotides, can subsequently be used to identify bacteria at the species level. 
Specific peak height, measured in relative fluorescence units, reflect the quantity 
of PCR product. To further analyze the obtained data, each peak in a profile 
was considered as an operational taxonomic unit (OTU) and its corresponding 
intensity as its abundance. Species determination of IS-pro peaks was done 
by matching of profiles to a database of IS profiles of known bacterial species. 
In previous analyses, the effect of sampling on IS profiles was assessed. The 
correlation of profiles from samples of the same excrement was found to be 
96% for Bacteroidetes and 90% for FAFV 17.
454 pyrosequencing
Raw pyrosequencing reads were passed through quality filters to reduce the 
overall error rate using Mothur version 1.23 (19). Only sequences with perfect 
proximal primer fidelity and a threshold quality score of $20, a read length 
between 200 and 540 nucleotides, a maximum of 1 ambiguous base call, and 
a maximum homopolymer length of 6 were retained for further analysis. Data 
processing was done with Quantitative Insights Into Microbial Ecology, version 
1.5.1 (20). Barcodes were used to identify sequences from each individual sample. 
The UCLUST algorithm was used to cluster sequences into OTUs or phylotypes 
based on 97% similarity (species level) against the Greengenes reference set 
(21). The following non default search parameters for Uclust algorithm were 
applied: maxrejects = 100 and stepwords = 16. Creation of new clusters for 
sequences that did not cluster to reference sequences within the given similarity 
threshold was disabled to further reduce the influence of pyrosequencing errors. 
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Finally, OTUs that were only recovered in a single sample were removed from 
the dataset. In total, 1,403,456 sequences were recovered from454 sequencing. 
After trimming, filtering, binning, and clustering, 722,109 sequences (mean 
length 6 SD: 326 6 76.1 bases), ranging from 6195 to 18,662 sequences per 
sample, remained for further analysis. For downstream analyses, data were 
rarefied at a sequencing depth of 6195 sequences per sample.
Diversity and stability analysis
Diversity and stability analysis was performed on the IS-pro data. Microbial 
diversity was calculated as the Shannon diversity index based on the resulting 
profiles by conventional statistics. Diversity was calculated both per phylum and 
for overall microbial composition (by pooling the phyla FAFV, Bacteroidetes, and 
Proteobacteria together). Diversity analysis was performed with the R 2.15.2 
software package. Data visualizations and fitted curves were done with the 
Spotfire software package (Tibco, Palo Alto, CA, USA).In this study, compositional 
stability is defined as intra individual resistance to change in relative abundances 
of species over time, quantified by cosine distance (lower distance value 
represents higher stability), and expressed as a percentage value (e.g., when 2 
fecal samples of 1 individual collected over time would have identical microbial 
composition, compositional stability is 100%). The compositional stability of fecal 
microbiota of children through time was estimated by comparing all intervals 
per individual (i.e., for 1 week stability, all 1-wk intervals were compared; for 
2-wk stability, all 2-wk intervals were compared and so on). For 18 mo stability, 
the follow-up sample was compared with all other samples to minimize impact 
of potential outliers on this analysis. Sample compositions were compared by 
calculating cosine distances for log2-transformed data per phylum and for the 
phyla FAFV, Bacteroidetes, and Proteobacteria combined 17. Multivariate ANOVA 
was performed, when appropriate using a Greenhouse-Geisser correction, taking 
time and phylum as within-subject variables. Dissimilarities between samples, 
or between-sample diversity, were represented in a dissimilarity matrix that was 
built using the cosine distance measure. Given 2 vectors of attributes (2 profiles 
in our case), A and B, the cosine dissimilarity is represented using a dot product 
and magnitude as 
dissimilarity      =        
Network analysis
To analyze the potential presence of a microbial core at the level of OTU, a concept 
defined as a fixed set of bacterial species present in more than 80% of all healthy 
children, a network visualization approach was taken. An anchored bipartite 
network was generated from all IS-pro data 22. Samples were represented as 
anchored nodes in a circular layout and bacterial OTUs as unanchored nodes 
for which the position was calculated as the center of mass of all connected 
sample nodes. Edges were created between a sample and an OTU node when that 
particular OUT was present in that particular sample. OTUs that were present 
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in only a single sample were placed outside the circle of anchored sample nodes. 
The network visualization was made in Cytoscape 3.1.0 23. For this particular 
visualization, a custom plugin was made (available “as is” as Supplemental 
Data).The color of nodes was determined by degree and the size by betweenness 
centrality 24. Finally, edges were bundled with the “bundle edges” plugin. 
Parameters were as follows: number of handles, 3; Spring constant, 0.003; 
compatibility threshold, 0.3; maximum iterations. For an illustrated step-by-step 
description of how the network was built, we refer to Supplemental Methods.
Results
Participants
Between November 2011 and June 2014, sixty-one children were included 
in this study; each child collected one fecal sample a week, during six weeks.  
1 
 
 
 
 
 
 
 
 
Table 1. Subject characteristics
BMI, body mass index; IQR, interquartile range. aUrban area includes towns and cities; children from 
agriculture origin live on a farm.
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Forty-five children also collected a follow up sample after eighteen months. 
None of the children and parents reported relevant changes in health state 
between collection of first samples and follow-up sample, two children used 
antibiotics for a respiratory tract infection. All children reported a normal 
defecation patterns with more than three bowel movements per week. All 
parents were born in western Europe, except for three couples with diverse 
background (South Korea, Aruba and Peru). Characteristics of the participants 
are summarized in Table 1.
Diversity and Stability
Microbial compositional stability through time varied per time point (P < 
0.0005) and per phylum (P < 0.0005), with Bacteroidetes showing the highest 
compositional stability, followed by Proteobacteria and FAFV. Stability declined 
quite rapidly for short intervals, but then stabilized at a level that declined 
further only very gradually. P values for longitudinal decrease were 3.41 X 1027 
for Proteobacteria, 5.32 X 1019 for Firmicutes, and 1.33 X 1014 for Bacteroidetes. 
Overall compositional stability was on average 70% over a period of 18 mo 
(Fig. 1). Also at the level of the individual, it was found that Bacteroidetes 
composition was most stable, whereas the compositional stability of FAFV 
and Proteobacteria was lower on average. Finally, there seemed to be a slight 
increase in compositional stability with age, but this effect was not statistically 
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Fig. 1. Compositional stability of fecal microbiota of children through time. Dots represent 
median cosine distance of microbiota composition (y axis) per time interval (x axis). Microbiota 
stability declined quite rapidly for short intervals, but then stabilized at a level that declined 
further only very gradually, with the highest stability for phylum Bacteroidetes (red), followed 
by Protebacteria (yellow), and FAFV (blue). Overall compositional stability is depicted in green.
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significant (Fig. 2A). The identified variations in microbiota composition 
through time far exceeded the expected variation induced by multiple testing 
(i.e., taking a sample from the same source twice and performing the whole 
analysis procedure twice, from DNA isolation to final data analysis), indicating 
that the measured effect was indeed temporal variation.
Diversity of fecal samples was highest for the phylum Bacteroidetes with a 
median Shannon diversity index of 2.81, followed by the phyla Proteobacteria 
(2.62) and FAFV (2.46) at baseline. Stability of diversity indices over time 
was also assessed and was found to be highest for the phylum Bacteroidetes 
(Fig. 3). Diversity index for the phyla FAFV and Proteobacteria appeared to be 
more variable over time. A further assessment was done to analyze microbial 
diversity, its stability, and relation to age on an individual level. The results 
are shown in Fig. 2B. Here, diversity was highest and most stable over time 
for the phylum Bacteroidetes. For the phyla FAFV and Proteobacteria, median 
diversity indices and individual variation were much larger than for the phylum 
Bacteroidetes.
Importantly, compositional stability and stability of diversity of the measured 
phyla FAFV, Bacteroidetes, and Proteobacteria were highly individual specific. A 
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Fig. 2. Individualized analyses on IS-pro data for the phyla Bacteroidetes (red), FAFV (blue), 
Proteobacteria (yellow), and all phyla (green), sorted by age (in years, x axis). Dots represent 
median values of all samples from a given child, except the 18 mo follow-up sample, plotted as 
function of age in years. Error bars represent interquartile range (IQR). A) Compositional stability 
per child sorted by age as expressed by cosine distance between sequential samples (lower values 
represent higher stability). Compositional stability was highest for Bacteroidetes, whereas 
the stability for the other phyla appeared more individualized: especially in younger children, 
interindividual variation in stability of FAFV and Proteobacteria was high. B) Diversity was 
highest and most stable afor the phylum Bacteroidetes. For the phyla FAFV and Proteobacteria, 
diversity indices had a larger distribution and were less stable.
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higher diversity was correlated with higher stability for these phyla separately 
and for the combined microbiota. Also, higher diversity was correlated to a 
higher stability of the diversity index (Fig. 4). Children exposed to antibiotics 
in their first year of lifehad similar Shannon diversity indices compared with 
unexposed children (data not shown).
When allocating children to 1 of 3 defined age groups (blocks of 5 yr: from 2 to 
7 yr of age; from 8 to 13 yr; and from 13 to 18 yr), no statistically significant 
differences were observed in composition, stability, and diversity between these 
3 age cohorts with an unpaired Student’s t test. Furthermore, no particular 
clustering was seen based on sex.
Microbiota core 
In the network analysis, a bacterial core consisting of species that were present 
in the fecal samples of the majority of children became apparent (Fig. 5). This 
core was dominated by species from the phylum Bacteroidetes, with the genera 
Bacteroides and Alistipes having the highest average abundances. From the 
phylum Firmicutes, the families Ruminococcacaea and Lachnospiraceae were 
Most dominant. The presence and identity of this shared core was confirmed 
in all baseline samples with 454-pyrosequencing (Fig. 6). Table 2 summarizes 
the most abundant OTUs in 454 data (present in .70% of all subjects) and their 
matching to the most common species as found with IS-pro. Figure 7 represents 
IS-pro and 454-sequencing data of the most abundant taxa at the family level, 
including their relative abundance. 
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Fig. 3. Boxplot of Shannon diversity indices at different time points (T1–6 correspond with 
sampling number in weeks, T7 is follow-up at 18 months). Bacteroidetes had the highest and most 
stable diversity at all time points, followed by Proteobacteria and FAFV. Distribution of diversity 
was considerably larger for the latter phyla than for Bacteroidetes. Notably, at T7, Bacteroidetes 
diversity seemed to be increased for all children.
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Discussion
In this study, we showed that microbial composition stability in children 
is individualized and varied per phylum at both short-term and long-term 
intervals. This was consistent throughout all age cohorts of youth. Diversity 
and stability for all bacterial phyla were correlated: diversity of the phylum 
Bacteroidetes was highest, and this phylum also showed the highest stability 
compared with the phyla Proteobacteria and FAFV. Finally, we observed the 
presence of a shared microbial core, consisting of a limited number of species 
that was present in the majority of healthy children.
Dynamics
Human gut microbiota stability patterns were first described in 1998 by Zoetendal 
et al. 25. They showed that the composition of the gut microbiota of  2 adults 
remained fairly stable over a course of months. Subsequent studies confirmed 
the existence of relatively stable, host dependent microbiota, characterized by 
prominent fluctuations around the average, at both species and phylum levels 
26– 34. However, this generally stable course has been shown to be affected by 
lifestyle and major events in human life, such as dietary alterations, enteric 
infections, and traveling from the developed to the developing world, which could 
rapidly and profoundly impact microbiota dynamics 35. More recently, 2 studies 
including 5 and 37 healthy adults, respectively, showed that stability of the gut 
microbiota differed per phylum 36, 37. In adults, the composition of Bacteroidetes 
and Actinobacteria was more stable and that of Proteobacteria was less stable 
over time compared with overall stability. Firmicutes showed a more variable 
All phyla Bacteroidetes FAFV Proteobacteria
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.8
0.6
0.4
0.2
1.2
1.0
0.8
0.6
0.4
0.2
2.8 3.0 3.2 3.4 3.6 3.8 4.0 2.4 2.5 2.6 2.7 2.8 2.9 3.0 3.1 3.2 1.0 1.4 1.8 2.2 2.6 3.01.4 1.8 2.2 2.6 3.0
1.0
0.8
0.6
0.4
0.2St
D
ev
 D
iv
er
si
ty
Av
g 
di
st
an
ce
Average Shannon diversity
0.2
0.3
0.4
0.5
0.2
0.3
0.4
0.5
0.2
0.3
0.4
0.5
0.2
0.3
0.4
0.5(R-0.62. P=6.65E-07)
(R-0.71. P=2.39E-09)
(R-0.58. P=4.24E-06)
(R-0.62. P=8.58E-07)
(R-0.47. P=3.78E-04)
(R-0.60. P=2.10E-06)
(R-0.44. P=1.20E-03)
(R-0.78. P=1.10E-11)
Fig. 4. Correlation of average diversity values per child with average cosine distances (upper) and 
standard deviation of Shannon diversity index (lower) for the phyla FAFV, Bacteroidetes, and 
Proteobacteria together (green) and Bacteroidetes (red), FAFV (blue), and Proteobacteria (yellow) 
seperately. A significant negative correlation was apparent in both analyses for all measured 
phyla. Children with a higher diversity of their microbiota thus showed a lower variation of that 
diversity through time, as measured by the standard deviation of diversity, Also, samples with 
higher diversity are compositionally more similar throughout time, as measured by the average 
cosine distance between all time points. Spearman rank correlation coefficients and associated P 
values are depicted for each correlation.
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pattern, consisting of both highly stable and less stable members. In our study 
including 61 children, we also observed that stability varied per phylum, with 
the phylum Bacteroidetes as the most stable component of the gut microbiota, 
followed by the Proteobacteria and FAFV. Similar to the observations in adults 
by others, we noticed that microbiota stability in children between 2 and 18 yr 
of age declined quite rapidly for short intervals, but then stabilized at a level 
that declined further only very gradually. In adults, on average, 70% and 60% of 
identified strains were preserved over the course of 1 and 5 yr, respectively. We 
found an overall compositional stability of on average 70% over a period of 18 mo. 
Phylum-specific temporal shifts in composition may be due to variation in 
individual diets, because most prominent fluctuations have been described in 
bacterial species involved in food digestion, such as Bifidobacterium adolescentis 
and Parabacteroides distasonis , and those possessing carbohydrate-degrading 
 
1 
 
 
Table 2. Matching of 454-sequencing and IS-pro data for identification of core 
species
The most abundant OTUs as detected by 454-pyrosequencing data and their matching to the most 
common species as found with IS-pro are displayed, including a column displaying prevalence of 
each taxon.
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enzymes, such as Clostridium clostridioforme and Faecalibacterium prausnitzii 38. 
This concept of dietary effects on intraindividual microbial dynamics was 
supported by a study on temporal compositional stability that compared 
Bangladeshi and U.S. children 39.
Remarkably, we noticed an increase in diversity index of the phylum 
Bacteroidetes at 18 mo of follow-up, whereas no increase was observed for 
the other phyla. In this respect, it should be noted that the majority of 18 mo 
follow-up samples were collected during the summer, whereas the first weekly 
Fig. 5. Anchored bipartite network depicting samples from all children at all time points in a 
circular layout, based on all IS-pro data. All samples of all children are displayed as nodes on 
the circumference of the circle. Bacterial OTU nodes were placed at the center of gravity of the 
sample nodes in which the OTUs occur. Thus, the more children who shared a certain OTU, the 
more central that OTU has been placed. Bacteria that were common in many individuals appeared 
as a visual core. Size and color of nodes were determined by the number of nodes these were 
connected to (red, highest connectivity; green, lowest connectivity). Core species appeared in the 
center, were larger, and had a hue toward red.
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samples were collected mainly during the winter. Seasonal shifts in microbiota 
composition, including shifts in Bacteroidetes, have recently been described in 
adults, and have been attributed to seasonal dietary differences 40.
We also observed a positive correlation between diversity and stability. This 
finding is of general ecological interest as this has been a long debated issue 
for non microbial ecosystems 41. Furthermore, this finding may also be of 
particular interest for the role of microbiota in health and disease, because low 
microbial diversity has been linked to various diseased states 42. It is interesting 
to observe that stability of diversity may be higher than compositional stability, 
as we found for the phylum Proteobacteria. This suggests succession of different 
species within the population while maintaining the same level of diversity.
Composition and core
Until recently, it has been assumed that at the age of about 3 yr, the gut microbiota 
composition has converged toward a relatively stable, adult-like pattern 11, 43, 44. 
In 2 recent studies, however, substantial compositional differences between 
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occur in almost all individuals (shown as horizontal lines). These genera correspond with the core 
species as detected by IS-pro data.
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children of different ages and adults were described, suggesting that, also from a 
microbial point of view, children cannot be regarded as miniaturized adults 45, 46. 
In the present study, we observed a slight, but not statistically significant, 
increase in compositional stability with age.
The presence of a dominant microbial core, usually defined as a set of phylotypes 
shared by the majority of subjects, has been considered in several studies 38, 47. 
The search for such a core has been a major target of the human microbiome 
project 48. Data on the existence of a shared, temporal core are contradictory, due 
to differences in definition of what is considered a common core and differences 
in depth of the analysis. Depth of the analysis is particularly important when 
studying phylogenetic groups with low abundances 49, 50. Two recent studies based 
on whole metagenome sequencing provide further evidence for the presence 
of a shared microbiome core in adults, with Actinobacteria, Bacteroidetes, and 
Verrucomicrobia populations as the most stable members 38, 51. In contrast, it has 
been reported that only a small fraction of all taxa found within a single body 
was constantly present over time, suggesting that a core temporal microbiome 
of high abundant taxa does not exist 52. In concordance, in a study describing 
intestinal microbiota composition in 154 adults, no single bacterial phylotype 
was present at an abundant frequency in fecal samples of all included subjects. 
Instead, the authors concluded that a core gut microbiome seems to exist at the 
level of metabolic functions 48. In the present study, we observed the presence 
of a shared microbial core in children, independent of age, dominated by species 
from the phylum Bacteroidetes, with the genera Bacteroides and Alistipes as the 
most abundant members.
The strengths of this study were the large size of the cohort, the number of 
fecal samples per individual, and that microbial analysis was performed using 
2 different bacterial DNA-specific techniques, IS-pro and 454-pyrosequencing, 
allowing us to cross-validate our findings. Observed species present in the 
shared core as measured by IS-pro were similar to core microbes established by 
454-pyrosequencing. Although our cohort has characteristics of heterogeneity, 
because healthy children aged 2– 18 yr are heterogeneous, we examined 
subgroups based on age and sex. Because findings in stability and composition 
did not differ between sex or the 3 age cohorts, we assumed the presented data 
to be generalizable to healthy (Dutch) children overall: the limited standard 
deviation in the collected specimens indicated that the number of analyzed 
samples was sufficient to draw universal conclusions. The present study 
also had limitations; the influence of environmental factors on microbiota 
composition, in particular later in childhood, such as antibiotic use during 
the first year of life, way of delivery, and neonatal feeding pattern, could not 
be assessed. Specifically, formula-fed children were underrepresented in this 
study. Additionally, food intake was not recorded daily during the study period, 
Figure 7. Bar chart representing data by 454-sequencing (A) and IS-pro (B) of most abundant 
taxa at the family level. Although observed abundances are not identical, the detected families 
are largely the same. A notable difference is the relatively high abundance of the family 
Enterobacteriaceae (mainly E. coli) in the IS-pro data.
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because detailed understanding of the influence of day-to-day changes in diet 
on temporal microbial dynamics would need a cohort consisting of at least 
hundreds of subjects; thus, the current series of children was too small for 
suitable statistical analysis addressing influence of diet 53, 54. 
Future perspectives
We have shown that gut microbiota composition in children is not rigid, 
but subject to prominent fluctuations even at intervals of weeks. Presented 
compositional variability in health may further increase understanding of the 
role of the intestinal microbiota in the course of pediatric diseases linked to 
microbiota alterations, such as inflammatory bowel disease.
Furthermore, the observed intraindividual dynamics may have implications for 
future strategies assessing healthy individuals’ gut microbiota signature. The 
currently used single-sampling strategy to analyze microbiota composition in 
population-wide (pediatric) studies, but also in single individuals, might not 
accurately reflect the entire compositional variability over time. Determination 
of the average composition measured at different time points could offer a more 
integral view. Such an approach of multiple sampling is common practice in the 
diagnostic workup of parasitic infections, in which a triple feces test is performed 
to enhance the sensitivity and specificity of the test. Regarding the observed 
shared microbiome core, future studies are needed to establish its precise role 
in health and whether disruption is linked to (increased risk for) disease and to 
assess environmental factors potentially influencing core composition.
In summary, in the largest study thus far on the short term and long-term 
stability of the intestinal microbiota in healthy children between 2 and18 yr of 
age, we showed that stability in children is an individual characteristic varying 
per phylum at both short-term and long-term intervals. Stability declined 
rapidly for short intervals but stabilized at a level that declined further only 
very gradually. This was consistent throughout all age cohorts of youth.
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Supplemental Methods
Construction of the anchored bipartite network
To construct the anchored bipartite network, two basic node types were 
chosen: samples (red) and OTUs (orange). When a specific OTU was present 
in a sample, it was connected to that sample with an edge. In panel 1, a fictive 
sample (red node) can be seen which contains three OTUs (B1, B2 and B3). In 
panel 2, a second sample is added to the network. This sample too, contains 
three OTUs (B1, B4 and B5). Because the OTU B1 is present in both sample 
1 and sample 2, it now has two edges, connecting it to both these samples. 
In panel 3, a next sample is added. This sample contains only B1. B1 now has 
three edges. The sample nodes (red nodes) are all placed on the perimeter of 
a (not visible) circle at equally spaced distances. The position of an OTU node 
is determined by the sample nodes it is connected to. If an OTU is found in 
only one sample, is it connected to only this sample and is placed outside the 
circle on which the sample node lies. When an OTU is present in more than 
one sample, it is placed at the center of mass of the nodes it is connected to. 
Necessarily, this point always falls within the circle. As more sample nodes 
are added, OTUs will fall in different locations within the circle (panel 4). It 
follows from this that an OTU that is present in all samples will fall exactly in 
the center of the circle. More generally, the more common an OTU is, the closer 
it will come to the center of the circle. However, this generalization does not 
always apply. For instance, if an OTU is relatively rare, occurring in only two 
samples, it may be positioned in the center of the circle if the sample nodes 
to which it is connected are on opposite sides of the circle by coincidence. 
To discriminate rare OTU nodes that fall within the center of the circle per 
coincidence from those that fall in the center of the circle because they are truly 
common, the size of all nodes is made proportionate to the number of edges 
(connections) it has. Thus, common nodes are much larger than rare nodes. The 
same scaling is applied to sample nodes, thus samples harboring many OTUs 
are larger than those with few OTUs. Finally, in the final figure, the number 
of edges was so large, that the center of the circle became a tangle of edges. 
Therefore, we applied an algorithm (available as a standard plugin in cytoscape 
3.1.0) to bundle edges. In this way, more structure became discernable. 
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Fig S1. Panel 1: Sample node with three OTUs. Panel 2: two sample nodes sharing a single OTU
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Fig S2. Panel 3: Three sample nodes sharing an OUT. Panel 4: Five sample nodes. One OTU is 
shared by all samples, one OTU is present in sample 1, 4 and 5
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Fig S3. Panel 5: Sizes of all nodes are adjusted to correspond to the number of edges (connections) 
it has to other nodes.
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Fig S4. Heatmap of all 454 data of T=0 samples. It can be clearly seen here that some species occur 
in almost all individuals. These species correspond with the core species as found with IS-pro data.
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Abstract
Rationale
The composition of the respiratory microbiome is associated with an increased 
risk of viral infection. Since childhood Rhinovirus (RV) wheezing is associated 
with subsequent persistent wheeze and asthma we hypothesize that these 
children have a distinct microbiome compared to non-RV wheeze. 
Methods
This was a prospective study part of the EUROPA-cohort comparing the 
nasopharyngeal microbiome of wheezy children, during acute symptoms 
and after recovery, to symptomatic controls with non-wheezing respiratory 
illness and asymptomatic healthy controls. Specificity of outcomes for RV was 
determined by matched analysis in RV-negative (RV-) children. Nasopharynx 
swabs were analyzed for RV by qPCR. Bacterial microbiota analysis was done 
by IS-pro, a 16S-23S PCR-based profiling technique. Data were presented as 
relative abundance and Shannon diversity index. 
Results
160 pre-school children were included in the study. RV-induced wheeze had the 
highest (p<0.01) normalized total bacterial abundance (mean±SEM: 0.95±0.08) 
followed by symptomatic controls (0.77±0.08) and asymptomatic controls 
(0.57±0.09). This increase was related to upregulation of bacterial species 
belonging to the phyla of Firmicutes and Bacteroidetes. Notably, the latter 
phylum persisted after recovery from infection in RV+ children. None of the 
asymptomatic subjects carried Bacteroidetes. Microbial diversity was decreased 
(p=0.04) in RV+ wheezing children (Median[IQR] 1.60[0.97] ) compared to RV- 
wheezing children (2.00[0.75]). 
Conclusion
We established an increased microbial abundance and decreased microbial 
diversity in children with Rhinovirus induced wheeze. This was observed both 
during symptoms and after recovery. Our findings hold potential implications 
for early prediction of asthma and therapeutic approaches aimed at restoring 
microbial dysbiosis.
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Background
The end of the 20st century has seen an increase in the prevalence of asthma and 
allergic airways disease. This increase has been strongly linked to an affluent 
lifestyle1 and migration to industrialized countries, especially in infancy2. Both 
suggest a causal role for environmental exposures of which changes in microbial 
exposure have been linked to both western lifestyle and urban dwelling3. 
Further evidence for an interaction between asthma development and 
microbial exposures comes from epidemiological studies indicating that lack 
of diverse early life microbial exposures are associated with the development 
of asthma4,5. Conversely, wheezing Rhinovirus illness in pre-school children has 
been associated with school-aged asthma6,7. In addition, many environmental 
and lifestyle factors such as, obesity, formula feeding, C-section and antibiotics 
use have been associated with both decreased microbial exposure and the 
development of asthma3. This is supported by experiments indicating that 
germ-free mice are more prone to develop the asthma phenotype8. This could be 
prevented by neonatal colonization with ‘healthy’ gut microbiota or transfer of 
adult T-regulatory cells prior to allergen exposure9. Strikingly this effect was not 
observed in adult mice pointing towards a clear window of opportunity in early 
life for host-microbe interactions8,9 with respect to the development of allergy 
and asthma. The underlying mechanism may be the induction of T-helper 1 cell 
differentiation and immune tolerance9–12 away from the inborn t-helper 2 cell 
bias associated with asthma13,14. 
Recent advances in molecular biology have created innovative techniques to 
study these microbial exposures in a radically novel way. DNA based techniques 
allow profiling of the microbiome, the aggregate of the millions of microbes 
that inhabit our bodies as their ecosystem15. Such an omics approach largely 
extends the studied species beyond those found by classic culture techniques 
allowing for a more holistic appraisal of human-microbiome interactions. This is 
highly suited when addressing dysbiosis as potential risk factor in (respiratory) 
disease16.
In adults with asthma both the lower airways17 (brush) and sputum18 
microbiome have been shown to differ from controls and was associated with 
bronchial hyperresponsiveness19. Data from pediatric studies suggest that a low 
microbial gut diversity in early life is associated with development of asthma20. 
Taken together evidence to date suggest that microbial exposures in early life 
can predispose a child to develop along a trajectory towards health or asthma. 
In view of developing potential interventions to correct this early life dysbiosis 
it is mandatory to study the composition of the microbiome in children at risk 
for the development of asthma. This may also allow early prediction of asthma 
development by assessing microbial composition. 
We therefore hypothesized that children with an increased risk of developing 
asthma have a distinct microbiome compared to controls. We studied this by 
assessing children with Rhinovirus induced wheeze, as this phenotype has been 
associated with a tenfold increased risk to develop asthma6,7.  We aimed to do 
so by comparing children with physician confirmed wheeze to symptomatic 
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controls with non-wheezing respiratory illness and asymptomatic healthy 
controls. To assess specificity of our outcomes for Rhinovirus infections we 
compared them to matched analysis in Rhinovirus negative children for all three 
subject categories. 
Methods
Study population
This study is part of the EUROPA project21 addressing early signs of asthma 
development. The EUROPA cohort is a population based birth cohort recruited 
in greater Amsterdam, the Netherlands, through targeted mailing of parents 
of 12.033 children between 0 and 12 months old at inclusion. The cohort is 
unselected besides the exclusion of children born under 31 weeks of gestation 
and those known to have manifest inborn illnesses, specifically any pulmonary 
disorders. Figure 1 depicts the consort diagram for this study in which 1216 
infants were included after obtaining parental consent. All parents completed 
a baseline questionnaire regarding the pregnancy, family history and general 
health of their child which was modified from the EuroPrevall study22. 
Design
This prospective case control follow-up study monitored the full cohort for the 
occurrence of respiratory tract symptoms from December 2010 until December 
2012. Parents were instructed to contact the research team when their child 
experienced coughing, wheezing and/or dyspnea severe enough to warrant 
a visit to their general practitioner. Subjects subsequently received a home 
visit within 8 hours of establishing these symptoms. During these visits the 
presence of wheeze was evaluated through auscultation by a trained researcher, 
classifying children as having either physician confirmed wheezing respiratory 
illness or non-wheezing respiratory illness. Assessment of other respiratory 
symptoms was standardized by means of a questionnaires based on the Pediatric 
Respirator Assessment Measure (PRAM)23 and Asthma Control Questionnaire 
(ACQ)24, although the ACQ has not been validated for use in this age group. 
At the same time naso- and oro-pharyngeal swabs were obtained for both viral 
and microbiota analysis (Copan Swabs, Brescia, Italy) allowing stratification of 
children according to the presence or absence of  Rhinovirus (RV). A random 
selection of these samples was used for this study.
To gain more detailed understanding regarding the effect of symptoms on 
our outcome we included both symptomatic and asymptomatic controls. 
Symptomatic controls were children with non-wheezing respiratory illness, 
exhibiting symptoms such as cough, dyspnea and rhinorrhoea. Asymptomatic 
controls were children from the same cohort never meeting the criteria for a 
symptomatic visit (i.e. cough, wheezing and/or dyspnea). If asymptomatic 
control subjects became symptomatic during follow up they were excluded from 
this study and a novel control was recruited. Finally, we re-assessed wheezing 
children after recovering from their symptoms (no respiratory symptoms 
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for>1 wk) to establish stability of the microbiota and assess the influence of acute 
illness on our findings. All parents were instructed to fill out an online bi-annual 
ISAAC-based questionnaire25 regarding their child’s respiratory symptoms and 
general health status matched to birthdate. The EUROPA-study was approved 
by the Medical Ethical Committee of the Academic Medical Centre Amsterdam 
(09/066) and registered in the Dutch Trial Register (NTR-1955) and parent(s) 
and/or caretaker(s) provided written informed consent. 
Viral diagnosis
Within six hours of collection all nasal and oropharyngeal swabs were analyzed 
for a panel of 14 respiratory viruses by a multiplex qPCR assay developed in 
our lab26 (Rhinovirus, Respiratory Syncytial Virsus, Influenza A and B, Enterovirus, 
Metapneumovirus, Coronavirus, Parechovirus, Parainfulenza 1,2,3 and 4, Bocavirus 
and Adenovirus). A viral infection was defined as a positive qPCR of either swab. 
Invited to participate
n=12,033
Assessed for eligibility 
n=1,798
Did not respond
n=10,235
Included into cohort 
n=1,216
Unwilling to participate 
n=547
Not eligible 
n=35
Asymptomatic 
n=1,097
Symptomatic
n=117
En
ro
llm
en
t
M
on
ito
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g
St
ud
y 
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ts
Symptomatic wheeze
n=69
Asymptomatic
n=43
Symp. non wheeze
n=48
Figure 1.  Consort Diagram for this study showing enrollment of the cohort from the general 
population, subsequent monitoring of the cohort for respiratory symptoms and the selection of 
children studied analyzed in this study from the larger EUROPA-project cohort. Symptomatic 
wheezing children were children with physician confirmed wheeze. Symptomatic controls were 
children with non-wheezing respiratory symptoms. Asymptomatic controls were children never 
experiencing these symptoms. 
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Microbiome analysis
For this study we chose to focus on analysis of the nasopharyngeal microbiome 
because there is intensive contact between the respiratory system and the 
environment at this site and it is the primary focal point of Rhinovirus infections. 
After collection samples were stored in minus 80 degrees Celsius until analysis. 
Prior to analysis samples were shaken at 1400 rpm for 5 minutes.  The bacteria 
in 200 µl of sample were lysed for 10 minutes in NucliSens easyMag lysesbuffer, 
followed by DNA extraction by NucliSENS easyMag automated DNA isolation 
machine (Biomérieux, Marcy l’Etoile, France). The PCR assays were performed 
with 10µl isolated RNA/ for each target.
Microbiota analysis was performed by IS-pro (IS-Diagnostics Ltd, Amsterdam, 
the Netherlands) as previously described by our group27. IS-pro achieves 
taxonomic classification by phylum-specific fluorescent labeling of PCR primers 
and differentiates bacterial species based on the length of the 16S-23S rDNA 
interspace region. Amplification was done by means of a GeneAMp PCR 
system9700 (Applied Biosystems, Foster City, CA) according to the following 
cycling conditions 72°C for 2 min; 35 cycles of 94°C for 30 s, 56°C for 45 s, and 
72°C for 1 min; and finally 5 min at 72°C. Subsequently 5 µl of PCR product was 
mixed with 20 µl of IS-pro fragment analysis mix (IS-Diagnostics, Amsterdam, 
the Netherlands). DNA fragments were analyzed by an ABI Prism 3500 Genetic 
Analyzer (Applied Biosystems). 
Data analysis
Microbial abundance and diversity were compared between the groups. The 
obtained DNA fragments were pre-processed by means of the IS-pro software. In 
these peak profiles (example figure 2), colors represent the phylum group (either 
Firmicutes/Actinobacteria/Fusobacteria/Verrucomicrobia (FAFV), Bacteroidetes 
or Proteobacteria), peak positions on the x-axis represent the length of the 
interspace fragment and peak height reflects the quantity of the PCR product 
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Figure 2. Example raw output of IS-pro on a nasopharyngeal sample from a patient with 
Rhinovirus induced wheeze. Peaks represent individual operational taxonomic units (OTU’s), 
colors indicate the specific phylum (blue FAFV, red Bacteroidetes, yellow Proteobacteria). The x-axis 
represents the length of the 16S-23S rDNA interspace region used to identify OTU’s. The y-axis 
represents the abundance of the OTU’s in relative fluorescence units (RFU’s).  
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in relative fluorescence units (RFU). Individual peaks were considered to reflect 
separate bacterial operational taxonomic unit’s (OTU’s) and the peak height 
as that OTU’s abundance. All abundances were expressed as a fraction of the 
highest observed abundance which was set to 1. The Shannon diversity index28 
was calculated per phylum and for the overall microbial composition. This index 
rises when the number of different species or the evenness of their distribution 
increases. Median and inter quartile range (IQR) were subsequently calculated 
for each group and compared by Mann-Whitney test. Subject data were 
analyzed by means of SPSS 22 (IBM, New York, USA) by parametric or non-
parametric tests whenever applicable. 
Results
Subjects
Subject characteristics are outlined in table 1. Asymptomatic controls were 
significantly older than wheezy infants. This was due to the per protocol 
recruitment of novel controls when controls became symptomatic during 
follow-up. As can be anticipated the use of β2-agonists was significantly higher 
for wheezing infants compared to both control groups. For the use of inhaled 
corticosteroids (ICS) this significant difference was not observed. Within RV- 
cases significantly more wheezing children had a viral infection compared to 
asymptomatic controls. No between group differences were observed for the 
use of antibiotics. The median follow-up time between the acute wheezy episode 
and the recovery visit was mean±SD: 5.6±3.3 months. RV negative wheezy 
infants had the highest RFU value which was normalized to 1 and used as a 
reference to all other abundances.
Microbial abundance – Rhinovirus positive (RV+)
Quantification revealed that for RV positive children (RV+) the total microbial 
abundance appeared to be associated with clinical symptomatology. Within RV+ 
children, wheezing subjects had the highest mean abundance of mean±SEM: 
0.95±0.08. A lower abundance was observed for symptomatic controls 
(0.77±0.08) and asymptomatic controls whose abundance was nearly half of 
that of wheezy infants (0.55±0.09), p=0.01. These observations appeared to be 
primarily driven by differences in the phyla of FAFV and Bacteroidetes. Firstly, in 
RV+ children, FAFV had a higher abundance in wheezing children (mean±SEM: 
0.42±0.05) compared to asymptomatic controls (0.29±0.07) and symptomatic 
controls  (0.29±0.05), p-values 0.19 and 0.08, respectively. Secondly none of the 
asymptomatic controls had Bacteroidetes in their nasopharyngeal microbiome, 
whereas this was found in 24% of wheezing children and 30% of symptomatic 
controls. The abundance of Bacteroidetes was significantly increased compared 
to asymptomatic controls for all symptomatic Rhinovirus infections (wheezing: 
0.2±0.05, p=0.03 and non-wheezing: 0.15±0.03, p=0.002). This increase was 
related to various OTU’s across the phylum of Bacteroidetes and could not be 
linked to an upregulation of an individual species. 
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The overall microbial abundance of wheezy children decreased significantly 
(p=0.05) after full recovery from symptoms to a similar level observed for 
asymptomatic controls (0.74±0.07).  Furthermore  10% of these children 
displayed the presence of Bacteroidetes in their nasopharynx (abundance 
0.17±0.05), p=0.068 for comparison to asymptomatic controls. Surprisingly, 
detailed analysis showed that the subset of children exhibiting Bacteroidetes 
in their microbiome during acute symptoms only showed a 16% overlap with 
those children carrying Bacteroidetes after recovery (n=3). 
Microbial abundance – Rhinovirus negative (RV-)
The overall abundance for Rhinovirus negative (RV-) children showed a similar 
pattern to that of RV+ children for wheezy children. In contrast to what was 
observed for RV+ children, the microbial abundance for RV- symptomatic 
controls was significantly lower than that of wheezy infants (0.67±0.08 and 
01.00±0.07, respectively p=0.003). For RV- children asymptomatic controls 
also showed a complete absence of Bacteroidetes (Figure 3). In RV+ children we 
found that Bacteroidetes abundance remained elevated even after symptomatic 
♀
β
Table 1. Baseline subject characteristics
Table 1.  Subject characteristics. Wheezing children were children with physician confirmed 
expiratory wheeze. Asymptomatic controls were healthy controls. Symptomatic controls were 
children with non-wheezing respiratory symptoms. Data are presented as mean±SD unless stated 
otherwise. Prenatal smoke exposure was defined as smoking by or near the mother while she was 
pregnant. Antibiotics at birth was defined as antibiotics administered to the child within the first 
week of life.  Antibiotics at visit was defined as antibiotics use in the past week. Parental asthma was 
defined as a parent-reported doctor diagnosis of asthma for either parent. Breastfed infants were 
breastfed at least during the first month of their life. A positive viral qPCR was defined as positivity 
for a panel of 14 respiratory viruses (see methods) for either the naso- or oro-pharynx sample. ICS: 
inhaled corticosteroid; N.A. Not applicable ; * = p0.05 for comparison with wheezing children.
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recovery whereas a significant decrease was found for RV- wheeze (p=0.043). 
After recovery wheezy infants had a significant 53% decrease in Bacteroidetes 
abundance (p=0.043). Nonetheless this remained significantly elevated 
compared to asymptomatic controls (p=0.001). No differences in abundances of 
other phyla were observed for RV- children. Detailed information regarding the 
abundances are displayed in table 2 and figure 3. Figure 4 represents the overall 
abundance per subject class.
Post-hoc analysis – Clinical characteristics of Bacteroidetes carriers
As a post-hoc analysis we explored the clinical characteristics of the 32 
children with Bacteroidetes in their nasopharynx. Bacteroidetes were found 
in 33% of wheezing children and 19% of symptomatic controls. We found 
that RV+ children had a significantly lower (p=0.012) gestational age when 
carrying Bacteroidetes compared to children not carrying this phylum 
(mean±SD ; 38.0±2.6 and 39.7±1.8). Furthermore they significantly (p=0.003) 
more often had a c-section; 38% versus 7%. Although only 3 subjects, all children 
colonized with Bacteroidetes before and after recovering from Rhinovirus 
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Figure 3. Abundances of the separate phyla; Bacteroidetes (red), FAFV (Blue) and Proteobacteria 
(Yellow). Values are mean with standard error. All values are expressed relatively to the total 
abundance of wheezing Rhinovirus negative children. FAFV is the combined phyla of Firmicutes, 
Actinobacteria, Fusobacteria and Verrucomicrobia. Wheezing children were children with physician 
confirmed expiratory wheeze. Asymptomatic controls were healthy controls. Symptomatic 
controls were children with non-wheezing respiratory symptoms. Top panel:  RV+ cases;  Wheezing 
children and symptomatic controls display a similar distribution across all phyla. Asymptomatic 
controls lack the phylum of Bacteroidetes. Bottom panel; RV- cases, Wheezing children without 
RV show an abundance of Bacteroidetes similar to that of RV infected cases. This remains elevated 
even after symptomatic recovery. 
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induced wheezing were born by c-section (p<0.001) compared to only 9% 
of Bacteroidetes negative children. These observations were not found for 
RV- cases. No differences regarding the other clinical parameters described 
in table 1 were observed nor with any of the other respiratory viruses found, 
including RSV.  
Microbial diversity 
The Shannon Index for microbial diversity was not calculated for the phylum 
of Bacteroidetes because of the relatively low number of subjects exhibiting 
Bacteroidetes.  We observed no differences regarding microbial diversity between 
any of the subject classess within Rhinovirus positive children. For Rhinovirus 
negative children we established a significantly higher diversity for wheezing 
children (Median IQR ; 2.00 [0.75]) compared to both symptomatic controls 
(1.61 [0.98], p<0.01) and asymptomatic controls (1.69 [1.24], p=0.01). This 
difference appeared to be driven by an increase in FAFV which dissapeared after 
wheezy infants recovered from their infection. 
Upon comparing RV+ and RV- wheezing children we established a significantly 
decreased (p=0.04) overall diversity for RV infected children (Median [IQR] 
1.60 [0.97] and 2.00 [0.75], respectively. This was predominantly driven 
by a decreased diversity of Proteobacteria (p= 0.04) although the FAFV also 
showed a downward trend (p=0.08). These differences were no longer observed 
after children recovered from their symptoms nor where they established in 
Table 2. Microbial abundances relative to the highest observed total abundance (RVnegative 
wheezy children) and as percentage of overall abundance for that phenotype.  FAFV is the 
combined phyla of Firmicutes, Actinobacteria, Fusobacteria and Verrucomicrobia. Values for 
wheezing children are presented both during acute symptoms and after full recovery.  Wheezing 
children were children with physician confirmed expiratory wheeze. Asymptomatic controls were 
healthy controls. Symptomatic controls were children with non-wheezing respiratory symptoms. 
* = p0.05 for comparison with wheezing children with acute symptoms ; † = p 0.05 for comparison 
with wheezing children after symptomatic recovery. 
Table 2. Abundance in relative fluorescence units and as percentage of all 
phyla for wheezy children versus controls stratified according to the presence 
of Rhinovirus.
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   164 21-9-2016   15:09:54
Microbiota in children at risk for asthma
165
symptomatic or asymptomatic controls. The bacterial species driving these 
differences were different among subjects and could therefore not be appointed 
to individual bacterial strains. Details regarding diversity are provided in table 
3 and figure 5. 
Discussion
 
In this study we described the nasopharyngeal microbiome in the context of 
respiratory wheeze in pre-school children which is a high risk phenotype for 
asthma development. Firstly we found that an increased microbial abundance 
was associated with confirmed wheeze as opposed to non-wheezing respiratory 
symptoms and asymptomatic controls. These shifts in microbial abundance 
W
he
ez
e
Re
co
ve
ry
Sy
m
pt
om
at
ic
As
ym
pt
om
at
ic
A
bu
nd
an
ce
 (R
FU
)
1.0
0.8
0.6
0.4
0.2
0
R
hi
no
vi
ru
s 
po
si
tiv
e
R
hi
no
vi
ru
s 
ne
ga
tiv
e
1.0
0.8
0.6
0.4
0.2
0
p=0.05
p=0.01
p=0.019
p=0.015
p=0.003
Figure 4. Stacked bars revealing overall microbial abundance. Bars are colored according to the 
separate phyla; Bacteroidetes (red), FAFV (Blue) and Proteobacteria (Yellow).  Values are mean with 
standard error. All values are expressed relatively to the total abundance of wheezing Rhinovirus 
negative children.  FAFV is the combined phyla of Firmicutes, Actinobacteria, Fusobacteria and 
Verrucomicrobia. Wheezing children were children with physician confirmed expiratory wheeze. 
Asymptomatic controls were healthy controls. Symptomatic controls were children with non 
wheezing respiratory symptoms. Top panel:  RV+ cases , bottom panel; RV- cases. Wheezing 
children show an increased microbial abundance for both RV+ and RV- children which returned to 
the levels of controls after symptomatic recovery. Asymptomatic RV+ controls displayed a slightly 
lower overall abundance mostly due to a lack of Bacteroidetes. 
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could be attributed to changes in either the abundance of FAFV (predominantly 
Firmicutes) or Bacteroidetes. The latter phylum was only identified in wheezing 
children and symptomatic controls (non-wheezing respiratory symptoms) and 
in none of the asymptomatic controls. Longitudinal follow-up of wheezy children 
revealed that Bacteroidetes were persistently more abundant in children who had 
previous Rhinovirus induced wheeze, whereas they decreased significantly in 
children with non-Rhinovirus wheezing. These children with Rhinovirus induced 
wheezing also displayed a lower microbial diversity compared to children with 
non-Rhinovirus wheezing. Taken together these findings may point towards 
existence of a microbial endotype29 associated with Rhinovirus-induced wheezing 
and thereby with an increased risk of developing asthma.
This study is the first to comprehensively describe the effects of wheezing 
Rhinovirus illness in children on the upper airway microbiome. Previous studies 
have associated upregulation of Proteobacteria with the presence of asthma 
in adults and adolescents17,18 and with bronchial hyperresponsiveness19. In 
our studies we did not observe a strong association between Proteobacteria 
and Rhinovirus induced wheezing. Besides the age differences between the 
populations this apparent contradiction is likely due to differences between the 
analyzed samples: nasopharynx versus lower airways19 and sputum18 samples 
which affect the composition of the microbiome17.
Additionally, the viral infections in our study population are likely to have 
influenced the nasopharyngeal microbiome. In fact a previous study assessing 
the effect of experimental Rhinovirus infection on the sputum microbiome in 
COPD patients30 showed a marked increase in the sputum microbial abundance 
for COPD patients whereas this was not seen for healthy controls. Our results 
are in keeping with these findings by showing an increased microbial abundance 
Table 3. Shannon Diversity index for wheezy children (during symptoms and 
after recovery) compared to symptomatic and asymptomatic controls.
Shannon diversity index for wheezing children (during symptoms and after recovery and two 
groups of controls (symptomatic and asymptomatic). Data are presented as median and inter-
quartile range or IQR. Diversity values for the phylum of Bacteroidetes were not calculated in view 
of the relatively low number of subjects carrying this phylum which precludes reliable analysis. * 
p<0.05 for comparison with wheezing children. † P<0.05 for comparison with Rhinovirus negative 
children. 
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for children with Rhinovirus induced wheezing compared to asymptomatic 
infections. On the phylum level our results are similar to a study by Cardenas et 
al31 which revealed an increase in the presence of Firmicutes in the oropharynx 
of wheezy infants from Ecuador. Interestingly, a study of the nasopharynx 
microbiome of healthy children revealed that viral co-infections did not alter its 
composition. Our study reproduces these results in asymptomatic children and 
adds to this by showing effects of symptomatic infections on the microbiota. 
We believe our study has a number of strengths. The patients from the cohort 
closely resemble the population of a general practitioners office, increasing the 
external validity of our findings. Furthermore we very strictly assessed the 
specificity of our findings for the high-risk phenotype of Rhinovirus induced 
wheezing. We did so by including both symptomatic and asymptomatic controls, 
by re-assessing wheezy  children after symptomatic recovery and by stratifying 
all analyses according to the presence or absence of Rhinovirus. Furthermore 
the relatively high number of subjects for a microbiome study and the detailed 
clinical follow-up allowed us to do reliable in depth phenotyping32. 
Given the fact that assessing the lower airway microbiome through 
bronchoscopy would be unethical in this population we assessed the relationship 
between the upper airway microbiota and wheezing. Despite the fact that the 
RV+RV- RV+RV- RV+RV- RV+RV- RV+RV- RV+RV-
RV+RV- RV+RV- RV+RV- RV+RV- RV+RV- RV+RV-
Wheeze Recovery
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Figure 5. Matched comparison of the microbial diversity of Rhinovirus positive (RV+) and Rhinovirus 
negative (RV-) children. Colors represent phyla: green : all phyla, blue : FAFV, yellow: Proteobacteria. 
FAFV is the combined phyla of Firmicutes, Actinobacteria, Fusobacteria and Verrucomicrobia. Wheezing 
children were children with physician confirmed expiratory wheeze. Asymptomatic controls were 
healthy controls. Symptomatic controls were children with non wheezing respiratory symptoms. 
Diversity values for the phylum of Bacteroidetes were not calculated in view of the relatively low 
number of subjects carrying this phylum which precludes reliable analysis. Significant differences 
between RV+ and RV- children were found only during acute wheeze. 
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nasopharyngeal and lower airway microbiome differ17, evidence from mice and 
human experiments is mounting to suggest there is clear cross-talk between the 
mucosal sites of the body with respect to microbiome-immune interactions20,33. 
It is therefore likely that the nasopharyngeal microbiome holds relevance with 
respect to systemic immune maturation and asthma development, something 
which is supported by the results from this study.
Interpretation of our results is challenged by the fact that children in our cohort 
experienced a wide variety of viral infections and sometimes had multiple 
simultaneous infections, which potentially influence the microbiome33. Virus 
specific effects may therefore exist in the Rhinovirus negative (symptomatic) 
children but could become obscured by their mix with children having non-
virus induced symptoms or symptoms induced by a different virus.  Within 
the current study we can therefore not draw conclusions with respect to virus 
microbiome interactions for other viruses than Rhinovirus. This would require 
a far larger sample size and was outside the scope of the current study. Due 
to per protocol recruitment of a novel control upon becoming symptomatic, 
asymptomatic controls were significantly older compared to symptomatic 
children, potentially biasing our results. A recent paper analyzing temporal 
patterns of the microbiome in pre-school children however suggests that age is 
not a primary determinant of microbial composition32.
This is a descriptive study that doesn’t allow determination whether shifts in the 
microbiome are a consequence of the altered micro-environment affecting the 
available microbial niches or will be causally related to the future development 
of asthma. Nonetheless, this study can help to identify the microbial dysbiosis 
that is related to preschool wheezing. Firstly, we established an increased overall 
microbial abundance in children with confirmed respiratory wheeze. This may 
be related to an impaired mucosal immune response facilitating outgrowth 
of already present bacteria. Alternatively, this could be related to differences 
in viral pathogenicity. Data from experimental Rhinovirus infection in COPD 
suggest that differences in microbial shifts are possible even when the causative 
agent is identical30. 
We established an overrepresentation of the phylum of Bacteroidetes in children 
with respiratory symptoms compared to the asymptomatic controls. In children 
with Rhinovirus induced wheeze, this upregulation was maintained on a group 
level after recovery from infection, whereas a significant decrease was seen 
for Rhinovirus negative subjects. As is apparent from the significantly higher 
bacterial load of Bacteroidetes in RV- wheezing children compared to RV- 
symptomatic controls, the presence of Bacteroidetes was also associated with 
wheezy symptoms in RV- children. Bacteroidetes are the predominant bacterial 
phylum in the gut and are commonly found in the oropharynx. We can therefore 
speculate that changes in airway and breathing mechanics directly related to 
wheezing may enable translocation of Bacteroidetes from the oro- to the naso-
pharynx. Alternatively, a disturbance in mucosal immunity (associated with 
the development of asthma) may allow translocation and colonization of the 
nasopharynx potentially predisposing to symptomatic Rhinovirus infection35–37. 
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Interestingly, upregulation of gut Bacteroidetes has previously been associated 
with a positive asthma predictive index38.  Finally a recent study by Biesbroek 
et al analyzing bacterial colonization patterns in the first two years of life found 
that stable colonization over time was associated with less parent reported 
respiratory infections39. This observation may be in agreement with our 
data; those children with respiratory wheeze had variable colonization with 
Bacteroidetes. 
Although numbers of patients were relative small, children carrying Bacteroidetes 
had a significantly lower gestational age and were predominantly born by 
c-section. A recent study in mice found that gut Bacteroidetes were upregulated 
in mice born by c-section, which was associated with a lower proportion of 
Foxp3(+) regulatory T cells, tolerogenic CD103(+) dendritic cells, and lower IL-
10 expression39. This raises the hypothesis that these children had a less mature 
immune system upon birth and were not exposed to bacteria in the birth channel 
affecting their first microbial exposure. As is apparent from epidemiological and 
experimental studies changes in early life microbial exposures can predispose 
an individual to develop asthma4,8,9. The decrease microbial diversity established 
in children with Rhinovirus induced wheeze relative to non-Rhinovirus wheeze is 
also in keeping with the observation that reduced early life microbial exposures 
are associated with asthma development. On basis of our data we could therefore 
speculate that a diverse microbial community is required to provide sufficient 
community stability, protecting from viral induced perturbations.
The currently ongoing follow-up of the study population will help to determine 
whether microbial profiles have predictive potential with respect to the 
development of asthma, as is suggested by the current results in conjunction 
with epidemiological literature40. These results may impact the clinic in two 
ways. They may contribute to the non-invasive early prediction of asthma by 
identifying a child that is developing the accompanying microbiome. Moreover 
identification of core strains carried by children who do not develop asthma 
despite having the same environmental exposures as children developing 
asthma may enable personalized substitution of microbiota. Such approaches 
may include direct administration of beneficial strains to the airways or gut. 
Alternatively dietary interventions with metabolic products of microbiota such 
as short chain fatty acids and peptidoglycans may convey a protective effect 
against allergic airway inflammation through systemic modulation of the 
immune response32,41. The coming years will help us to determine whether such 
approaches yield valuable new therapies. 
In summary this is the first study to assess the upper airway microbiome in 
pre-school wheezing children. Relative to controls we established an increased 
microbial abundance and decreased diversity in children with Rhinovirus induced 
wheeze, who are at increased risk to develop asthma. In a subset of these children 
this could primarily be attributed to an overrepresentation of microbiota from 
the phylum of Bacteroidetes. Our findings hold potential implications for the 
early diagnosis of asthma and possibly novel therapeutic approaches aimed at 
restoring microbial dysbiosis. 
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IS-pro analysis of subgingival plaque in periodontal 
health and disease. A novel molecular approach
Chapter 8
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Abstract
Aim 
Periodontitis is a disease of the gingiva, connective tissue and alveolar bone 
that may ultimately lead to tooth loss. It is caused by dental plaque consisting 
of many bacterial species. A number of key organisms has been identified that 
are associated with progression of disease. Many current assays to diagnose 
and predict outcome of periodontitis are based on culture or qPCR of these 
putative pathogenic species. While current techniques have proven their value 
for clinical practice, there remains ample room for improvement. This notion 
is underpinned by the fact that new species associated with periodontitis 
continue to be identified. Best results might be obtained by characterizing 
the entire dental plaque community. Here we compare IS-pro, a novel rapid 
molecular technique that can characterize the entire bacterial community in 
dental plaques to a panel of seven qPCRs for putative periodontal pathogens.  
Materials and Methods 
Periodontal pockets were sampled from ten patients with healthy dentition and 
ten patients with evident parodontitis. Samples were analyzed both by qPCR 
of seven putative periodontal pathogens and by whole community profiling by 
IS-pro. 
Results 
With both techniques, there was separation of samples by disease state. However, 
for the qPCR approach, the separation was gradual, with no clear cutoff between 
groups. The IS-pro analysis showed two clearly separated groups. 
Conclusion 
Whole community microbiota analysis by IS-pro shows a more clear 
classification into healthy and parodontitis groups. This may greatly improve 
clinical diagnostics.
Clinical relevance
Scientific Rationale for Study 
Microbiological diagnosis of periodontitis is mainly done by culture or qPCR of 
selected putative pathogenic species. However, it is clear that there are more 
species involved in this complex microbiological affliction. Here, we compare 
a qPCR panel against whole community analysis by IS-pro for diagnosis of 
periodontitis
Principal Findings
We find that IS-pro gives a more clear cut differentiation of the healthy and 
periodontitis groups than the targeted qPCR panel.
Practical Implications
As IS-pro can readily be performed in standard laboratories, whole-community 
profiling by IS-pro may serve as a better diagnostic platform than conventional 
techniques. 
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Introduction
Periodontal disease is a multifactorial chronic disorder that is characterized 
by gingival inflammation and periodontal pocket formation.  In periodontitis, 
there is also loss of supporting alveolar bone and connective tissue. Tooth loss 
is the ultimate outcome of the disease. It has long been known that bacteria 
play an essential role in the pathogenesis of periodontitis. In contrast to classic 
infection, which is typically caused by a single causative organism, periodontitis 
is caused by dental plaque that consists of a great number of bacterial species 
that are organized in different clusters (Socransky et al. 1998).  A number 
of cultivable species including Porphyromonas gingivalis, Aggregatibacter 
actinomycetemcomitans, Prevotella intermedia, and Tannerella forsythia have been 
associated with progressions of periodontitis (Socransky, Haffajee, Cugini, 
Smith, & Kent, Jr. 1998;Zambon 1996). More recently, new species, such as 
Parvimonas micra and Filifactor alocis(Aruni et al. 2014) have been proposed as 
putative pathogens (Belstrom et al. 2014;Colombo et al. 2009;Colombo et al. 
2012). Traditionally, culture techniques have been used to study the composition 
of the subgingival plaque in healthy and diseased subjects. In recent years, new 
molecular techniques including DNA-DNA  hybridization (Socransky et al. 
1994), microarray analysis (Colombo, Boches, Cotton, Goodson, Kent, Haffajee, 
Socransky, Hasturk, Van Dyke, Dewhirst, & Paster 2009), RNA-oligonucleotide 
quantification technique and pyrosequencing (Griffen et al. 2012) have been 
used to describe the microbiological diversity of human subgingival plaque in 
periodontitis.   
In this study we evaluate the performance of a novel, rapid molecular technique 
called IS-pro. This technique is a 16S-23S interspace (IS)-based profiling 
technique that characterizes all bacteria present in a microbial consortium. 
In previous studies, we demonstrated technical performance of the IS-pro 
technique on various sample types (Budding et al. 2010;Budding et al. 2014) 
and its clinical application (Daniels et al. 2014).
Here we used this technique to study the composition of the subgingival plaque 
in periodontitis and non-periodontitis subjects.  We analyzed data by classical 
statistical methods and by predictive modeling and compared results with 
detection of a set of seven putative periodontal pathogens using qPCR. 
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Materials and Methods
Design
This study was set up as a prospective cohort study, including adult patients 
with severe periodontitis and subjects without destructive periodontal disease. 
Two microbiological methods, i.e. qPCR and the novel IS-pro technique were 
used to analyze subgingival biofilms and were investigated in their ability to 
microbiologically distinguish periodontitis patients from non-periodontitis 
subjects. 
Study population
For this study we selected ten subjects without periodontitis and ten subjects 
with advanced periodontal breakdown. For the selection of the participants 
we used  the Dutch periodontal screening index (DPSI) which is a tool for the 
screening of the periodontal status of an individual (Van, V 2009). In this study 
we selected 10 subjects with a DPSI score of 0 or 1, which indicates periodontal 
health or minimal gingivitis and 10 patients with a DPSI score of 4, which is 
indicative for advanced periodontitis. Patients had not used antibiotics in the 
past 3 months and oral informed consent was obtained from all trial subjects. 
Sampling technique
For periodontal sampling,  the deepest, bleeding periodontal pockets in each 
quadrant of the dentition were selected. Sampling sites were isolated with 
cotton rolls, supragingival plaque was carefully removed with a curette and the 
sites were air-dried. Subgingival plaque samples were obtained by inserting two 
sterile paper points into the bottom of the sulcus or the pocket. After 10 seconds, 
paper points were removed and deposited in a labeled sterile tube containing 1,5 
ml Reduced Transport Fluid (RTF, (Loesche and Syed 1978))  and transported 
to the laboratory where they were stored at -20oC until further processing. 
DNA Isolation
DNA was isolated from paper points by DNA extraction with the NucliSENS® 
easyMag® automated DNA isolation machine (Biomérieux, Marcy l’Etoile, 
France). One ml of nucliSENS® lysisbuffer, containing guanidine thiocyanate, 
was added to each vial containing the paperpoints and the mixture was shaken 
at 1400rpm (Thermomixer comfort, Eppendorf, Hamburg, Germany) by RT for 
five minutes. Samples were added to the easyMag container and DNA extraction 
was performed on the easyMag machine with the Specific A protocol as described 
by the manufacturer.
Quantitative real-time PCR
The primer/probe sets and real-time PCR conditions were performed as 
described previously (Boutaga et al. 2005;Price et al. 2007;Saygun et al. 2008). 
qPCR was specific for Aggregatibacter actinomycetemcomitans (AA), Treponema 
denticola (TD), Fusobacterium nucleatum (FN), Porphyromonas gingivalis(PG), 
Parvimonas micra (PM), Prevotella intermedia (PI) and Tannerella forsythia (TF). 
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In short, 3 duplex and one monoplex real-time PCR was performed with total 
reaction volumes of 15 μl, covering all seven species mentioned above. Duplex 
PCRs consisted of the combinations AA/PI, PM/PG and TF/TD. The monoplex 
PCR was specific for FN. 
IS-pro
Total microbiota analysis was performed by IS-pro as described previously (2). 
IS-pro involves bacterial species differentiation by the length of the 16S–23S 
rDNA interspace (IS) region with taxonomic classification by phylum-specific 
fluorescent labeling of PCR primers. For amplification of bacterial IS regions 
for IS-pro, two PCRs were performed. One PCR reaction amplifies IS regions 
of bacteria belonging to the phyla Firmicutes, Actinobacteria, Fusobacteria, 
Verrucomicrobia and Bacteroidetes. The second PCR amplifies IS regions of 
bacteria belonging to the highly diverse phylum Proteobacteria. For the first 
reaction, five primers were used. Two fluorescently labeled phylum-specific 
forward primers in the 16S rDNA region: one FAM-labeled primer, specific 
for Firmicutes, Actinobacteria, Fusobacteria and Verrucomicrobia and one HEX-
labeled primer specific for Bacteroidetes. Three unlabeled reverse primers were 
specific for the 23S rDNA region. The primers are used in a multiplex PCR, 
which amplifies the 16S-23S IS region.  The length of this IS region and its PCR 
product is species-specific. The fluorescent label provides identification of all 
fragments at the phylum level. For the second PCR, specific for Proteobacteria, 
a single FAM labeled forward primer is used in combination with seven reverse 
primers.
Amplifications were carried out on a GeneAmp PCR system 9700 (Applied 
Biosystems, Foster City, CA). Cycling conditions for PCR were 35 cycles of 94°C 
for 30 s, 56°C for 45 s, and 72°C for 1 min and a final extension at 72°C for 11 
min. Each PCR mixture, with a final volume of 25 μl, contained 10 μl of buffered 
DNA, 1x superTaq buffer (SphaeroQ, Gorinchem, the Netherlands), 200 μM 
deoxynucleoside triphosphate, 0.04% BSA, 1 U of superTaq, and 0.13 μM of 
each of the primers.
After PCR, 5 μl of PCR product was mixed with 19.8 μl formamide and 0.2 μl 
Mapmaker 1500 ROX-labeled size marker (BioVentures, Murfreesboro, TN, 
USA). DNA fragment analysis was performed on an ABI Prism 3500 Genetic 
Analyzer (Applied Biosystems). 
 
Data pre-processing
All data were pre-processed with the IS-pro proprietary software suite (IS-
Diagnostics, Amsterdam, the Netherlands). This process resulted in profiles 
consisting of peaks with a specific length, measured in nucleotides, reflecting 
lengths of IS fragments, and a specific height, measured in relative fluorescence 
units (RFU), reflecting quantity of PCR product. In order to further analyze 
the data, we considered each peak in a profile as an operational taxonomic unit 
(OTU) and its corresponding intensity as its abundance. All intensities were 
log2 transformed. This conversion was used in all downstream analyses such as 
calculating within-sample and between-sample microbial diversity. 
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Heat maps and Diversity Analysis
Dendrograms of heat maps were constructed by first generating correlation 
matrices based on Pearson product-moment correlation coefficients (IS-pro) 
or Euclidian distance (qPCR) and subsequent clustering by UPGMA. Diversity 
was calculated both per phylum and per the overall microbial composition 
(by pooling all phyla together). Within-sample diversity was calculated as the 
Shannon index, which was shown to be a robust estimate of microbial diversity 
(Haegeman et al. 2013). Diversity analysis was performed using the vegan 
software package in R.
Partial least squares discriminant analysis (PLS-DA)
A partial least squares discriminant analysis (PLS-DA) regression model was 
used for the prediction of clinical status of samples; i.e. whether it belonged to a 
periodontitis patient or to a control subject. PLS-DA is a supervised classification 
method, which aims to find linear transformations of a matrix of predictors and 
categorical responses so as to maximize their covariance. The PLS-DA model 
was constructed on the basis of four different datasets: one for each of the three 
separate phylum groups and one for the overall microbial composition, by pooling 
all phyla. Under the assumption that the more discriminant variables are the 
ones with a higher variance, we performed a preliminary variable selection by 
filtering out low variance predictors. Only the top 25% most variable predictors 
were considered in the analysis.
We used the Variable Importance for Projection (VIP) criterion to rank the 
different OTUs based on their contribution to the response variable (clinical 
status) and PLS components. PLS-DA provides a quantitative estimate of the 
discriminatory power of each descriptor by means of VIP (variable importance 
for the projection) parameters. VIP values rank the descriptors by their ability 
to discriminate different groups and is therefore considered an appropriate 
quantitative statistical parameter. Only the OTUs with the highest contribution 
(VIP score > 1.2) were considered. PLS-DA analysis was performed using 
the DiscriMiner package in R (version 2.15.2). All data visualizations were 
performed with the Spotfire software package (TIBCO, Palo Alto, CA, USA).
Results
The periodontitis group and the non-periodontitis group had a mean age of 46,6 
(range 32-66) and 34,4 (range 24-48) resp.
Quantitative real-time PCR
The real time qPCR clearly distinguished periodontitis patients from non-
periodontitis subjects. Of the seven periodontal species only F.nucleatum and P. 
micra were detected in both healthy and diseased subjects. The other five species 
were detected in diseased subjects only. T. forsythia was most discriminative, 
being present in all ten diseased samples and in none of the healthy subjects 
(Figure 1, OR=441). When loads were taken into account and patients were 
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clustered based on Euclidian distances of the loads of all seven periodontal 
pathogens combined, samples of periodontitis patients generally harbored 
higher loads of the one or more of the seven periodontal pathogens. However, 
clustering of samples from periodontitis and non-periodontitis subjects did not 
show a clear separation into two distinct groups. Rather, a gradual decline in 
loads of the periodontal pathogens was seen from the diseased group towards 
the healthy group with no distinct level of separation (figure 2).
IS-pro
IS-pro results showed presence of bacteria form all phyletic groups for most 
samples. When a heat map was constructed and clustered, there was no gradual 
separation as with the qPCR. In contrast, samples from healthy and diseased 
subjects clearly fell into two distinct clusters (figure 3). Furthermore, it was seen 
in the heat map that phyla did not show equal presence in samples from healthy 
and diseased subjects. Most notably, Proteobacteria showed much higher presence 
in the periodontitis group than in the non-periodontitis group. Bacteroidetes 
too showed a higher presence in the periodontitis group. These effects were 
quantified by a diversity analysis. Shannon diversity index was calculated for 
all samples and showed significant differences between healthy and diseased 
samples (figure 4). Difference in diversity was most outspoken for the phylum 
Proteobacteria with a mean shannon diversity index of 2,38 for samples from 
periodontitis subjects (IQR 0,56) and 0,69 for samples from non-periodontitis 
subjects (IQR 1,09). This difference was highly significant as calculated by a 
students t-test (p=0.0022). A significant difference in diversity between the 2 
groups was also found for Bacteroidetes (p=0.0048). For Firmicutes, Shannon 
diversity index was similar for both groups. When all phyla were combined, 
diversity was still significantly different between the two groups (p=0.0037).
Clustering of heat maps and diversity analyses are both based on whole-profile 
analysis. To investigate the contribution of individual OTU’s to sample differences 
based on health status, PLS-DA was employed. With PLS-DA, we were able to 
Figure 1. Presence of the seven periodontal pathogens detected by real-time PCR in periodontally 
healthy subjects and periodontitis patients. Periodontal pathogens are displayed by patient 
category (healthy or diseased). Bar heights correspond to the number of subjects positive for 
that pathogen. It can be seen that five of the seven periodontal pathogens are detected only in 
diseased subjects.
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classify samples into healthy and diseased groups with 100% accuracy. In figure 
5 a low dimensional projection of the PLS-DA analysis is depicted. Interestingly, 
the OTU’s with highest VIP scores belonged to the phylum Firmicutes, followed 
by Bacteroidetes. Thus, while Proteobacteria showed the most outspoken group 
effect, this was not attributable to single species. In contrast, presence or 
absence of particular species was the most important predictor of clinical status 
for the phylum Firmicutes, and to a lesser extent Bacteroidetes.
Discussion
Whole microbiome analysis of samples from periodontitis subjects shows a 
disease specific microbial pattern, defined by differential presence of specific 
species of Firmicutes and Bacteroidetes and an overall increase in diversity of 
Proteobacteria. With a predictive modeling approach, we show that these 
characteristics may be harnessed to generate highly accurate clinical predictions.
In this study we evaluate employing total microbiota analysis not only as a 
research tool, but also as a diagnostic tool and compare it with the current gold 
standard of periodontitis diagnostics. We used a periodontitis group as well as a 
non-periodontitis group that were well defined. The total microbiota data were 
analysed by classical methods such as correlation and diversity analysis and by 
predictive modeling. The classical methods are well suited for analysis of whole 
community structure, while the predictive modeling can assign importance to 
individual species. 
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Figure 2. Clustered Heat map depicting load as measured by quantitative real-time PCR of each 
periodontal pathogen per patient. Blue is lowest load, red is highest load. Columns are clustered 
by Euclidian distance; the dendrogram corresponds to these distances.
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A shortcoming of the current study was that the study population was too small 
to draw final conclusions. The observed effects on total microbiota should be 
confirmed in a larger population. A larger population in combination with cross-
validation of the PLS-DA will be necessary for robust evaluation of applicability 
of IS-pro as a clinical tool for diagnosing periodontitis.
qPCR is a well validated method that has shown its value in clinical practice. 
However, as it can only measure presence of a limited number of distinct species, 
it does not give information over total community status or dynamics. IS-pro 
does give an overview of the total periodontal microbial community. Differences 
in diversity were very outspoken for the different phyla. For Proteobacteria, this 
effect was greatest, varying from absence of Proteobacteria in a subset of the non-
periodontitis individuals to a highly diverse population in diseased individuals. 
A very interesting finding in this context was that the increase in Proteobacteria 
was not attributable to particular species, but consisted of different species 
between individuals. This may suggest a niche opening up in diseased subjects, 
which may be exploited by different species of Proteobacteria, but not by members 
of the other phyla. It is interesting to note in this context, that an increase in 
Proteobacteria presence has been found in various inflammatory processes in 
the gut (Tyler et al. 2013;Walujkar et al. 2014). Furthermore, the presence of 
several distinct species of the phyla Firmicutes, Fusobacteria and Bacteroidetes in 
periodontitis has been well established and has been confirmed in this study. 
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Figure 3. Clustered Heat map depicting IS-profiles of the three major phyletic groups covered in 
IS-pro. Note that Firmicutes group also includes Actinobacteria, Fusobacteria and Verrucomicrobia. 
It can be seen that there is a clear bipartite separation of microbiota profiles into the healthy and 
diseased groups, while there is also significant variation within these groups. It can be seen that 
more species, especially Proteobacteria, are present in the periodontitis group.
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However, taken together, our data suggest a process in which distinct species 
are involved in (initiation of) periodontitis. After this, possibly because of 
the inflammatory process, a niche might open up which can be exploited by 
members of the phylum Proteobacteria. 
This study contributes to a better understanding of the role of the oral 
microbiota in periodontitis. Furthermore, it demonstrates how microbiota 
profiling may be applied to improve clinical diagnostics in healthcare. While 
diagnostic tests aimed at a limited set of known periodontal pathogens have 
been established, analysis of the total microbiota enables measuring presence 
and relative quantity of all bacteria present in a sample. By applying a predictive 
model such as PLS-DA to such datasets, many more parameters can be taken 
into account for clinical prediction than in defined species assays. Not only can 
these species be taken into account, but by applying weights to the presence and 
relative quantity of all of the detected species, clinical prediction may become 
much more accurate.
In conclusion, we demonstrate that even in a small sample set, whole microbiota 
analysis by IS Pro analysis of oral subgingival samples can predict clinical status 
with high accuracy. This study warrants further evaluation of this approach in a 
larger sample set with a cross-validated predictive modeling approach.
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Figure 4. Shannon diversity per phylum and for all phyla combined. Proteobacteria and 
Bacteroidetes display a significantly higher diversity in diseased than in healthy individuals. This 
also results in a higher diversity for all phyla combined.
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Figure 5. Sample separation by PLS-DA. It can be clearly seen here that samples fall into distinct 
groups.
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Abstract
Aim
Peri-implantitis is an inflammatory disease of the tissues and bone surrounding 
a dental implant. Ultimately, peri-implantitis may lead to implant loss if not 
treated appropriately. Currently, there is no standard proven treatment and no 
clear understanding of the pathogenesis of peri-implantitis. Here we investigate 
the composition of the peri-implant microbiota in health and disease and 
whether changes herein are distinct and reproducible enough to be used in the 
clinical diagnosis of peri-implantitis.
Materials and Methods
To do this, we used a rapid molecular technique, optimized for clinical 
applications: IS-pro. We compared 10 subjects with active peri-implantitis to 
9 subjects with healthy implants and 8 subjects with healthy dentition without 
implants. We compared paperpoint samples taken directly from the crevices 
around teeth/implants to mouthswab samples in all patients.
Results
We found that peri-implantitis could indeed be defined by a change in microbiota 
which appears to be distinct enough for clinical diagnostics. This change was 
only detectable in paperpoint samples, and not in mouth swabs.
Conclusion
It is feasible to identify patients with peri-implantitis based on the implant 
associated crevice microbiota. By using a rapid eubacterial profiling method, IS-
pro, this approach may hold potential for clinical diagnostics.
Clinical relevance
Scientific rationale for study
Peri-implantitis and is a major cause of implant loss. Microbes have been 
implicated in its pathogenesis, but a microbiota-based diagnostic tool is lacking. 
Here we demonstrate the use of a rapid clinical microbiota analysis tool (IS-pro) 
in diagnosing peri-implantitis.
Principal findings
Pathogenic microbiota profiles were associated with peri-implantitis. These 
profiles were readily distinguishable from profiles associated with healthy 
implants or healthy dentition.
practical implications
With further optimization, IS-pro may be implemented in clinical routine to 
establish a standardized diagnostic approach to peri-implantitis and holds 
promise as an early detection tool. 
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Introduction
For many years extensive research has been conducted regarding the cause and 
treatment of peri-implantitis. The incidence of peri-implantitis in the literature 
is estimated between 10 and 20%(Schwarz et al. 2015;Swierkot et al. 2012) 
of a total group of more than 1.2 million implants in the Netherlands alone. 
Peri-implantitis can ultimately lead to implant loss if not treated appropriately. 
There is still great controversy about the treatment and at the same time all 
existing treatments have a high degree of unpredictability. This controversy 
in treatment is caused by the lack of a clear pathogenesis of peri-implantitis. 
For many years the dogma was that peri-implantitis is caused by the already 
known periodontal bacteria and that peri-implantitis is basically not different 
from the pathogenesis of periodontitis. The standard culture technique for 
peri-implantitis is therefore identical to that in periodontal disease. However, 
the periodontal treatment protocol seems less effective for peri-implantitis 
and also the presence or absence of paro-related microbiota is often only a 
moderate predictor for the development of peri-implantitis or the treatment 
outcome. Recent research using the pyrosequencing technique suggests that 
the peri-implant microbiota around both healthy and infected implants may 
substantially differ from the microbiota of a healthy dentition and periodontitis 
patients(Swierkot, Lottholz, Flores-de-Jacoby, & Mengel 2012). Moreover, 
Dabdoub et al. demonstrated a significantly higher diversity in the periodontal 
microbiome compared to implant sites (Dabdoub et al. 2013). Tamura et al. have 
shown that conventional periodontopathic bacteria are not the only periodontal 
pathogens active in peri-implantitis, and that other species like asaccharolytic 
anaerobic gram-positive rods (AAGPRs) may also play an important role 
(Tamura et al. 2013).
Further research is necessary to resolve this controversy and to determine the 
exact composition of the peri-implantitis associated microbiota for a better 
understanding of the pathogenesis of peri-implantitis. Secondly, a better insight 
in the pathogenesis of peri-implantitis will probably result in a differentiated 
prevention and treatment option with the ultimate objective to improve the 
predictability of the treatment of peri-implantitis or to reduce the risk of 
developing peri-implantitis. 
A disadvantage of the traditional culture technique is the limited number of 
bacteria that can be detected. Culture-independent techniques such as next 
generation sequencing give a much more detailed overview of the microbiome 
but are rather time consuming and costly, with results that are currently still too 
variable between laboratories to be implemented in clinical diagnostics (Brooks 
et al. 2015). Here, we use IS-pro (Budding et al. 2010), a highly standardized 
DNA -based profiling technique that was developed for rapid and reproducible 
analysis of complex microbiota in a clinical setting. This technique combines 
species differentiation by the length of the 16S-23S rDNA interspace region 
with instant taxonomic classification by phylum-specific fluorescent labeling of 
PCR primers and yields an accurate overview of microbiota composition at the 
species level. 
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The aim of this study was to evaluate the application of IS-pro for diagnosing 
peri-implantitis. To do this, we mapped the complete microbial profile in 
crevices around healthy teeth, healthy implants and peri-implantitis with this 
new and more cost effective method. We further compare the option of taking 
mouth swabs as an alternative to sampling the periodontal crevices.
Materials and methods
Study design
For this study subjects were assigned to three groups: the first group was a 
peri-implantitis group, consisting of subjects presenting peri-implant sites 
with radiographic defects >3 mm, bleeding on probing and/or suppuration and 
a probing depth of >5mm; the second group was a control group, consisting 
of subjects with healthy implants without radiological defects and the above 
mentioned clinical findings. A third group consisting of individuals without 
implants and without periodontal disease was also included. The clinical 
parameters evaluated were age, gender, smoking, plaque index, bleeding on 
probing, suppuration and probing depth. Standardized x-rays were taken 
to measure peri-implant bone loss. A potential subject who met any of the 
following criteria was excluded from participation in this study: DMII, DMI, 
HIV, or intake of bisphosphonates or immunosuppressive medication. Subjects 
were consecutively enrolled in the Amphia Hospital, Breda, between January 
2013 and January 2015.
Sampling
Samples were collected by inserting 4-6 sterile endodontic paper points into the 
pockets or peri-implant crevice for 10 s. From subjects with healthy or diseased 
implants, samples were collected from the selected peri-implant crevice. From 
periodontally healthy teeth, samples were collected from sulcus of a randomly 
selected tooth. Probing pocket depths (PPD) were recorded throughout the 
mouth on 4 sites per tooth or implant. Bleeding on probing was recorded as 
present/absent. Additionally, mouth swabs from the right buccal mucosa was 
taken from all individuals. Samples were placed in 1.5 ml microcentrifuge tubes 
containing 1,5ml Reduced Transport Fluid (RTF)(Loesche and Syed 1978) and 
frozen at 80°C until further analysis. 
DNA Isolation
DNA was isolated from paper points by DNA extraction with the NucliSENS® 
easyMag® automated DNA isolation machine (Biomérieux, Marcy l’Etoile, 
France). One ml of nucliSENS® lysisbuffer, containing guanidine thiocyanate, 
was added to each vial containing the paperpoints and the mixture was shaken 
at 1400rpm (Thermomixer comfort, Eppendorf, Hamburg, Germany) by RT for 
five minutes. Samples were added to the easyMag container and DNA extraction 
was performed on the easyMag machine with the Specific A protocol as described 
by the manufacturer.
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IS-pro
Total microbiota analysis was performed by IS-pro as described previously (2). 
IS-pro involves bacterial species differentiation by the length of the 16S–23S 
rDNA interspace (IS) region with taxonomic classification by phylum-specific 
fluorescent labeling of PCR primers. For amplification of bacterial IS regions 
for IS-pro, two PCRs were performed. One PCR reaction amplifies IS regions 
of bacteria belonging to the phyla Firmicutes, Actinobacteria, Fusobacteria, 
Verrucomicrobia and Bateroidetes. The second PCR amplifies IS regions of bacteria 
belonging to the phylum Proteobacteria. For the first reaction, five primers were 
used. Two fluorescently labeled phylum-specific forward primers in the 16S 
rDNA region: one FAM-labeled primer, specific for Firmicutes, Actinobacteria, 
Fusobacteria and Verrucomicrobia (FAFV) and one HEX-labeled primer specific 
for Bacteroidetes. Three unlabeled reverse primers were specific for the 23S rDNA 
region. The primers are used in a multiplex PCR, which amplifies the 16S-23S IS 
region.  The length of this IS region and its PCR product is species-specific. The 
fluorescent label provides identification of all fragments at the phylum level. 
For the second PCR, specific for Proteobacteria, a single FAM labeled forward 
primer is used in combination with seven reverse primers. Amplifications were 
carried out on a GeneAmp PCR system 9700 (Applied Biosystems, Foster City, 
CA). Cycling conditions for PCR were 35 cycles of 94°C for 30 s, 56°C for 45 s, 
and 72°C for 1 min and a final extension at 72°C for 11 min. Each PCR mixture, 
with a final volume of 25 μl, contained 10 μl of buffered DNA, 1x superTaq 
buffer (SphaeroQ, Gorinchem, the Netherlands), 200 μM deoxynucleoside 
triphosphate, 0.04% BSA, 1 U of superTaq, and 0.13 μM of each of the primers. 
After PCR, 5 μl of PCR product was mixed with 19.8 μl formamide and 0.2 μl 
Mapmaker 1500 ROX-labeled size marker (BioVentures, Murfreesboro, TN, 
USA). DNA fragment analysis was performed on an ABI Prism 3500 Genetic 
Analyzer (Applied Biosystems). The whole process of IS-pro, from arrival of 
sample to analyzed data can be performed in 5 hours (Figure 1).
Data pre-processing
All data were pre-processed with the IS-pro proprietary software suite (IS-
Diagnostics, Amsterdam, the Netherlands). This process resulted in profiles 
consisting of peaks with a specific length, measured in nucleotides, reflecting 
lengths of IS fragments, and a specific height, measured in relative fluorescence 
units (RFU), reflecting quantity of PCR product. In order to further analyze 
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Figure 1. IS-pro timeline. The whole process of IS-pro from the moment the paperpoints and 
mouth swabs are sent in to the laboratory (left), through DNA isolation, PCR amplification, 
profile analysis and automated software analysis may be performed within five hours.
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the data, we considered each peak in a profile as an operational taxonomic unit 
(OTU) and its corresponding intensity as its abundance. All intensities were 
log2 transformed. This conversion was used in all downstream analyses such as 
calculating within-sample and between-sample microbial diversity. 
Diversity Analysis and cluster analysis
Dendrograms of heat maps were constructed by first generating correlation 
matrices based on cosine correlation coefficients (IS-pro) and subsequent 
clustering with the unweighted pair group method with arithmetic mean 
(UPGMA). Diversity was calculated per phylum. Within-sample diversity was 
calculated as the Shannon index, which was shown to be a robust estimate of 
microbial diversity (Haegeman et al. 2013). Diversity analysis was performed 
using the vegan software package in R.
Partial least squares discriminant analysis (PLS-DA)
A partial least squares discriminant analysis (PLS-DA) regression model was 
used for the prediction of clinical status of samples; i.e. whether it derived 
from the peri-implantitis group, the healthy implant or the healthy dentition 
group. PLS-DA is a supervised classification method, which aims to find linear 
transformations of a matrix of predictors and categorical responses so as to 
maximize their covariance. The PLS-DA model was constructed on the basis 
of four different datasets: one for each of the three separate phylum groups 
and one for the overall microbial composition, by pooling all phyla. Under the 
assumption that the more discriminant variables are the ones with a higher 
variance, we performed a preliminary variable selection by filtering out low 
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Figure 2. Shannon diversity per phylum group for the two different sample types: mouth swabs 
and paperpoints. For all three phylum groups median diversity is higher in paperpoints than in 
mouthswabs.
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variance predictors. Only the top 25% most variable predictors were considered 
in the analysis.
We used the Variable Importance for Projection (VIP) criterion to rank the 
different OTUs based on their contribution to the response variable (clinical 
status) and PLS components. PLS-DA provides a quantitative estimate of the 
discriminatory power of each descriptor by means of VIP (variable importance 
for the projection) parameters. VIP values rank the descriptors by their ability 
to discriminate different groups and is therefore considered an appropriate 
quantitative statistical parameter. Only the OTUs with the highest contribution 
(VIP score > 1.2) were considered. PLS-DA analysis was performed using 
the DiscriMiner package in R (version 2.15.2). All data visualizations were 
performed with the Spotfire software package (TIBCO, Palo Alto, CA, USA).
Results
Study population and samples
For this study 27 subjects were enrolled. 19 subjects with at least one implant 
restored and functional for at least 6 months were assigned to two groups: a 
peri-implantitis group (n=10) and a control group (n=9), consisting of subjects 
with healthy implants without radiological defect. For the third group, 8 healthy 
subjects without implants and without periodontal disease were enrolled.
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Figure 3. Shannon diversity per clinical group and sample type. More outspoken differences can 
be observed in the paperpoint samples. Healthy implants have the lowest overall diversity, while 
peri-implantitis microbiota diversity is more similar to healthy dentition.
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IS-profiling resulted in high quality profiles for all 27 mouthswab samples that 
were included. A single paperpoint sample did not result in an interpretable 
profile and was excluded.
Diversity analysis
First, a diversity analysis was performed per sample type (mouthswabs vs 
paperpoints) and per clinical group (healthy dentition vs healthy implant vs peri-
implantitis) for both sample types. On average, paperpoints harboured a more 
diverse microbiota than mouthswabs for all three phylum groups (Figure 2). 
When diversity is analysed per clinical group, more outspoken differences can 
be observed between the different groups in the paperpoint samples than in the 
mouth swabs. In the paperpoint samples, healthy implants showed the lowest 
overall diversity, while peri-implantitis microbiota diversity was more similar to 
healthy dentition (Figure 3).
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Figure 4. Cluster dendrogram of microbiota profiles. A. No clear clustering per clinical group can 
be seen with profiles derived from mouth swabs. B. With paperpoints, there is more clustering per 
clinical group, There is a cluster containing only peri-implantitis profiles. However, not all peri-
implantitis profiles fall into this cluster based on total profile comnposition.
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Cluster analysis
To identify whether whole-community profiles were similar per clinical group, 
we performed a cluster analysis. We did so for the mouth swab samples and 
the paperpoint samples seperately (Figure 4). For mouth swabs, while three 
clusters could be observed, there was no clear clustering per clinical group. 
For paperpoints, a more distinct clustering could be observed. Most notably, a 
cluster consisting only of peri-implantitis samples was found. However, not all 
peri-implantitis samples fell within this cluster.
PLS-DA analysis
While the cluster analysis uses the whole microbiota profile for clustering of 
samples, PLS-DA identifies the most discriminative elements of microbiota 
profiles and uses them in classification of samples. First, we used PLS-DA to 
discriminate between the different sample types. As suspected, with PLS-DA 
profiles derived from mouth swabs were easily seperable from profiles derived 
from paperpoints (Figure 5). Next, we used PLS-DA to classify samples into 
the three clinical groups. We performed this analysis separately for the two 
sample types. For mouth swabs, classification into the correct clinical group 
was not possible with PLS-DA (Figure 6A). However, for paperpoints, a distinct 
separation could be made between all three clinical groups: healthy dentition 
could be clearly separated from both implant groups, and the healthy implant 
and peri-implantitis samples also showed a clear separation, thus creating three 
distinct groups, matching the clinical status of the samples (Figure 6B).
PaperpointMouthswab
Figure 5. PLS-DA analysis of microbiota profiles from mouthswabs vs those from paperpoints. 
Profiles can clearly be seperated, regardless the disease state (healthy, healthy implant and peri-
implantitis). Here seperation is shown for total profiles, but classification was also accurate for the 
different phylum groups (FAFV, Bacteroidetes and Proteobacteria), indicating that compositions 
within each phylum were highly divergent between sampling sites.
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Discussion
In this study we have shown that the microbiota associated with a healthy 
dentition, healthy implants and peri-implantitis can be discriminated by 
the IS-pro technique. The discrimination can only be achieved by assessing 
the local microbiota using paperpoints for sampling. With mouth swabs, the 
different clinical states could not be discriminated, not even with a supervised 
classification algorithm.
Here we found that healthy implants harbored the least diverse microbiota, while 
infected implants had a more diverse microbiota, similar in diversity to healthy 
dentition. This finding contrasts with Kumar et al., who found peri-implant 
biofilms to be less diverse in both health and disease and suggested that peri-
implantitis was a simple infection, dominated by a limited, yet variable number 
of bacterial species (Kumar et al. 2012). However, three other studies found 
peri-implantitis associated microbiota to be markedly more diverse than that of 
healthy implants, suggesting a poly-microbial pathogenesis of peri-implantitis 
(Koyanagi et al. 2010;Tamura, Ochi, Miyakawa, & Nakazawa 2013;Zheng 
et al. 2015). These different findings could be explained by differences in the 
techniques applied, but may also be attributed to normal variation in microbiota 
of peri-implantitis, as it has been shown that healthy and peri-implant oral 
microbiota may be highly influenced by environmental exposure and lifestyle 
habits (Stahringer et al. 2012;Tsigarida et al. 2015). This issue is likely to be 
solved with larger studies, which can better assess overall group characteristics 
and variation.
Peri-implantitisHealthy implantHealthy dentition
A. Mouthswabs B. Paperpoints
Figure 6. PLS-DA analysis of oral microbiota profiles from individuals with either healthy dentition 
with no implants, a healthy implant or an implant with peri-implantitis A. In profiles derived from 
mouth swabs no obvious grouping can be seen by comparing the associated microbiota profiles. B. 
Profiles obtained from paper points. A clear grouping can be seen for all three categories.
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   196 21-9-2016   15:10:14
Microbiota based diagnostics of peri-implantitis
197
Our finding that the different clinical states studied here can easily be separated 
with a method that is fast and readily implementable in standard clinical 
microbiology laboratories is highly relevant for dental practice. The distinct 
microbiota profiles as found by IS-pro might be used for early diagnostics and 
monitoring of the effect of therapy. This is important as it has been shown that 
peri-implant mucositis, which is a precursor stage of peri-implantitis is highly 
treatable, whereas the later stages of peri-implantitis are much more difficult 
to treat and often require surgical intervention (Khammissa et al. 2012). 
The difficulty to treat peri-implantitis may be aggravated by individualized 
aspects of the associated microbiota; not only may environmental and lifestyle 
aspects predispose to the development of different peri-implantitis associated 
microbiota, in vitro studies have shown that texture and composition of 
different implant surfaces significantly influence the peri-implant community 
profile (Grimm et al. 2000;Grossner-Schreiber et al. 2009). 
A rapid molecular diagnostic tool could be used in the early diagnosis of peri-
implantitis, greatly improving the treatability. Furthermore, such a tool would 
assist in selecting a personalized treatment, based on the individual peri-
implantitis associated microbiota. We confirm in this study that the peri-implant 
community profiles are individualized as they do not form a homogeneous 
cluster in whole-community-based cluster dendrogram, but also show that 
disease states are separable with a supervised classification algorithm. While 
the study presented here is relatively small and should be followed-up by a 
larger study to accurately determine the exact sensitivity and specificity of IS-
pro classifications, it demonstrates the potential of IS-pro as a diagnostic tool 
in peri-implantitis.
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Gut mucosa and microbiota analysis in diverticulosis. 
Not different from a control population
Chapter 10
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Abstract
Background 
It has been suggested that the low fibre diet that may lead to diverticula formation 
could also alter the colonic microbiome and play a role in the development of 
diverticulitis. The altered microbiome may induce a form of chronic low grade 
inflammation, eventually leading to clinically manifest stages of disease. As a first 
step in further understanding the development of diverticulitis we compared 
the colonic microbiome of individuals with diverticulosis on colonoscopy, but 
without symptoms, and compared it to a population without diverticulosis. 
Furthermore we assesed mucosal inflammation on histology specimens to 
identify possible low grade inflammation.
Methods 
A total of 43 patients were enrolled into the study of which 19 had diverticulosis 
and 24 did not have have diverticulosis on colonoscopy. To asses the microbiome 
a high‐throughput PCR‐based profiling technique (IS-pro) was performed on 
DNA isolates from histology samples. Differences in bacterial phylum abundance 
and diversity (Shannon index) of the resulting profiles were assessed by 
conventional statistics. Dissimilarity in microbiome composition was analyzed 
with principal coordinate analysis (PCoA) based on cosine distance measures. 
The presence of inflammatory changes was assessed by performing a neutrophile 
and lymphocyte count on 10 different colonic fields at 40-x magnification. 
Results 
We found that the microbiome of patients with diverticulosis is not different 
to that of a control population. This is true for the sigmoid colon as well as 
the transverse colon. The Firmicutes to Bacteroidetes ratio is commonly used 
to describe and characterize a dysbiosis of the gut microbiota. Therefore, 
we compared their relative abundance between patients and controls. For 
diverticulosis patients, Bacteroidetes represented 62% and Firmicutes 38% 
of the total abundance in the Firmicutes/Bacteroidetes PCR. Almost identical 
proportions were found for the patient group (Bacteroidetes 63%, Firmicutes 
37%) with no statistical differences between the two groups (p=0.69, Students 
T-test). The total load of bacteria of the Proteobacteria phylum was also similar 
between patients and controls (P=0.56, Students T-test). On histological 
examination of the specimens no influx of neutrophilic granulocytes was seen 
at all. We furthermore found no differences in mean lymphocyte count neither 
in the whole crypt nor in the bottom of the crypts. This was true for the sigmoid 
colon as well as the transverse colon.
Conclusions 
Diverticulosis patients do not have a higher diversity of faecal microbiota than 
controls without diverticulosis. Furthermore, no inflammatory changes in the 
colonic mucosa could be detected.
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Introduction
It has long been believed that all forms of diverticulitis are the result of a colonic 
(micro) perforation due to an inpissated fecolith in the diverticular lumen. The 
original Hinchey classification is based on this premise.1 Remarkably little 
however is known about the true etiology of diverticulitis. Recently a different 
pathogenesis has been proposed indicating that diverticulitis could be considered 
a form of inflammatory bowel disease.2 Chronic subclinical inflammation may 
be a precursor stage to the clinically manifest stages of acute diverticulitis. 
Some research has been done on the mucosa of patients with varying degrees 
of diverticular disease. Tursi found signs of mucosal inflammation in specimens 
taken from the close proximity of diverticula in individuals without complaints 
and without endoscopic or systemic signs of inflammation.3 These results 
however could not be substantiated in another study.4
Fibre deficiency in the Western diet, which leads to diverticula formation, could 
also lead to alterations in the gut microbiota5 and play a role in the development 
of diverticulitis.  It is known that the human endogenous microbiota plays an 
important role in health and disease.6-10 Advances in nucleic acid sequencing 
methods have recently made it possible to reliably assess the entire fecal 
microbiome. It is believed that at the level of the individual up to 5000 
different bacterial species may exist. Recently, the IS-pro technique, a 16S-23S 
based bacterial profiling technique validated for the intestinal microbiota,11 
was used to analyze the fecal microbiome in diverticulits patients. Here it 
was demonstrated for the first time that the fecal micobiome is different in 
patients with diverticulitis as compared to other individuals.12 To date however 
no information is available on the fecal microbiome in individuals with 
diverticulosis.
Much unclarity therefore remains as to the real pathway of development of 
diverticulitis and it may well be multifactorial.13 The aim of this study was 
to characterize mucosal inflammation and changes in colonic microbiome 
in individuals with diverticula as compared to a control population. This can 
contribute to further unravel the etiology of diverticulitis and guide future 
research on treatment and prevention.
Materials and methods
Study design
A prospective study was carried out in patients undergoing routine follow up 
colonoscopy for causes not related to diverticular disease or inflammatory bowel 
disease. Colonoscopy was performed by one gastroenterologist (JK). Prior to 
colonoscopy informed consent was obtained. 
All patients underwent the same standard bowel preparation. When diverticula 
were encountered during colonoscopy a total of five biopsies were taken from 
the mucosa around diverticula in the sigmoid colon and five biopsies were taken 
from the transverse colon as a control location. In the control group without 
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diverticula on colonoscopy, five biopsies were taken from the sigmoid colon at 
random and from the transverse colon at random. 
Subjects 
Patients aged 18 years or older with hematochezia, gastrointestinal hemorrhage, 
unexplained changes in bowel habit, weight loss, iron-deficiency anemia, 
chronic constipation without succesfull conservative treatment, screening for 
and follow-up of colorectal cancer were eligible for recruitment. 
Exclusion criteria were: suspicion of diverticular related complaints, proven 
history of symptomatic diverticular disease, use of coumarin derivates, unless 
stopped one week before colonoscopy, use of NSAID’s unless stopped one week 
before colonoscopy, use of platelet aggregate inhibitors, including aspirin, 
unless stopped one week before colonoscopy, sedation before informed consent, 
history of inflammatory bowel disease.
The local ethics committee approved the study. All persons gave their informed 
consent before inclusion in the study.
Sample size calculation
Only one previous study was preformed on this subject.3 This study found a 
difference in mean lymphocytic density count of 1.8 between individuals with 
endoscopic signs of diverticula and patients without diverticula. The mean 
lymphocytic density count in the diverticulosis group was 5.9 compared to 4.1 
in the group without diverticula. The standard deviation was 1.7. To be able 
to reproduce this difference a minimal total of 2 x 17 individuals have to be 
included. We planned to enroll 2x 20 patients, one group with diverticula and 
one group without diverticula.
Histology samples 
The presence of inflammatory changes was assessed as previously described by 
performing a neutrophile and lymphocyte count on 10 different colonic fields at 
40-x magnification.3 Hematoxylin and eosin staining was performed. To identify 
lymphocytes, antiCD3 antibodies (ready to use rabbit anti human polyclonal 
antibodies, Dako, Copenhagen, Denmark) were used and for neutrophils anti-
CD15 antibodies. (Ready to use mouse antihuman monoclonal antibodies, 
Dako, Copenhagen, Denmark) The number of lymphocytes and neutrophils 
were scored both at the bottom and in the whole crypts.
For histological evaluation the means of lymphocyte and neutrophils infiltrate 
were compared using the Mann-Whitney test. A P value of <0.05 was considered 
statistically significant.
 
Table 1. Patient characteristics
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DNA isolation and amplification
Colonic biopsies used for analysis of the adherent microbiota were washed in PBS 
after harvesting to remove residual fecal material and non-adherent bacteria. 
Directly after this, biopsies were snap frozen in liquid nitrogen after which 
they were stored at -20ºC. After thawing of the samples, total DNA extraction 
was performed on all samples with the NucliSENS® easyMag® automated DNA 
isolation machine (Biomérieux, Marcy l’Etoile, France). One ml of nucliSENS® 
lysisbuffer, containing guanidine thiocyanate, was added to each vial containing 
a swab tip and the mixture was shaken at 1400rpm (Thermomixer comfort, 
Eppendorf, Hamburg, Germany) for five minutes. Afterwards, all samples were 
centrifuged for four minutes at 12.000g and added to the easyMag container. 
We have described exact DNA isolation previously.11
IS-profiling of the intestinal microbiota and data analysis
Amplification of IS-regions was performed with the IS-pro assay (IS-diagnostics, 
Amsterdam, the Netherlands). IS-profiling was done as described previously. 
All data were pre-processed with the IS-pro proprietary software suite (IS-
Diagnostics, Amsterdam, the Netherlands). This process resulted in peak 
profiles with the length of each peak, measured in nucleotides, corresponding to 
a specific operational taxonomic unit (OTU), and a specific intensity, measured 
in relative fluorescence units (RFU), reflecting quantity of PCR product and 
corresponding to the abundance of that OTU. Finally, fluorescent labels 
categorize peaks into three phylogenetic groups: Proteobacteria, Bacteroidetes or 
Firmicutes/Actinobacteria/Fusobacteria/Verrucomicrobia (FAFV). All intensities 
were log2 transformed. Log2 transformation of complex profiles compacts the 
range of variation in peak heights, reducing the dominance of high peaks and 
including less abundant species of the microbiota in downstream analyses. 
This results in improved consistency of estimated correlation coefficient, lower 
impact of inter-run variation and improved detection of less prominent species. 
This conversion was used in all downstream analyses. 
Correlation and diversity analysis
To analyze similarities between samples, a correlation and a diversity analysis 
was performed. Correlation was analyzed by calculating Pearson correlations per 
 
Table 2. Indications for colonoscopy
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phylum and for total microbiota within individuals (sigmoid versus transverse 
colon biopsies) and between individuals (sigmoid versus sigmoid colon) for 
control and diseased groups. Diversity was calculated both per phylum and for 
the overall microbial composition (by pooling all phyla together). Within-sample 
diversity was calculated using the Shannon index.14 Dissimilarities between 
samples, or between-sample diversity, were represented in a dissimilarity 
matrix that was built using the cosine distance measure.12 Diversity analysis was 
performed using the vegan software package in R. 
Partial least squares discriminant analysis (PLS-DA)
A partial least squares discriminant analysis (PLS-DA) regression model 15 was 
used for the prediction of clinical status of samples; i.e. whether it belonged to a 
diverticulosis patient or to a control subject. The PLS-DA model was constructed 
on the basis of four different datasets: one for each of the three separate phylum 
groups and one for the overall microbial composition, by pooling all phyla. Only 
the top 25% most variable predictors were considered in the analysis.
PLS-DA model validation was carried out by a 10-fold cross validation procedure. 
The PLS-DA was described extensively in a previous study performed by us.12 
PLS-DA analysis was performed using the DiscriMiner package in R. All data 
visualizations were performed with the Spotfire software package (TIBCO, Palo 
Alto, CA, USA).
Clustered heat map
For a global analysis of all versus all samples, we generated a clustered heat 
map. First, a correlation matrix was generated by means of cosine correlation, 
and then clustering was done with the unweighted pair group method with 
arithmetic mean (UPGMA).
Results
A total of 43 patients were enrolled into the study of which 19 had diverticulosis 
and 24 didn’t have diverticulosis. Table 1 shows the baseline characteristics and 
table 2 the indications for colonoscopy.
 
Tabel 3. Lymphocyte count
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Histology
On histological examination of the specimens no influx of neutrophilic 
granulocytes was seen at all. We furthermore found no differences in mean 
lymphocyte count neither in the whole crypt nor in the bottom of the crypts. 
This was true for the sigmoid colon as well as the transverse colon. (table 3.)
Intestinal microbiota analysis 
The Firmicutes to Bacteroidetes ratio is commonly used to describe and 
characterize a dysbiosis of the gut microbiota.17,29 Therefore, we compared their 
relative abundance between patients and controls. For diverticulosis patients, 
Bacteroidetes represented 62% and Firmicutes 38% of the total abundance in the 
Firmicutes/Bacteroidetes PCR.  Almost identical proportions were found for the 
patient group (Bacteroidetes 63%, Firmicutes 37%) with no statistical differences 
between the two groups (p=0.69, Students T-test). The total load of bacteria 
of the Proteobacteria phylum was also similar between patients and controls 
(P=0.56, Students T-test). 
Correlation and Diversity Analysis
A first approach to assessing differences in microbiota was by performing a 
correlation of microbiota profiles. To assess local diverticula-related variations 
in microbiota, we compared profiles from sigmoid and transverse colon within 
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Figure 1. Correlation of intestinal microbiota profiles within and between individuals. Microbiota 
profiles are highly similar within individuals for all phyla, regardless of disease status (C = control, 
D = diverticulosis). Between individuals microbiota profiles are dissimilar. If there was a specific 
diverticulosis signature, higher similarity within the diverticulosis (D) than control (C) group 
would be expected.
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individuals for both patients and controls. Indeed, some variation was identified 
between the two locations, most outspokenly so for Proteobacteria and less so for 
Firmicutes and Bacteroidetes. However, the extent of these variations was similar 
in patients and controls. Furthermore, to get a first impression of the presence 
of a specific diverticula-related microbiota in patients, we compared sigmoid 
colon samples from all patients to each other and we compared all sigmoid 
colon samples of controls to each other. In these inter-individual comparisons, 
correlations were generally low. Again, distribution of correlation coefficients 
was similar for patients and controls (Figure 1).
As diversity is a commonly applied measure to assess differences in microbiota, 
we performed a diversity analysis on all samples. Then, diversity indices for all 
phyla and sample types were compared to each other (Figure 2). This analysis 
showed that diversity was highest for Bacteroidetes, followed by Firmicutes and 
Proteobacteria. In this analysis too, no differences were found in different sample 
types or between patients and controls.
Partial least squares discriminant analysis (PLS-DA)
To identify individual species or sets of bacterial species related to the presence 
of diverticula, we performed a partial least squares discriminant analysis (PLS-
DA). We were able to construct a model that had 74% accuracy in predicting 
clinical status, i.e. in 74% of samples the model was able to discriminate 
diverticulosis samples from healthy controls based on a selection of the most 
variable bacterial predictors. However, when the model was cross-validated, 
all predictive power was lost, indicating the absence of truly disease-specific 
bacterial species in this data set (Figure 3). 
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Figure 2. Diversity analysis of intestinal microbiota per phylum. Diversity is highest for 
Bacteroidetes, followed by FAFV group and Proteobacteria. Diversity is not different in sigmoid and 
transverse colon or for diverticulosis patients or controls.
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Clustered heat map
For a per-sample analysis of all data, we generated a clustered heat map (Figure 4). 
Here, it can be seen that most biopsies from the sigmoid colon show highest 
correlation to the corresponding transverse colon sample. Sometimes, samples 
show highest correlation to a sample from another individual. However, this is 
not disease-state specific. No clustering is apparent for diverticulosis or control 
samples
Discussion
We demonstrated in this study that there are no evident changes in the mucosa 
or its associated microbiota in individuals with diverticula as compared to a 
control population. 
The absence of inflammation of the mucosa is in line with a previous report 
on this subject 4 but in contrast with another study that did find a significant 
difference in lymphocyte infiltration in asymptomatic diverticular disease.5 There 
are no previous reports on microbiota composition in diverticulosis. Our study 
is hampered by a few drawbacks. Firstly inflammation assessment was done by 
assessing lymphocyte and neutrophilic granulocyte influx in gut mucosa only. It 
would be interesting to see whether other inflammation markers or cytokines 
show any difference. Furthermore microbiota analysis was done on mucosal 
samples after bowel preparation, which has been shown to impact intestinal 
microbiota composition.17  It can be debated if our results would be the same on 
rectal swabs or feces in unprepped subjects. Moreover, a larger sample size may 
yet reveal differences in microbiota composition. However, in a previous study 
Healthy
Diverticulosis
Figure 3. Three dimensional PLS-DA scores plot of microbiota samples based on the most 
discriminative PLS components. It can be clearly seen that there is no separation, suggesting the 
absence of discriminative species for either state (healthy or diverticulosis)
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Figure 4. Clustered heat map of all mucosal biopsy samples. Each column represents a sample 
from either sigmoid (S) or transverse (T) colon. Each band corresponds to an OTU, the intensity 
to its abundance, the color to its phylum group. Generally, microbiota of the sigmoid colon 
shows high correlation to the microbiota of the transverse colon of the same individual (all blue 
squares). Sometimes, correlation is stronger to a sample from another individual (yellow squares). 
However, no clear pattern can be seen here: samples from diverticulosis patients have a similar 
likelihood to having a low intra-individual correlation as control samples. Thus, random variation 
seems to be a more likely explanation here than an underlying biological phenomenon. Finally, 
there is no evident clustering of healthy or diseased individuals.
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we were able to clear microbiota signature in diverticulitis patients with the 
same technique and similar sample size.12 Given this background, the absence 
of a microbiota signature for diverticulosis in this study seems highly indicative 
that there is no association between the presence of diverticula and microbiota.
In this study, we used a number of different techniques to identify changes 
in colonic microbiota associated with diverticulosis. If there would be local 
differences in microbiota related to diverticular disease, differences between 
sigmoid and transverse colon samples would be expected to be larger in patients 
than in controls. This was however not the case. What is more, inter-individual 
variation in sigmoid colon microbiota was similar for the patient group and the 
control group for all bacterial phyla. This indicated that there was no obvious 
diverticula-specific microbiota, as patient-related samples would then have been 
expected to be more similar than control samples. A specific diverticula-related 
microbiota or a pronounced structural difference in diverticula-associated 
microbiota could also not be identified by diversity analysis.
The PLS-DA analysis we performed is a technique that generally performs very 
well in identifying biomarkers associated to disease state in complex data. While 
the technique was not developed to demonstrate absence of differences, the lack 
of discriminating species found with this sensitive technique, does strongly 
suggest their absence in this data set.
Recent hypotheses have focused more on a multifactorial etiopathogenis of 
diverticulitis with an important role for a changed microbiome than on the 
old dogma of an inpissated fecolith causing a microperforation.13 We recently 
demonstrated that the colonic microbiota in patients with diverticulitis differs 
from that of a control population.12 Therefore it would be interesting to see 
whether this change in colonic microbiome is also present in individuals before 
they develop diverticulitis. This is the first study to date to evaluate the colonic 
micobiome in patients with diverticula without symptoms. 
In conclusion, there does not seem to be an evident change in microbiota or 
in mucosal inflammation in diverticulosis patients. Whether the changes in 
microbiota as identified in diverticulitis are a cause or the effect of the disease 
remains unclear and warrants more research. 
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Abstract
Purpose Disease specific variations in intestinal microbiome composition 
have been found for a number of intestinal disorders, but little is known about 
diverticulitis.  The purpose of this study was to compare fecal microbiota of 
diverticulitis patients with control subjects from a general gastroenterological 
practice, and to investigate the feasibility of predictive diagnostics based on 
complex microbiota data.
Methods Thirty-one patients with CT-proven left-sided uncomplicated acute 
diverticulitis were included and compared with 25 control subjects evaluated for 
a range of gastrointestinal indications. A high‐throughput PCR‐based profiling 
technique (IS-pro) was performed on DNA isolates from baseline fecal samples. 
Differences in bacterial phylum abundance and diversity (Shannon index) of 
the resulting profiles were assessed by conventional statistics. Dissimilarity 
in microbiome composition was analyzed with principal coordinate analysis 
(PCoA) based on cosine distance measures. To develop a prediction model for 
the diagnosis of diverticulitis, we used cross-validated partial least squares 
discriminant analysis (PLS-DA).
Results Firmicutes/Bacteroidetes ratios and Proteobacteria load were comparable 
among patients and controls (P=0.20). The Shannon index indicated a higher 
diversity in diverticulitis for Proteobacteria (P<0.00002) and all phyla combined 
(P=0.002). PCoA based on Proteobacteria profiles resulted in visually separate 
clusters of patients and controls. The diagnostic accuracy of the cross-validated 
PLS-DA regression model was 84%. The most discriminative species derived 
largely from the family Enterobacteriaceae.
Conclusions Diverticulitis patients have a higher diversity of fecal microbiota 
than controls from a mixed population, with the phylum Proteobacteria defining 
the difference. Analysis of intestinal microbiota offers a novel way to diagnose 
diverticulitis.
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Introduction
The human endogenous intestinal microbiota is known to play a fundamental role 
in health and disease. Functions of the commensal gut flora include protection 
against direct epithelial cell injury [1], regulation of host fat storage [2] as one 
of many metabolic functions, stimulation of intestinal angiogenesis [3] and 
influencing the development and function of the gut immune system[4‐5].
Nucleic acid sequencing methods have undergone tremendous developments[6], 
and have provided a major advance in culture-independent analysis of the 
intestinal microbiota. However, these techniques are typically laborious and 
expensive for application on small batches of samples as is common in clinical 
practice. Profiling techniques are a cheap and reliable alternative. We have 
recently validated and optimized a specific profiling technique termed IS‐pro for 
human intestinal microbiome analysis. It has proved to be a highly reproducible 
method suitable for high‐throughput profiling of the human intestinal 
microbiota[7].
With molecular techniques, it has been shown that the intestine harbours a 
complex bacterial community that consists largely (>95%) of 2 bacterial phyla, 
the Bacteroidetes and the Firmicutes[8]. Molecular genetics research suggests 
that at the level of the individual, the colonic microbiota may consist of up to 
5000 different bacterial species[9]. The composition seems to be relatively stable 
in time and is more or less conserved throughout the colonic tract[8,10-12]. 
Between individuals, however, the composition is highly variable [8,10,13]. 
There are also differences between mucosal and fecal communities[14].
Disease specific variations in the composition of the colonic microbiota have 
been identified, for example in inflammatory bowel disease (IBD)[3,15-16] and 
metabolic syndrome[17‐18]. Furthermore, specific bacterial species have been 
found to infiltrate the epithelium and submucosa in acute appendicitis[19]. 
Diverticular disease (DD) patients have also been hypothesized to harbour a 
change in colonic flora that promotes disease and inflammation, either due 
to altering the immune process or by permitting an abnormal response to 
potentially harmful bacteria[20]. However, neither a diverticulitis specific 
microbiome nor a single causative microorganism has yet been found.
Currently, theories are shifting away from the traditional dogma that posits 
fecalith obstruction of a diverticulum to cause acute diverticulitis towards a 
view in which microbiota may play a central role. Characterization of the colonic 
microbiota composition is the first step in elucidating their possible role in the 
etiopathogenesis of DD and its inflammatory complications.  
The aim of our study was to characterize the fecal microbiota by means of IS-
pro [7] in patients with a first episode of uncomplicated acute diverticulitis and 
compare these to the microbiota of controls. Identification of a diverticulitis-
specific microbial composition could lead to clinical application of this technique 
in diagnosing disease. No published data on species composition during a first 
episode of uncomplicated acute diverticulitis are available yet.
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Materials and methods
Study design
This study was ancillary to the ‘DIABOLO Trial: A multicenter randomized 
clinical trial investigating the cost‐effectiveness of treatment strategies with or 
without antibiotics for uncomplicated acute diverticulitis’, which was approved 
by the Medical Ethics Committee, Academic Medical Center, Amsterdam, 
The Netherlands (no. 2009_233), and registered at ClinicalTrials.gov (no. 
NCT01111253)[21]. We carried out this prospective cohort study in three of 
the 22 participating centers (one academic and two teaching hospitals), based 
on practical grounds and logistics.
Subjects
Eligible diverticulitis patients were consecutive trial subjects from the three 
including centers of 18 years or older with a first episode of acute left-sided 
uncomplicated modified Hinchey 1A or 1B [22] diverticulitis demonstrated by 
computed tomography (CT). Included patients were recruited between August 
2011 and September 2012. Informed consent was obtained from these trial 
subjects.
The control subjects were derived from an existing database of a mixed 
population of adult patients evaluated in another academic hospital for a range 
of gastrointestinal complaints, notably with no diagnosis of diverticulitis. 
Diverticulosis is a common finding at colonoscopy, with a prevalence of DD that 
increases with age from less than 10% in people younger than 40 years to 50-
66% in octogenarians. The lifetime risk to develop diverticulitis is less than 25% 
in these patients [23-24]. Possibly a continuum in the microbiota composition 
exists in patients with diverticulosis and diverticulitis. To incorporate the 
possibility to distinguish mild diverticulitis from diverticulosis, the control 
group also included patients with diverticulosis. 
The indications for and/or the diagnoses after colonoscopy in the control 
subjects were the following: follow-up after polypectomy (n=1), anaemia e.c.i. 
(n=1),benign neoplasm (n=3), malignant neoplasm (n=1), Morbus Crohn (n=4), 
ulcerative colitis (n=2), indeterminate colitis (n=1), irritable bowel syndrome 
(n=2), abdominal pain e.c.i. (n=1), surveillance for familial cancer susceptibility 
(n=3) and diverticulosis (n=6).
Rectal swabs
In the diverticulitis patients, sampling by means of a rectal swab (FLOQSwabs 
552C, Copan, CA, USA)  was performed at presentation on the emergency 
ward, prior to starting antibiotics when allocated to this treatment. The control 
subjects had their rectal swab taken prior to colonoscopy which was performed to 
evaluate their gastrointestinal complaints or for other indications. Rectal swabs 
were inserted into the anal canal, beyond the anal verge (±3cm). Subsequently 
the tips of the swabs were gathered in sterile containers with 1ml of reduced 
transport fluid (RTF) medium[25] and stored at ‐20 °C within two hours of 
collection.
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   218 21-9-2016   15:10:27
Fecal microbiome analysis as diagnostic test for diverticulitis 
219
DNA isolation and PCR amplification
After thawing of the samples, total DNA extraction was performed on all samples 
with the NucliSENS® easyMag® automated DNA isolation machine (Biomérieux, 
Marcy l’Etoile, France). One ml of nucliSENS® lysisbuffer, containing guanidine 
thiocyanate, was added to each vial containing a swab tip and the mixture was 
shaken at 1400rpm (Thermomixer comfort, Eppendorf, Hamburg, Germany) 
for five minutes. Afterwards, all samples were centrifuged for four minutes at 
12.000g and added to the easyMag container. DNA extraction was performed 
on the easyMag machine with the Specific A protocol as described by the 
manufacturer. DNA was eluted in 110µl buffer and stored at 4°C until use for 
polymerase chain reaction (PCR) amplification. 
IS-profiling of the intestinal microbiota
Amplification of IS-regions was performed with the IS-pro assay (IS-diagnostics, 
Amsterdam, the Netherlands). IS-pro involves bacterial species differentiation by 
the length of the 16S–23S rDNA interspace region with taxonomic classification 
by phylum-specific fluorescent labelling of PCR primers. Essentially, the IS‐pro 
procedure consists of two multiplex PCRs: a first PCR for the phyla Firmicutes, 
Bacteroidetes, Actinobacteria, Fusobacteria and Verrucomicrobia and a second 
PCR for the phylum Proteobacteria. The assay was performed according to the 
protocol provided by the manufacturer. Amplifications were carried out on a 
GeneAmp PCR system9700 (Applied Biosystems, Foster City, CA). 
After PCR, 5µl of PCR product was mixed with 19.8µl formamide and 0.2µl 
Mapmaker 1000 ROX-labeled size marker (BioVentures, Murfreesboro, TN, 
USA). DNA fragment analysis was performed on an ABI Prism 3130XL Genetic 
Analyzer (Applied Biosystems). Results are presented as color-labeled peak 
profiles (figure 1). 
Data analysis
Log2 transformation and phylum abundance 
All data were pre-processed with the IS-pro proprietary software suite (IS-
Diagnostics, Amsterdam, the Netherlands). This process resulted in profiles 
consisting of a set of 1071 peaks with a specific length, measured in nucleotides, 
reflecting lengths of IS fragments, and a specific height, measured in relative 
fluorescence units (RFU), reflecting quantity of PCR product. In order to further 
analyze the data, we considered each peak in a profile as an operational taxonomic 
unit (OTU) and its corresponding intensity as its abundance. All intensities were 
log2 transformed. Log2 transformation of complex profiles compacts the range 
of variation in peak heights, reducing the dominance of high peaks and including 
less abundant species of the microbiota in downstream analyses. This results in 
improved consistency of estimated correlation coefficient, lower impact of inter-
run variation and improved detection of less prominent species. This conversion 
was used in all downstream analyses such as calculating within-sample and 
between-sample microbial diversity. A clustered heat map was made by generating 
a correlation matrix of all log2 transformed profile data followed by clustering 
with the unweighted pair group method with arithmetic mean (UPGMA). 
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Diversity Analysis
Diversity was calculated both per phylum and for the overall microbial 
composition (by pooling all phyla together). Within-sample diversity was 
calculated as the Shannon index, that was recently shown to be a robust 
estimate of microbial diversity [26]. Dissimilarities between samples, or 
between-sample diversity, was represented in a dissimilarity matrix that was 
built using the cosine distance measure. Given two vectors of attributes (two 
profiles in our case), A and B, the cosine dissimilarity is represented using a dot 
product and magnitude as:
 dissimilarity = 
The resulting dissimilarity matrix was summarized and visualized in a low-
dimensional space using principal coordinate analysis (PCoA). Diversity analysis 
was performed using the vegan software package in R.
Partial least squares discriminant analysis (PLS-DA)
A partial least squares discriminant analysis (PLS-DA) regression model was 
used for the prediction of clinical status of samples; i.e. whether it belonged 
to a diverticulitis patient or to a control subject. PLS-DA is a supervised 
classification method, which aims to find linear transformations of a matrix 
of predictors and categorical responses so as to maximize their covariance[27]. 
The PLS-DA model was constructed on the basis of four different datasets: one 
for each of the three separate phylum groups and one for the overall microbial 
composition, by pooling all phyla. Under the assumption that the more 
discriminant variables are the ones with a higher variance, we performed a 
preliminary variable selection by filtering out low variance predictors. Only the 
top 25% most variable predictors were considered in the analysis.
PLS-DA model validation was carried out by a 10-fold cross validation procedure. 
In practice, the dataset was split into 90% of samples for model construction 
(i.e. the training set) with the aim to predict the other10% (i.e. the test set). This 
procedure was repeated for 10 iterations, where each sample served as a test 
sample exactly once. Accuracy rates, speciﬁcity and sensitivity were computed 
for the samples that were used as a test set in every iteration, and the model 
predictive power was further assessed using a receiver operating characteristic 
(ROC) curve, a function of the true positive rate (TPR or sensitivity) and false 
positive rate (FPR or 1-speciﬁcity).
PLS-DA provides a quantitative estimate of the discriminatory power of 
each descriptor by means of  VIP  (variable importance for the projection) 
parameters.  VIP values rank the descriptors by their ability to discriminate 
different groups and is therefore considered an appropriate quantitative 
statistical parameter. We used the VIP criterion to rank the different OTUs based 
on their contribution to the response variable (clinical status, i.e. diverticulitis: 
yes or no) and PLS components. Only the OTUs with the highest contribution 
(VIP score > 1.2) were considered. The OTUs resulting from this selection were 
translated to most likely bacterial species by comparison to a database 
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consisting of >1500 bacterial species and their associated IS lengths. PLS-DA 
analysis was performed using the DiscriMiner package  in R (version 2.15.2). All 
data visualizations were performed with the Spotfire software package (TIBCO, 
Palo Alto, CA, USA).
Results
Patient characteristics
Thirty-one patients diagnosed with a first episode of uncomplicated acute 
diverticulitis were included, of which 20 were males and 11 females, with a mean 
age of 58years (95% Confidence Interval (CI): 54-62). In the control group, a 
total of 25 subjects were included, 12 males and 13 females, with a mean age of 
53 years (95% CI: 47-59). Patients’ characteristics are listed in Table 1. 
Bacterial phylum abundance and profile clustering
The Firmicutes to Bacteroidetes ratio is commonly used to describe and 
characterize a dysbiosis of the gut microbiota in different disease states, such 
as irritable bowel syndrome (IBS) and obesity [17,28]. Since these two phyla 
are being amplified in the same PCR reaction, we could compare their relative 
abundance between patients and controls. The phylogenetic characterization 
 
Table 1 Demographic and baseline characteristics of diverticulitis patients and 
control subjects
Abbreviations: ASA, American Society of Anesthesiologists (physical status classification); BMI, body 
mass index; UK, unknown; CRP, C-reactive protein; WBC, white blood cell (count);
*Data are means with 95% confidence intervals (CI);
†Data are medians with interquartile ranges.
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   221 21-9-2016   15:10:28
Chapter 11
222
Bacteroidetes
Control
Diverticulitis
Firmicutes
Proteobacteria
13
0
29
2
45
4
61
6
77
8
94
0
19
3
35
5
51
7
67
9
84
1
57
2
73
4
89
6
10
58
12
00
Bacteroidetes Firmicutes Proteobacteria
Fig 1 Heatmap of all profiles sorted and colored by phylum. When profiles are clustered by total 
profile, it can be seen that there is a separation between profiles from diverticulitis patients and 
controls. Proteobacteria profiles can be seen to generally harbour more species in diverticulitis 
patients than in controls.
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of samples from control subjects uncovered that Bacteroidetes represented 51% 
and Firmicutes 49% of the total abundance in the Firmicutes/Bacteroidetes PCR. 
Exactly the same proportions were found for the patient group. The total load 
of bacteria of the Proteobacteria phylum was relatively similar between patients 
and controls (10.2 ± 1.9 log2 RFU and 10.1 ± 2.0 log2RFU for patients and 
controls, respectively; P=0.20, Mann-Whitney U-test). 
A heat map was generated from all IS-profiles separated by phylum. IS-profiles 
showed a general separation of samples from diverticulitis patients and controls 
when clustering was performed on total profiles (Fig. 1). 
Microbial diversity and composition in diverticulitis patients versus 
controls
While diversity of the phyla Bacteroidetes or Firmicutes did not differ between 
patients and controls, the Shannon index indicated that the diversity of the 
Proteobacteria phylum was significantly higher in patients compared to controls 
(2.6[IQR: 1.07] and 3.2 [IQR: 0.5] for controls and patients respectively; 
P<0.00002, Mann-Whitney U-test), which also affected the difference in 
diversity measured when considering all phyla together (3.9[IQR: 0.3] and 
4.1 [IQR: 0.3] for controls and patients respectively; P<0.002, Mann-Whitney 
U-test) (Fig.2).
Differences in overall bacterial community composition were assessed using 
cosine distances between samples. PCoA did not segregate diverticulitis 
patients and controls into different groups for the phyla Bacteroidetes and 
Firmicutes. However, patients could be clustered separately from controls in a 
3-dimensional space based on their Proteobacteria profiles (Fig.3).
All phyla combined Bacteroidetes Firmicutes Proteobacteria
4.5
4
3.5
3
2.5
2
1.5
1
Fig 2 Boxplot comparisons of within sample diversity as calculated by Shannon index all phyla 
combined and per phylum for diverticulitis patients and control subjects, with a significant higher 
diversity of the phylum Proteobacteriaand all phyla combined in diverticulitis patients
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Discriminative ability of PLS-DA
The use of an unsupervised approach for classification (PCoA) already 
demonstrated diagnostic potential of Proteobacteria profiles in predicting the 
health status of a given patient. This potential was born out in a supervised 
analysis, using PLS-DA known to be suitable for high-dimensional data [27,29-
30]. The PLS-DA model used 268 OTUs, representing the 25% most variable 
OTUs, as predictors and the clinical status of the samples (i.e. diverticulitis: yes 
or no) as the response variable. In order to quantify the discriminative ability of 
the model we first considered the full datasets (three individual phylum datasets, 
and one composed of all phyla). Taking the Bacteroidetes or Firmicutes data as 
input resulted in low predictive accuracy rates (55% and 53% for Bacteroidetes 
and Firmicutes, respectively; 
data not shown). Taking the 
Proteobacteria data as input 
resulted in a predictive accuracy 
rate of 95% (Fig.4). Three out of 
56 samples were misclassified: 
one control and two patients, 
whose samples are the encircled 
ones in the PCoA scatterplot 
(Fig. 3). Resulting specificity was 
thus calculated to be 96% with 
a sensitivity of 94%. Taking the 
combined data set, composed 
of all three phyla, as input 
resulted in an accuracy rate 
of 96% with two misclassified 
controls, corresponding to a 
specificity of 92% and 100% 
sensitivity. The misclassified 
controls were two subjects 
with diverticulosis. The most 
discriminative OTUs were found 
to derive largely from the family 
Enterobacteriaceae (Table 2). 
Prediction of diverticulitis using the PLS-DA model
The predictive ability of the model was assessed by cross-validation. The dataset 
was randomly divided into 10 subsets, such that in each iteration one subset was 
chosen to serve as a test set. The prediction results from all iterations were then 
pooled together and enabled us to estimate the performance of the model by 
means of predictive power. Taking account of the Bacteroidetes or the Firmicutes 
phylum only resulted in a low predictive accuracy. For both the Bacteroidetes and 
the Firmicutes the cross-validated accuracy rate was 51%. Considering only the 
Proteobacteria, we reached a cross-validated accuracy rate of 80%. Six controls 
Patient
Control
Fig 3 Principle coordinate analysis (PCoA) 
scatterplot to express between sample diversity 
displays clustering of diverticulitis patients separate 
from control subjects for the phylum Proteobacteria. 
Three samplesthat were wrongly classified by PLS-DA 
are encircled
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   224 21-9-2016   15:10:31
Fecal microbiome analysis as diagnostic test for diverticulitis 
225
and five patients were wrongly classified, which resulted in a specificity of 76% 
and a sensitivity of 84%. When we combined the three phyla, we could reach a 
diagnostic accuracy rate of 84% (spec=80%; sens=87%). Figure 5 summarizes 
the predictive power of the PLS-DA model by means of ROC curves.
Discussion
The results of our study suggest that the fecal microbiota diversity of patients 
with a first episode of acute uncomplicated left-sided diverticulitis differs 
significantly from control subjects from a general gastroenterological practice, 
with the Proteobacteria phylum mainly defining this difference. Furthermore, 
predictive diagnostics based on complex microbiota data seems feasible for 
diagnosing diverticulitis, with a diagnostic accuracy rate of 84%. The most 
discriminative species derived from the family Enterobacteriaceae.  
Several studies have identified characteristics of the intestinal microbiota that 
may be associated with disease, but clinical diagnostic tools based on microbiome 
analysis still need to be developed. Whereas most studies into microbiota 
composition in health and disease identified correlations, here we demonstrate an 
approach in which microbiota composition may be used as a clinical predictor. By 
employing a supervised algorithm in combination with cross-validation, we show 
how microbiota analysis may move towards prediction instead of correlation. 
PLS regression provides a dimension reduction strategy in situations where a 
set of response variables need to be related to a set of predictor variables [27]. It 
is considered a supervised learning method since it uses the dependent (clinical 
status in this study) as well as the independent variables (OTUs) to construct 
variable selection and importance ranking. PLS-DA refers to the particular case 
where the response variable is a set of binary variables describing the categories 
of a categorical variable, e.g. disease states. This model is commonly used in 
the field of chemometrics and in the analysis of microarray expression data, 
as it is especially suited to deal with a much larger number of predictors than 
observations and with multi-colinearity [29-32]. In this study we encountered 
similar challenges; the number of OTUs is much larger than the number of 
samples and some of them are highly correlated. Due to the properties mentioned 
above, we found this approach also very appropriate to apply to IS-pro data. 
The VIP criterion was previously used in PLS-DA microarray analyses to assess 
which genes were useful to discriminate between different groups [29,31-32]. 
Specific shifts in the phylum Proteobacteria -other than general measures like 
diversity- have not been found to be associated with disease before. This might 
be caused by the fact that Proteobacteria generally have a low relative abundance 
in the intestinal microbiota [8,33]. Because almost all current approaches to 
analyze the intestinal microbiota use universal bacterial amplification as a 
starting point, low abundant phyla such as the Proteobacteria remain relatively 
underexplored as other, more prevalent taxa will dominate the PCR reaction and 
following analyses. In contrast, the IS-pro molecular technique comprises two 
separate phylum-specific PCR reactions: one for the amplification of Bacteroidetes/
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Firmicutes and another for the specific amplification of Proteobacteria. While the 
separation of the different phyla in two PCRs prevents us from addressing all 
three phyla together when presenting their relative abundances -consequently 
hampering direct comparisons of abundances- it does allow us to zoom in and 
analyze the Proteobacteria community composition in-depth.
Brook et al. retrospectively studied the aerobic and anaerobic microbiology 
of 110 specimens from the peritoneal cavity after intestinal perforation and 
in 22 specimens from abdominal abscesses of patients with complicated 
diverticulitis [34]. With conventional culture techniques they identified E. 
coli and Streptococcus spp as the predominant aerobic and facultative bacteria. 
The most frequently isolated anaerobes were Bacteroides spp (B. fragilis group), 
Peptostreptococcus, Clostridium and Fusobacterium spp. The only study up to 
date with PCR based sequencing of the microbiota in diverticulitis patients 
was conducted by Gueimonde et al.[35]. They identified a significant higher 
occurrence of Bifidobacterium longum and Bifidobacterium animalis in patients 
with diverticulitis, and their overall conclusion was that aberrances in mucosa 
associated microbiota are present in different intestinal diseases. However, in 
their study only nine diverticulitis patients were included. Resected mucosal 
samples were compared with those of 21 colon cancer patients and four 
inflammatory bowel disease patients, but no healthy controls. Surprisingly, 
they looked only at the genus Bifidobacterium and did not analyze the entire 
profile; they stated they used the bifidobacterial microbiota as an indicator of 
alterations in the mucosal colonization pattern. The bifidobacterial microbiota 
however, is known to constitute only a small fraction of the intestinal microbial 
composition in adults.
Currently, antibiotics are often used in the conservative treatment of 
uncomplicated diverticulitis despite the lack of sound evidence [36-37]. Cyclic 
 *11 types of unknown Proteobacteria species were identified
Table2 Most discriminative OTUs based on a Variable Importance for Projection 
value >1.2
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administration of rifaximin has been proven to be effective in reducing symptoms 
and complications [38-41] and possibly prevents recurrence in patients after 
complicated diverticulitis [42]. Relatively new therapies, such as probiotic 
therapy, are proposed as well for the management of diverticular disease (DD). 
Indeed, a few small open label studies already show promising results [43-46]. 
Considering that antibiotic and probiotic treatments are regularly prescribed 
to DD patients, it is striking that relatively few studies have been performed to 
improve our understanding of the composition of the colonic microbiota. The 
pathophysiology of diverticulitis was assumed to be clear and well understood 
but actually astonishingly little is known about causal factors for this disease. Our 
understanding of the effect of changes in microbiota abundance, diversity and 
composition is limited. Our study therefore, is a first step in further elucidating 
the etiopathogenesis of diverticular disease and its inflammatory complications.
Since a clinical diagnosis of diverticulitis can not be made with a high certainty 
without imaging [47], it seems appropriate to evaluate a test intended for 
making a specific clinical diagnosis against a patient group with variable 
clinical presentation. By taking a cross-section of patients in a general 
gastroenterological practice instead of a healthy control group, the specificity of 
the prediction becomes more meaningful.
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Fig 4 The partial least square-discriminant analysis (PLS-DA) scores plot for the phylum 
Proteobacteriashows a clear differentiation between diverticulitis patients and control subjects
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This tudy has some limitations. First, we have data on only a small study group. 
As a result we are not able to estimate and optimize predictive ability robustly. 
The performance of a predictive tool is prone to be overestimated in its own 
study cohort. For diagnostics by microbiome to be applied in daily practice 
a study like this one should be externally validated and followed by a larger 
study to confirm results and calculate sensitivity and specificity more robustly. 
Second, as a consequence of a small sample size, we were not able to firmly 
compare diverticulitis patients with subjects with diverticulosis. It has been 
hypothesized that DD patients have a changed colonic microbiome. From an 
etiopathogenetic point of view, it would be informative to know to what extent 
the microbiome in diverticulosis resembles the microbiome in diverticulitis 
or health.  Indeed, the two controls that were misclassified, were subjects 
with diverticulosis. This seems to underline a shift in microbiota related to 
diverticular disease. It would be interesting to further investigate whether there 
is a gradual shift in microbiota composition from patients with diverticulosis 
towards diverticulitis. Such a phenomenon should be investigated in a larger 
study group. Further it should be noted that species identification was done by 
in-silico comparison of fragment lengths. While this technique generally gives 
consistent results, identification is not definitive. 
Present study demonstrated that the diagnosis of diverticulitis can be done by 
microbiome analysis with relatively good accuracy. More generally, this study 
illustrates a proof of concept of how diagnostics based on complex microbiota 
data in a broader sense may be applied. This could lead to the use of fecal 
microbiota as diagnostic tool for diverticulitis, with possible patient stratification 
directing a personalized treatment strategy, whether or not to prescribe 
antibiotics, the type of antibiotic, and even to monitor disease course. Clinical 
application as a diagnostic tool could reduce the need for imaging to diagnose 
diverticulitis. Clinical applicability needs to be confirmed in a larger study. 
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Summary and Discussion
In this thesis we set out to explore culture-free bacterial diagnostics and its 
potential for clinical microbiology and translational microbiological research. 
To do this, we developed a eubacterial molecular assay, and named it IS-pro. The 
IS-pro technique detects and identifies bacteria by a specific fragment of their 
ribosomal DNA: the 16S-23S IS-region.
First part: Technical evaluation and validation of the IS-pro technique
The basic technological aspects of the IS-pro technique are explored in the first 
part of this thesis. Chapter one defines the fundaments of IS-pro and thereby 
provides the basis for all following chapters of this thesis. The main themes of 
chapter 1 are applicability and reproducibility. The basic characteristics of IS-
region polymorphisms are explored first: how good is the differential potential 
of bacterial IS-polymorphisms, i.e. to what taxonomic level can bacterial 
strains be differentiated and what is the natural variation in IS fragment length 
within the same bacterial species? We found that most strains (>99%) could be 
differentiated to species level. Some strains could be differentiated only to genus 
level, especially very closely related species like those of the Streptococcus mitis 
group, and some strains could be differentiated to sub-species level, as shown in 
chapter 2. Only very rarely (<0,1% of tested species) did taxonomically distant 
species exhibit identical IS-polymorphisms. For now, in these cases, clinical 
interpretation or additional tests should further guide the microbiologist. In 
the future, additional (labeled) primers or additional PCR reactions might solve 
these issues where relevant. 
Chapter 1 further focuses on more complex aspects of reproducibility such as 
biases towards specific bacterial taxa in the PCR reaction and on reproducibility 
of results for clinical samples obtained within the same host. No biases in the 
PCR reaction for specific taxonomic groups were detected. Variation between 
samples from the same host, but from different locations of the colon turned 
out to be minor. This spatial stability has since been confirmed by others, who 
further showed that the main biogeographical variation in gut microbiota could 
be found over a cross-sectional axis, from lumen to mucus layer (10). However, 
it is still possible that the detected microbiota stability over the longitudinal axis 
of the gut might have been influenced by contamination of the working channel 
of the endoscope through which biopsies were taken; with the same endoscope 
working its way through the entire colon, meanwhile taking various samples, 
it is possible that the working channel and thus all samples passing through 
it may have come to contain a mix of all microbes encountered underway and 
thus represent an ‘average’ colonic microbiota. We are currently investigating 
a technique to keep the working channel sterile. To our knowledge, a validated 
device to do this has not yet been described. When this will be operational, we 
will be able to re-evaluate the findings presented in chapter 1. 
Chapter 2 investigates the nature of sub-species differentiation of IS-
polymorphisms. Such sub-species polymorphisms occur only in a limited 
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number of species. In chapter 2 this feature was explored in Staphylococcus 
aureus, a common microbe with pathogenic potential. We found a clear 
underlying system in the polymorphisms: a total of 16 IS fragments of 
different lengths were detected across a large number of different S. aureus 
strains. Individual strains harboured a limited selection (typically 3-5) of 
these fragments. Bacterial strain typing based on these sub-species IS-
polymorphisms correlated well with other strain typing methods such as Multi-
Locus Sequence Typing (MLST) and Amplified Fragment Length Polymorphism 
(AFLP). This correlation demonstrated the potential of IS-polymorphisms for 
use in epidemiological typing of this species.  Sub-species IS-polymorphisms 
have also been demonstrated in Clostridium difficile by Cartwright et al. and is 
the basis of ribotyping, the most widely used typing method for this bacterial 
species (4). The underlying systematics of these highly structured sub-species 
IS-polymorphisms and their relation to evolutionary distance between bacterial 
strains has been examined to some extent (7,8) but remain largely obscure. The 
close correlation of IS-polymorphisms to whole-genome based typing methods 
such as AFLP clearly suggests that the system of IS-polymorphisms has an 
evolutionary rate that does not exceed that of the rest of the genome.
In chapter 3, IS-pro was tested in clinical practice. IS-pro was performed in 
parallel to routine culture on clinical samples from patients with suspected 
infection. Only samples from normally sterile body sites were included, to make 
the comparison as straightforward as possible. 
We showed that IS-pro detected at least the same bacteria as culture in all but 
one sample, but detected additional bacteria that had not been found by culture 
in many other samples. To further study discrepancies between the culture and 
IS-pro, an additional comparator was used. For the best comparison, we needed 
not only to test for presence of the bacteria found by IS-pro or culture; we needed 
a method that would link the two techniques as accurately as possible. For this 
we developed a molecular technique, which could directly match taxonomical 
classification by sequence information of the ribosomal 16S region (and thus 
to culture) to length information of the IS-region (and thus to IS-pro). We were 
able to do this with a sequencing technique that can read long DNA sequences: 
Pacific biosciences Small Molecule Real Time (SMRT) sequencing. With this 
technique, we were able to confirm IS-pro findings in most cases where culture 
and IS-pro were discrepant. Probably more important: the technique that we 
developed to do this was perfectly suited to populate our IS-pro database. 
With this technique, Woese’s 16S region could be directly matched to IS length 
polymorphisms. We analyzed samples from different body sites to demonstrate 
the universal applicability of IS-pro, with the drawback that sample numbers 
were small for each individual sample type. This precluded making an accurate 
estimation of sensitivity and specificity per sample type. In upcoming studies 
we plan to evaluate these parameters for all clinically important sample types.
In conclusion, in the first part of this thesis it was demonstrated that IS-pro 
gives reproducible results and has a high discriminatory potential, enabling 
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identification of most bacterial taxa up to the species level and some up to strain 
level. In clinical samples, IS-pro was able to detect more bacteria than culture. 
These additional findings were shown to be clinically relevant. Of course, IS-
pro is not the only culture-free method that has been shown to detect more 
bacteria than culture, eubacterial 16S qPCRs or next-generation sequencing 
approaches can also find more bacteria than culture (12,13). However, these 
approaches either need additional steps (sequencing after positive 16S PCR) 
or are currently not (yet) suited for routine clinical application.  IS-pro holds 
promise as a single-step eubacterial molecular diagnostic tool that may be 
readily implemented in clinical routine. Future studies should focus on robustly 
establishing the performance of IS-pro for each clinical sample type.
Second part: Evaluation and validation of IS-pro for intestinal microbiota 
analysis 
The second part of this thesis presents the validation steps that we followed for 
the use of IS-pro as an easily applicable tool for intestinal microbiota analysis. We 
demonstrate that every means of sampling the intestinal microbiota, be it with 
mucosal biopsies, feces or rectal swabs, has its own specific microbial signature. 
The type of sample used to infer gut microbiota composition thus has a big 
influence on the results. In chapter 4, we further show that samples obtained 
by rectal swabbing yield very similar results to those obtained by analyzing 
fecal samples. A major advantage of rectal swab samples is that these are easy 
to collect on demand at bedside or at the polyclinic, and that the microbiota 
profiles that they yield are highly reproducible. When stored in a specific buffer 
at room temperature for 2 hours, resulting microbial profiles are the same as 
those obtained with directly snap frozen samples. Taken together, these results 
suggest that rectal swabs, stored in buffer after sampling, may represent the 
optimal sample type for analysis of the intestinal microbiota in clinical routine. 
In this study we did not yet evaluate whether microbiota alterations due to 
gastrointestinal disease were as detectable in rectal swabs as in other sample 
types. Therefore, in current studies on gut microbiota in disease, we aim to 
collect rectal swabs, fecal samples, and where possible mucosal biopsies, to 
determine the optimal sample type for diagnostic purposes.
Chapter 5 follows up on the work of Escherich in the 19th century. In this chapter 
we too studied initial microbial colonization of the infant gut and its early 
development, only now with a culture-free approach. We were interested to know 
whether differences in the earliest stages of life might influence the development 
of the gut microbiota. We compared children that were born by cesarean section 
to children that had been delivered vaginally and compared the effect of breast-
feeding to formula feeding in both groups. In agreement with existing literature, 
we found a marked difference in microbial colonization between children that 
were delivered vaginally or by cesarean section (14). Children that had been born 
vaginally had inherited certain bacterial species from their mother’s intestinal 
microbiota, while children born by cesarean section had not. While it has been 
also been noted before that the gut microbiota of children delivered by cesarean 
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section are depleted in Bacteroidetes (3), our study found that a large percentage 
(40%) of children that were born vaginally also exhibited a cesarean section-
type microbiota. This finding has been described only once before for a small 
study population (9) and could be due to increasingly medicalized deliveries, in 
which children may be exposed less to the maternal (fecal) microbiota than with 
more traditional home deliveries. The fact that other studies did not describe 
cesarean-type microbiota in vaginally delivered children may be due to the fact 
that comparisons have generally been made between delivery modes, without 
performing unsupervised classifications of data sets. Nonetheless, our finding 
may shed new light on the correlations that have been made between delivery 
by cesarean section and later-life pathology such as asthma, allergy and obesity: 
if these associations are caused by differences in early life microbiota acquisition 
and development, these associations might become even more evident and 
understandable when children would be classified not by delivery mode but by 
settler type: the signature of the first colonizing microbiota. In agreement with 
existing literature, in this study we observed only minor effects of breast or 
formula feeding on gut microbiota development (1,2). Possibly, increasing both 
group size and follow-up period might reveal more details on these effects.
Chapter 6 was aimed at setting reference standards for healthy gut microbiota to 
which diseased microbiota may be compared for future diagnostic applications. 
In this chapter our analysis of the composition and stability of the gut microbiota 
of 61 healthy children from 2-18 years is described. 
Here we identified a core microbiota in children: a set of bacterial species 
that is commonly present in almost all healthy children. This is of interest 
to clinical practice, as we have now seen in currently unpublished work that 
these core species are often missing in intestinal disease. This finding not only 
presents diagnostic opportunities, but also suggests that a microbiota-based 
remedy for the disease might be worth exploring. Stability of the microbiota in 
children was highly phylum specific. Bacteroidetes showed the highest stability. 
Stability analysis showed quite some short-term variation, but a relatively high 
long-term compositional stability. Together, these findings suggest that the 
intestinal microbial ecosystem of children consists of a stable microbial core 
in combination with an ever-changing population of short-term residents. Our 
findings are in line with existing literature: the emergence of a microbial core in 
children has been shown previously with a different technique (5) and findings 
on stability of the microbiota are similar to data that has been described for 
adults (6). What we add here is confirmation of a microbial core in a larger group 
and stability data on children instead of adults.
Interestingly, besides describing the composition and stability of the microbiota 
of children, we were able to confirm a longstanding but unproven dogma of 
general ecology; ecological theorists have long postulated that diversity of an 
ecosystem is positively correlated with its stability: the higher the biological 
diversity of an ecosystem, the more stable it is. However, this hypothesis was 
difficult to confirm, as it is not easy to find a set of ecosystems with different 
diversity existing under more or less the same conditions and to monitor these 
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ecosystems through time. However, the gut microbiota of different children can 
certainly be considered different instances of ecosystems under highly similar 
conditions. Indeed, in our study we found a very clear positive correlation 
between diversity and stability. This may not only be interesting for theoretical 
ecology, but also for clinical practice: low diversity of gut microbiota has been 
associated with various diseases. Increasing the diversity may stabilize gut 
microbiota and ameliorate the clinical condition, a hypothesis that may also 
partially explain the beneficial effect of fecal transplantation in Clostridium 
difficile associated diarrhea (16). 
In conclusion, in part two of this thesis, we further elaborated on the validation 
of IS-pro for gut microbiota analysis as described in chapter 1. We demonstrated 
that microbiota analysis can be performed on rectal swabs, which is convenient 
for clinical practice and simplifies standardization of sampling. We further 
showed that first colonization of the gut of newborns could be classified into 
two settler types: a Bacteroidetes dominant settler type associated exclusively 
with vaginal delivery and a Firmicutes dominant settler type, which occurred 
in both children born by cesarean section and by vaginal delivery. These settler 
types had different development through the first three months of life and may 
be important in development of allergies or asthma in later life. Finally, we 
investigated stability of gut microbiota and identified stable microbiota with a 
common microbial core in children. These findings may be very useful in clinical 
diagnostics and possibly in microbiota-based therapies.
Third part: application of IS-pro to different microbial ecosystems and 
demonstration of clinical applications
In the third and final part of this thesis we describe how the IS-pro technique 
can be applied for the analysis of complex microbiota of different parts of the 
human body. We also studied the potential of IS-pro in clinical diagnostics 
based on complex microbiota; we tested this in applications ranging from 
relatively straightforward to very difficult. Further elements of standardization 
also became apparent in this third part of the thesis: timing of sampling and the 
exact sample type were critical for diagnostic applications. 
Chapter 7 explores whether a viral infection of the upper respiratory tract can 
give rise to a modification in the nasopharyngeal microbiota and whether such 
a change might be associated with the development of asthma. We explored 
this question in children with a predisposition for developing asthma, as it is 
known that a viral infection of the nasopharynx may trigger the development 
of asthma. We found that these infections give rise to an increase in abundance 
of species from the phyla Firmicutes and Bacteroidetes. Interestingly, the up 
regulation of Bacteroidetes persisted in the group of children who went on to 
develop asthma. These findings and the possible causal relation between changes 
in microbiota composition and the development of asthma are currently being 
further investigated in a larger follow-up study.
Chapter 8 describes a first step in the validation of complex microbiota analysis 
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with IS-pro as a diagnostic tool. To investigate this, we applied IS-pro for 
diagnostics of periodontitis, an inflammation of the tissues that surround and 
support teeth, which may lead to tooth loss. We chose to use periodontitis as 
a test case as the oral microbiota is complex, yet readily accessible and because 
there are already diagnostic tools to assess periodontitis available. Moreover, the 
disease is known to be caused by groups of cooperating bacterial species, thus 
it is clear that microbiota-based diagnostics should in principle be applicable. 
Finally, the disease can readily (visually) be assessed by dentists, making it 
relatively straightforward to select a well defined diseased and control group. 
Our aim was to evaluate the performance of IS-pro as a diagnostic tool in 
complex microbiota for a well-defined binary decision: periodontitis versus 
healthy. We compared the performance of IS-pro to that of a panel of seven 
specific bacterial qPCRs, which is currently the golden standard in periodontitis 
diagnostics next to culture. Oral microbiota analysis with IS-pro showed a clear-
cut separation into two groups: healthy and periodontitis, while the comparator 
test showed a less evident separation between these groups. This study does 
certainly not provide the final word on periodontitis diagnostics by IS-pro, as 
sample numbers were too small for this. However, this study provides proof of 
principle on the applicability of IS-pro in complex microbiota based diagnostics.
Chapter 9 describes another exploration into diagnostics of the oral microbiota. 
Here we investigated the microbiota associated with inflamed tooth implants, 
an affliction called peri-implantitis. As tooth implants are relatively new, peri-
implantitis has not yet been very extensively studied. Because we thought that 
(early) diagnosis of peri-implantitis might be an interesting clinical application, 
we explored an easy sampling approach by taking samples with oral swabs of the 
buccal mucosa, which are much easier to obtain than paperpoints. Paperpoints 
are small paper lancets, which must be inserted between tooth and gum to 
absorb the microbiota present in these pockets, and are currently the standard 
sampling instrument. The results indicated that the oral microbiota around the 
implants is indeed characterized by a distinct microbiota, which is different 
from that around uninflamed implants or healthy dentition. Interestingly, no 
disease-related microbiota composition signature was detected when samples 
were obtained by oral swabbing. Disease-specific signatures were only identified 
in samples obtained with paperpoints. This finding underlined the hypothesis 
that peri-implantitis is caused by a local poly-microbial inflammation around 
the implants, and that samples should thus be obtained from the inflamed 
tissue that surrounds the implants. 
Chapter 10 returns to the gut microbiota. This chapter investigates whether 
diverticulosis -a disease typically of elderly people, in which outward bulges 
of the colon are formed- is associated with a modified intestinal microbiota. 
To analyze this, we endoscopically sampled the mucosa of the sigmoid colon, 
directly adjacent to diverticula and the mucosa of the transverse colon, where 
no diverticula were found. For comparison, we also obtained mucosal biopsies of 
the sigmoid and transverse colon of individuals without diverticula. All samples 
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were analysed by histology and by microbiota analysis with IS-pro. It was found 
that microbiota composition of the sigmoid and transverse colon was highly 
similar in subjects with and without diverticula. Moreover, no disease specific 
changes were found either by histology or IS-pro. Hence, it appeared that the 
gut microbiota in diverticulosis was not altered.
In the final chapter, chapter 11, we followed up on our investigation into 
diverticula, but here we assessed whether an inflammation of these lesions -a 
condition known as diverticulitis- leads to alterations in the microbiota that can 
be detected with IS-pro. The symptoms of diverticulitis cover a wide range; for 
a definite diagnosis a computed tomography (CT) scan is needed. An important 
aspect of this study was that the control group did not consist of healthy 
control subjects. While the approach of assessing the efficacy of a diagnostic 
test by comparing healthy to diseased people is very popular, it is in essence 
incorrect. It is incorrect because this is not the situation as encountered in a 
clinical setting: healthy people do not usually visit a gastroenterologist. A test 
that claims to identify a specific disease should therefore be tested in a group 
of afflicted people versus patients suffering from a different disease but with a 
similar clinical presentation. This is how we evaluated the performance of IS-pro 
to detect diverticulitis: afflicted patients were set against patients presenting 
at the gastroenterology outpatient clinic with other intestinal diseases. In this 
setting, with IS-pro we were able to reach a diagnostic accuracy rate of 84% 
for diverticulitis compared against CT as golden standard (15). Nevertheless, 
we realized that the study would need a follow up. Control group samples had 
been taken from patients that had presented for endoscopic evaluation and 
had thus received medication to promote voiding of the intestines, thereby 
potentially disturbing the intestinal microbiota. We followed up on this issue by 
re-training the model with samples taken from subjects that had not undergone 
bowel cleansing. The results that we had found previously held true, however 
the sample sizes in this follow-up study were small. Currently a larger follow-up 
analysis is in progress.
The issue of standardization
A large part of this thesis is devoted to standardization. Standardization does 
not only relate to standard laboratory protocols, but includes setting standards 
for the diagnostic chain as a whole: which sample to take (addressed in chapters 
4 and 9), where exactly to sample (chapter 1), when to sample (chapters 5, 6 
and 7), to which reference to compare (not to healthy controls but preferably to 
patients presenting with similar complaints with a different diagnosis, chapter 
11), how to store a sample (snap freezing versus in buffer at room temperature, 
chapter 4), how to pre-process each specific sample type (e.g. bead beating or 
not, chapter 4), and, needless to say, all steps performed in the laboratory for 
sample analysis (chapters 1 and 3).
We found that every detail of the diagnostic chain has an impact on results, 
sometimes even an unexpectedly large impact (e.g. the specific brand or model 
of PCR machine is of great importance for the final result), some unexpectedly 
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small (the exact location of sampling in the colon did not influence the 
microbiota profile).
In a recent meta-analysis, Catherine Lozupone and colleagues elegantly showed 
what happens when workflows are not thoroughly standardized (11). These 
investigators compared eight large studies of the human gut microbiota, all 
performed with next generation sequencing. Different groups performed these 
studies, all with their own workflows, and even though workflows were similar 
in most cases, the results of this meta-analysis are startling. The gut microbiota 
composition and diversity clustered very strongly by study (figure 1), obscuring 
many biologically (and clinically) meaningful compositional differences. 
Needless to say, this kind of variation precludes any type of clinical diagnostic 
application. 
Next generation sequencing
During the period that the work for this thesis was performed, much has happened 
in the field of microbiology, in particular in the field of molecular microbiology. 
The most important development has been the advent of next generation 
sequencing techniques. New massively parallel sequencing technologies have 
become available on a large scale since the market introduction of the GS20 
pyrosequencing machine in 2005 by 454 technologies. Other developers 
of next-generation techniques (NGS) followed suit and the past decade has 
seen the introduction of four major new sequencing plaforms: illumina, 
Figure 1. Principal Component meta-analysis of eight different studies investigating the human 
microbiome by next generation sequencing. It is apparent that outcomes are highly study specific 
and thus determined to a large degree by experimental protocols. (HMP, human microbiome project; 
IBD, Inflammatory bowel disease; PC, Principal component) Adapted from Catherine A.Lozupone et al. 
Genome Res. 013 Oct; 23(10): 1704–1714.
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   241 21-9-2016   15:10:35
242
ionTorrent, PacBio and Oxford nanopore sequencing. All these techniques 
have their particular strengths and weaknesses, but they all share the ability 
to determine the sequence of large numbers of DNA molecules simultaneously. 
These techniques have made a tremendous impact on life-sciences research and 
continue to do so. One might wonder whether this leaves room for IS-pro as an 
application in the future. We believe it does: while NGS provides a truly amazing 
new analysis tool, the importance of which cannot be underestimated, it is not 
(yet) suited for application in clinical routine. There are three main drawbacks 
for standard application of NGS in clinical routine. The first is expense: NGS 
approaches remain too expensive for clinical diagnostics. This may be mitigated 
by running large batches of samples at the same time, but this is not very well 
suited to clinical microbiology, where clinicians typically want fast answers 
to choose optimal treatment regimens and thus cannot afford to wait for the 
moment that enough samples have come in to make an NGS run affordable. It is 
often said that prices will inevitably drop in the future, as they have done over 
the past years. While this is likely to be true, this same argument holds true for 
other techniques, such as IS-pro. A second drawback of NGS for clinical routine 
is the complex sample processing workflow. Sample work-up takes two days and 
many hours of hands-on time. It is claimed now for quite some years that this 
will become easier in the future, but no clear evidence of this has yet emerged. 
A third drawback has been shown by Lozupone and colleagues: the difficulty 
to standardize NGS to such an extent that identical results can be produced 
regardless the hospital or laboratory where it is performed. This issue is far from 
trivial, as we have experienced first hand while standardizing IS-pro. For the 
NGS techniques, this may prove significantly more difficult than it has been for 
the technically less complex IS-pro technique.
It is no novelty that new techniques are presented as ‘disruptive’ and ‘game 
changers’, stirring an entire field into unease in anticipation over the world 
to change. The same was said about micro-array fifteen years ago, and the 
same will be said about many novel techniques yet to come. In the end it is 
not promise or potential that counts, but added value and implementability in 
clinical practice. Indeed, few methods can meet the high standard required for 
clinical diagnostics: it is no coincidence that a plethora of new developments 
and new techniques have come and gone but the more than a hundred year 
old technique of nutrient and agarose-based microbial cultivation remains the 
mainstay of clinical microbiology. Novel up- and downstream techniques have 
been developed: machines to apply samples to agar plates upstream and the 
replacement of biochemical panels by MALDI-TOF downstream, but culture 
remains at the heart of the microbiological laboratory.
Addendum
Valorization of IS-pro
To achieve the high level of standardization needed to perform clinical 
diagnostics based on complex microbiota, an essential element -even a condition 
sine qua non- is standardization: centralized production of the reagent kits to 
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perform reactions, centralized issued Standard Operating Protocols and -if at 
all possible- centralized data analysis facilities. To formalize this process of 
standardization and to open up the IS-pro technique to laboratories other than 
our own, we decided to attain European CE/IVD marking for the IS-pro kit. 
Only by committing ourselves to these very high -externally set- standards, 
could we begin to consider applying clinical diagnostics based on complex 
microbiota analysis. This marking process is not considered to be research, so it 
is not described in this thesis, but it did involve a tremendous amount of work. 
To be able to fund and perform all tests and validation steps necessary for CE/
IVD marking, we founded a spin-off company, IS-diagnostics. By doing this, we 
were able to further technically develop the IS-pro technique and to develop and 
maintain an ICT platform supporting IS-pro and which can perform automated 
data analysis. The ICT platform further consists of a web-based tool to upload 
IS-pro data files from any laboratory worldwide to a centralized server for 
automated analysis. Next, we developed a multi-purpose internal control, which 
controls not only for PCR amplification, but also for the automated analysis 
performed by the ICT platform. With this internal control, potential technical 
errors that may occur during the IS-pro process can be automatically detected. 
This was an essential prerequisite to be able to achieve the high level of confidence 
of results necessary for CE/IVD marking. The conclusion of this thesis coincides 
with the official European CE/IVD marking of the first commercial IS-pro kit, 
coined the ‘Molecular Culture’ kit. The name Molecular Culture expresses our 
ambition to combine in one kit the best aspects of bacterial culture and PCR 
in a single assay. Just like a novel approved medicine would be the ultimate 
conclusion of any pharmaceutical research project, this kit represents to me the 
ultimate conclusion of research into a new diagnostic tool and is for me the 
crown on the work of this thesis.
Final thoughts
For me, the most rewarding feature of this thesis is that IS-pro truly works in 
the clinic. It can make diagnoses where other techniques cannot. Over the past 
two years we have been using IS-pro in clinical practice and we have detected 
many pathogens that were missed by culture. It fills me with joy whenever a 
diagnosis is made with IS-pro. One memorable occasion occurred recently, when a 
rheumatologist, who wanted to send in a punctate from an infected shoulder joint, 
called one of my colleagues. She had already administered antibiotics empirically 
to the patient and asked my colleague to just ‘skip the culture and do an IS-pro 
straight away’. As it turned out, culture was still performed and was negative, 
while the IS-pro result showed a Streptococcus agalactiae, a known causative agent 
of infectious arthritis. 
So could IS-pro completely replace culture in the future? At this point it is unlikely, 
as antibiotic susceptibility profiles cannot be given by IS-pro. For the time 
being, culture is still be needed for determining the best treatment regimens for 
pathogenic bacteria, but in the future we may witness a culture-free microbiology. 
Which technique will prevail as the future diagnostic tool of choice is almost 
impossible to predict, however IS-pro may certainly be a good candidate.
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Dankwoord
En dan nu, het belangrijkste deel van dit proefschrift, het dankwoord. Het 
belangrijkste, aangezien dit het enige deel is dat kans maakt daadwerkelijk 
gelezen te worden. Daarmee is dit ook meteen het gevaarlijkste deel: staan 
de bedankjes wel in de meest optimale volgorde, verval ik niet al te veel in 
zoetsappige clichés en natuurlijk de grootste valkuil: vergeet ik niemand? 
Wat betreft dit laatste punt heb ik een oplossing gevonden: mocht je nou 
onverhoopt niet genoemd worden in dit dankwoord, terwijl je dat wel 
degelijk verdiend hebt (een welgemeende knipoog ergens gedurende mijn 
promotietraject kan al voldoende zijn): geen paniek! Stuur gewoon even een 
briefje met je naam, een korte omschrijving waar ik je precies van zou moeten 
kennen en je vermeende bijdrage aan de totstandkoming van dit boek en voilà! 
Bij de volgende druk sta je er gewoon tussen.
En dan nu het daadwerkelijke bedanken. Ik heb het gevoel dat ik tijdens dit 
hele traject veel mensen veel te weinig bedankt heb voor al hun hulp, inzet en 
enthousiasme, dus ik ben blij dat ik dit nu eindelijk officieel kan doen. Dit project 
is echt multidisciplinair geweest, en veel mensen zijn essentieel geweest in het 
slagen ervan, dus er moeten nogal wat mensen bedankt worden. Dit dankwoord 
is dan ook vrij lang, maar dat is een realistische afspiegeling van de hoeveelheid 
mensen die in belangrijke mate hebben bijgedragen aan dit werk.
Ten eerste moet ik natuurlijk mijn promotor Paul Savelkoul bedanken. Paul, jij 
was voor mij de gedroomde promotor. Wij hadden direct een hele goede klik 
zowel wetenschappelijk als persoonlijk. Je hebt mij niet alleen onnoemelijk 
veel geleerd over moleculaire biologie maar ook over de vertaling van basaal 
onderzoek naar klinische toepassingen en alle onverwachte aspecten die daar 
bij horen, van patent strategieën tot kit productie. Als ik jou niet als promotor 
had gehad, was mijn leven anders gelopen, daarvan ben ik overtuigd.  Wat ik 
het meest ben gaan missen na jouw vertrek naar Maastricht zijn onze eindeloze 
gesprekken over nieuwe ideeën, bij voorkeur gevoerd in de deuropening terwijl 
we allebei eigenlijk al lang bij een andere afspraak hadden moeten zijn. Gelukkig 
is het afronden van dit boekje niet het einde van onze samenwerking. Ik hoop 
dat we nog vele jaren succesvol zullen samenwerken!
Dan mijn tweede promotor en opleider: Christina, door jou ben ik op het VUmc 
terecht gekomen, waar ik je erg dankbaar voor ben. Vanaf het prille begin van 
mijn opleiding heb je me altijd gesteund in mijn onderzoek, wat het ook was en 
hoe ver het ook afstond van de klinische praktijk: van het maken van fluorescente 
zwermende bacteriën tot het analyseren van mammoetpoep. Van jou heb ik 
heel veel geleerd, niet alleen over de medische microbiologie, maar ook over het 
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schrijven van artikelen, het goed opzetten van een studie, epidemiologie, er een 
nacht overheen te laten gaan voordat je een boze mail verstuurt en natuurlijk: 
de noodzaak van het stellen van deadlines. Dit laatste was in mijn geval zeker 
geen overbodige luxe. Ik ben je erg dankbaar dat je met name in de laatste fase 
van dit promotietraject structureel druk hebt gezet op het afronden ervan, 
anders was dit boek waarschijnlijk niet voor 2050 verschenen.
Mijn copromotor Ad van Bodegraven. Ad, ook jij bent tijdens mijn promotietraject 
naar Limburg vertrokken. Blijkbaar heb ik dat effect op mensen. Ik ben heel erg 
blij dat jij vanaf het begin bij mijn promotie betrokken bent geweest. Jij had 
vanuit de maag-, darm leverziekten vaak een totaal andere kijk op het onderzoek 
en hebt het onderzoek daardoor in belangrijke mate gestuurd. Door jou hebben 
we goede banden met de afdeling MDL opgebouwd, niet alleen aan de VU, 
maar door het hele land. Door deze hechte samenwerking van microbiologie en 
MDL, heb ik het idee dat we zoveel mogelijk werken aan toepassingen die ook 
echt aansluiten aan de klinische praktijk. Ik ben je erg dankbaar voor je niet 
aflatende enthousiasme en immer kritische blik, niet alleen op het onderzoek 
maar eigenlijk op alles.
De leden van de leescommissie. Graag wil ik Prof. dr. Remco Kort, Prof dr. Marc 
Bonten, Prof dr. Menno de Jong, dr. Erwin Zoetendal en Prof dr.  Rinse Weersma 
hartelijk bedanken voor hun bereidheid mijn proefschrift te beoordelen
Dan moet ik natuurlijk als de wiedeweerga de dames van IS-Diagnostics 
bedanken! Sommige momenten of gebeurtenissen zijn bepalend voor het 
verloop van je carrière. Voor mij was het krijgen van de NGI pre-seed subsidie 
daar zeker een van. Met dat geld kon IS-Diagnostics opgericht worden en kon er 
opeens structureel hulp komen voor het IS-pro project. 
Linda, nadat je mij als AIOS had opgeleid in het kweken van virussen, heb jij 
je later als eerste aangesloten bij team IS-pro. En daarmee veranderde alles. 
Door jou niet aflatende inzet en enthousiasme is het hele project echt van de 
grond gekomen. Jij bent van onschatbare waarde geweest voor het hele IS-pro 
project en bent dat tot op de dag van vandaag nog steeds. Met je vrolijkheid en 
oprechte wil om van iedere situatie het beste te maken is het altijd een feest om 
met je samen te werken. Ik ben je heel erg dankbaar voor al je inspanning en 
toewijding.
Malieka, jij maakte je grote zorgen of ik niet zou vergeten jou te bedanken in 
dit boekje. Op zich is het natuurlijk geen gekke gedachte dat ik iets zou kunnen 
vergeten, maar het is echt ónmogelijk dat ik jou zou vergeten te bedanken. Jij 
hebt je sinds de allereerste dag we samenwerken altijd volledig ingezet en hebt 
zo hard gewerkt om alle proeven, rapporten en alle andere dingen af te krijgen. 
Zelfs het figuur van de kaft van dit boek heb je samen met Ron in de avonduren 
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in je vrije tijd gemaakt. Voor al die jaren onafgebroken inspanning en toewijding 
wil ik je heel erg bedanken. Ik hoop dat we nog heel lang mogen samenwerken!
Suzanne, jij bent als laatste toegetreden tot het illustere team van IS-Diagnostics. 
Net als Malieka ben jij als stagiair bij mij begonnen en viel je op door je goede 
en harde werken. Jij hebt absoluut een gave als analist. Het lijkt wel alsof geen 
enkele proef die jij doet mislukt. Daarbij ben je enorm bescheiden en werk je 
zonder daar veel ophef over te maken keihard en volledig gestructureerd aan 
ieder project dat op je pad komt. Ik ben extreem blij dat je bij mij werkt en hoop 
dat je dat nog heel lang wil blijven doen. En nu ik toch een keer zo eerlijk ben: Ik 
weet heus wel dat paarden intelligente dieren zijn en dat ze hun baasje kunnen 
herkennen.
En dan vergeet ik nog bijna Joep. Joep, jij hebt werkelijk niets bijgedragen aan 
het tot stand komen van dit proefschrift, maar toch wil ik je graag bedanken. Jij 
hebt vanaf onze eerste ontmoeting laten zien dat je theoretisch een hartstikke 
degelijke werknemer zou kunnen zijn. Jij bleef altijd als laatste op kantoor en 
was er ‘s ochtends alweer als eerste. Weliswaar lag je vervolgens vrijwel de gehele 
werkdag te slapen in een bol watten, maar dat is iets wat ik zelf ook graag zou 
doen. Helaas hebben we afscheid van je moeten nemen toen we verhuisden naar 
het O2 gebouw en jouw soort daar niet welkom bleek. Het doet me deugd om 
op een recente foto te zien dat je inmiddels moddervet bent geworden. Leuk! 
Obesitas staat je goed. Het ga je goed Joep, je bent een fantastische muis.
Leden en aspirant leden van team IS-pro
Anat Eck, you have contributed a lot to this book. Thank you for all your work 
on the analyses of Dibiota and INCA studies, and thank you for all your work on 
implementing analyses in Spotfire. I really enjoy our endless discussions on data 
analysis. I wish you the very best with your own thesis!
Maysa Schepens, of eigenlijk Ma-yyyy-sa, zoals je het zelf nooit zegt: ik vind het 
prachtig dat ook jij hebt gekozen om je in de wondere wereld van de IS-pro te 
begeven. Helaas ben je momenteel nog erg veel tijd kwijt aan de wondere wereld 
van het succesvol includeren van patiënten in multicenter studies, maar ik heb 
er het volste vertrouwen in dat je dit succesvol gaat afronden en daarna als een 
dolle artikelen gaat produceren!
Evelien de Groot, heel erg leuk hoe jij vanuit de maag- darm leverziekten ook 
een vast onderdeel van team IS-pro bent geworden. Altijd in voor gezelligheid, 
een IS-pro run inzetten of een paar jaar aan een review werken (wat overigens 
typisch iets van MDL artsen is)! Erg jammer dat je er niet meer structureel bij 
kan zijn door je opleiding.
Claudette van den Broek, hoewel je feitelijk een stage deed, heb je je ook ontpopt 
tot een echt IS-pro teamlid en heb je zelfs een plek in de ISD whatsapp groep 
verworven. Goed werk en succes met je carriere!
Martine Hoogewerf, jij hebt een hoop werk gedaan voor de echte klinische 
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implementatie van IS-pro voor routine samples en daarnaast veel werk 
gedaan aan de ophanden zijnde schimmel IS-pro. Veel dank voor je inzet en 
enthousiasme!
Annemieke van de Craats, jij hebt ook veel mooi werk verricht aan het opzetten 
van de schimmel IS-pro. Het is heel jammer dat je nu weer volledig wordt 
opgeslokt door de diagnostiek. Je bent te alle tijden weer welkom binnen team 
IS-pro!
Alex Koek, jij runt eigenlijk alle IS-pro reacties voor de kliniek en je bent 
inmiddels volleerd in het interpreteren ervan. Dank voor je inzet en interesse!
Joffrey van Prehn, jij begint ook langzaam team IS-pro binnen gelokt te worden. 
Dat is een mooie ontwikkeling. Ik zou zeggen: verzet je niet, laat het gewoon 
gebeuren. Het is prachtig!
Susanne Stoof, ook jij wordt langzaam maar zeker binnen gehengeld bij team 
IS-pro. Resistance is futile. Na je zwangerschapsverlof kan je je klinische studies 
gewoon weer oppakken!
Bas Wintermans, ik heb jammerlijk gefaald jou binnen te halen bij team IS-pro. 
De aantrekkingskracht van Brabant bleek te overweldigend. Maar nu op afstand 
lijkt het misschien toch nog te gaan lukken. Nog één tripje naar Siberië deze 
winter en je bent denk ik volledig om.
Ascelijn Reuland, jij hebt nog nooit echt duidelijk stappen gemaakt om deel te 
worden van het team. Toch is er voor jou nog hoop. Mogelijk als chapter Utrecht. 
Ik vond het heel fijn om met jou de perikelen van het promoveren te kunnen 
delen, al lag jouw tempo beduidend hoger dan het mijne.
Thomas Binsl and Alex Michie, a.k.a. ClinicaGeno, you have of course been 
essential in making this project happen. You have made it possible for IS-pro 
to progress from a basic laboratory technique to an advanced interface between 
biology and bio-informatics. You are still working very hard on advancing 
and improving the ICT platform. Thank you very much for all your years of 
collaborating on this project!
Iedereen van Microbiome: Arnold, Martine, Christel, Sonja, Monique, Servaas, 
Cedric, veel dank voor jullie hulp bij een hele hoop verschillende dingen. Altijd 
waren jullie bereid hulp te bieden vanuit jullie verschillende expertises. Van 
testen inzetten en DNA isoleren tot adviseren over research contracten en zelfs 
het produceren van de eerste officiële IS-pro kits. Fantastisch! Arnold, jij nog 
in het bijzonder veel dank voor al jouw adviezen met betrekking tot de CE/IVD 
markering van de IS-pro kit.
Alle mede-auteurs, in alfabetische volgorde: Wim van Aalderen, Marc Benninga, 
Eelco Bergsma, Ad van Bodegraven, Marja Boermeester, Hans Bogaards, Herman 
Bril, Rene Buijsman, Esther Consten, Clarissa Crijns, Miguel Cuesta, Lidewine 
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Daniels, Engeline van Duijkeren, Anat Eck, Peter Gooris, Thijs Grasman, Evelien 
de Groot, Eric Haarman, Simone Hashimoto, Martine Hoogewerf, Fenna 
Jansen, Debby Kaersenhout, Jan Kluytmans, Niels de Korte, Frank Kneepkens, 
Johan Kuyvenhoven, Fong Lin, Tim de Meij, Clemens Meijssen, Damian Melles, 
Johanna Oudshoorn, John Penders, Linda Poort, Ger Rijkers, Nicole Rutten, 
Paul Savelkoul, Marc van der Schee, Aline Sprikkelman, Peter Sterk, Hein 
Stockmann, Christina Vandenbroucke-Grauls, Arine Vlieger, Edwin Winkel en 
Arie Jan van Winkelhoff. Heel veel dank voor jullie samenwerking, kritische 
beoordeling en suggesties ter verbetering van de manuscripten. Hans, Marc, 
Nicole en Lidewine, met jullie heb ik vrij intens gewerkt aan data analyses. Ik 
vond het mooi om dat met jullie vanuit zo verschillende vakgebieden te doen!
Heel veel dank ook aan de vele stagiaires die bij dit project betrokken waren. 
Uit Frankrijk: Camille, Anaelle, Pierre, Thomas, uit Oostenrijk: Carina, uit 
Iran: Nima, en uit Nederland: Fong, Hilde, Jordy, Leroy, Warsha, Cyriel, Mario, 
Martijn, Cornelis en Roderick. Thank you all! 
Mijn collega’s van het VUmc. Dank aan al mijn collega’s van de klinische 
microbiologie voor alle gezelligheid en het prettige samenwerken. Dank met 
name ook aan de AIOS en ex-AIOS voor de vele borrels en AIOS-weekenden, 
waar ik als emeritus AIOS gelukkig nog steeds mee naar toe mag. Schitterend! 
Ook dank aan mijn collega’s van de microbiologie research! Ben en Wilbert, 
dank dat jullie mij altijd, al zij het soms met enige argwaan, hebben gesteund/
gedoogd in mijn onderzoek. Ook dank aan alle AIO’s voor de vele mooie borrels, 
kerstdiners en labuitjes. Kinki, jij nog dank voor een zeer inspirerende trip naar 
Boston en New York.
Jasper Koning, veel dank voor het opmaken van dit hele boek in een 
verschrikkelijk korte tijd!
Vrienden en Familie
Allereerst wil ik mijn hele goede vrienden Bastiaan van der Reijt, aka de Yeti en 
Thomas Jongsma bedanken voor onze oneindige gesprekken over wetenschap, 
muziek en nihilistisch geneuzel. Yeti, heel veel dank voor alles wat je me hebt 
geleerd over programmeren en dat je mij hebt geïntroduceerd in de wondere 
wereld van machine learning. Dit zijn essentiële elementen gebleken voor dit 
hele project. Thomas, dank voor je voortdurende muzikale opvoeding en vele 
concertbezoeken en andere mooie dingen gedurende deze periode.
Uiteraard moet ik ook mijn grote dank uitspreken aan de leden van DA.  Jullie 
niet aflatende gebral heeft mij overal doorheen gesleept. Prachtig hoe we al 
zovele jaren iedere twee weken bijeen kunnen komen en in principe iedere 
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avond weer min of meer hetzelfde gesprek voeren, met slechts heel sporadisch 
wat variatie. Dit is het soort stabiliteit waar ik wat mee kan. Er zijn vijf frasen 
die DA echt kenschetsen wat mij betreft: Koesteren, Dierbaar, Dicht bij jezelf, 
Geborgenheid, en natuurlijk Eingang Nort. Veel dank en ik hoop nog vaak aan 
te kunnen schuiven.
Voor ik dan uiteindelijk over ga tot de grande finale van dit dankwoord, het 
bedanken van familie, moet ik nog twee hele belangrijke mensen noemen:
Mijn paranimfen Thijs Grasman en Tim de Meij. Thijs en Tim, jullie zijn twee 
hele groten binnen team IS-pro en ik zie jullie nog heel ver komen. Thijs, jij 
begon iets later dan ik met jouw promotietraject. Op een van jouw eerste dagen 
op de VU dumpte Ad je bij mij: ‘dit is Dries Budding en die gaat je uitleggen 
wat je zo ongeveer gaat doen de komende jaren’. Op dat moment kreeg ik een 
visioen en in een trance orakelde ik jou: ‘jij gaat de komende acht jaar werken 
aan een review over microbiota samplen voor inflammatoire darmziekten’. De 
rest is geschiedenis. Als ik nu zie hoe ver je inmiddels al bent gekomen met 
die review krijg ik kippenvel tot aan m’n tandvlees. De hoeveelheid liefde en 
aandacht die jij in dat stuk hebt gestoken is adembenemend. Vertrouw mij: jij 
gáát een hele grote worden. 
Tim, ik weet eigenlijk niet meer hoe wij elkaar hebben ontmoet. Ik vermoed op 
de VU. Wat ik wel weet is dat wij een nogal succesvolle ongoing samenwerking 
hebben. Het is onwaarschijnlijk hoe snel jij een studie hebt opgezet en 
gigantische aantallen patiënten hebt geïncludeerd. Ik ben ook groot liefhebber 
van onze lange analyse sessies. Soms succesvol, meestal teleurstellend, maar 
altijd gezellig! Thijs en Tim, ik vond het fantastisch dat jullie zo’n groot deel 
hebben uitgemaakt van mijn promotietraject en ben heel erg blij dat jullie mijn 
paranimfen wilden zijn. Heel veel dank!
Familie
Ik vind het eigenlijk een beetje raar om je familie die je al je hele leven kent 
en waarbij het zo evident is dat je dol op ze bent, hier in zo’n boek te gaan 
bedanken. Toch ga ik me er maar aan wagen. Ook omdat je je moet afvragen, als 
dit al niet een gelegenheid is, wat dan wel? Misschien als ik een keer een Oscar 
win. Maar de kansen daarop worden ook met de dag kleiner.
Ten eerste wil ik dan mijn ouders heel erg bedanken. Meer dan voor alle 
andere mensen die ik genoemd heb, geldt dat het een echt feit is dat zonder 
mijn ouders dit proefschrift er nooit was geweest. Poeke en Moeke, fijn dat 
ik geboren ben! Dat was een belangrijke randvoorwaarde voor het tot stand 
komen van dit proefschrift. Bedankt ook dat jullie mij met enig succes hebben 
opgevoed. Ik hoop dat jullie blij zijn met het resultaat. Ik ben heel blij dat jullie 
altijd hebben geloofd dat het wel wat zou gaan worden met mij en dat jullie mij 
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altijd meer geloofden (of althans deden alsof) dan leraren, buurtbewoners of 
andere mensen die hun beklag kwamen doen over mij. Poeke, jij hebt me altijd 
geïnspireerd om wetenschapper te worden. Ik vind het fantastisch hoe je al het 
onderzoek dat ik doe zo leuk vindt en hoeveel ik kan leren van jou over de relatie 
van bacteriën tot geologie en de invloed van bacteriën op de hele geschiedenis 
van de aarde. Moeke, fantastisch dat je dat allemaal helemaal niet zo interessant 
vindt, maar het veel belangrijker vindt hoe het gaat met mij en Cathelijn en de 
kindjes. Hoewel jij –hoe evident de feiten ook zijn- nooit wil toegeven dat ik 
jouw liefste kind ben, wil ik op mijn beurt best toegeven dat jij de liefste moeder 
bent. Ik kan jullie nog voor heel erg veel andere dingen bedanken, maar ik stop 
toch maar, anders loopt het uit de hand en verschiet ik bovendien al mijn kruit 
voor de komende jaren aan Sinterklaasgedichten.
Jord, fantastisch dat jij ook deel bent geworden van IS-Diagnostics en we zo 
onze jeugddroom om ooit samen een bedrijf te hebben, hebben waargemaakt! 
Het is dan wel geen BudSoft International geworden, maar toch wel een 
aardig alternatief lijkt mij. Lies, hoewel ik op mijn zesde van mening was dat 
‘twee kinderen wel genoeg was’, ben ik toch blij dat mijn mening destijds niet 
doorslaggevend was. Je heb altijd geloofd in mijn onderzoek en bent tijdens 
dit hele promotiegebeuren altijd super enthousiast geweest en hebt zelfs een 
fantastische animatie gemaakt van de IS-pro techniek. Heel erg bedankt! Jans, 
kleine knoedel, jij bent altijd zo lief voor mij en zo geïnteresseerd in alle dingen 
die ik doe! Altijd wil je het fijne ervan weten en nooit kan ik me ervan afmaken 
met ‘ja ja het gaat allemaal z’n gangetje’. Heel fijn en bedankt daarvoor! Kom 
ook maar gewoon naar Haarlem!
Dan wil ik toch ook even mijn schoonfamilie bedanken. Michiel, Ingrid en 
Christien, ik ben heel blij met mijn schoonfamilie, wat, als je de statistieken 
mag geloven, behoorlijk ongebruikelijk is. Heel veel dank aan jullie voor al jullie 
steun en interesse gedurende dit promotietraject!
En dan natuurlijk het laatste en belangrijkste dankwoord. Cathelijn, Bas, Piet 
en Mies. Ik lees in veel proefschriften dingen als schatje, jij bent de allerliefste, 
jij bent de meest fantastische, de meeste geweldige etc. Maar dan staat er 
vervolgens de verkeerde naam achter! Belachelijk!! Er is er namelijk maar één 
de meest fantastische, liefste en geweldigste, en dat ben jij, Cathelijn! Ik hou 
intens veel van jou en ben je oneindig dankbaar voor je onvoorwaardelijke steun 
en liefde. Gedurende dit hele lange promotietraject heb je me door dik en door 
dun, door voorspoed en door tegenspoed bijgestaan. En dat was nogal wat. Ik 
kan je niet genoeg bedanken. Overigens ga ik dat -mocht je dat verwachten- hier 
ook niet proberen te benaderen door nu supervaak het woord ‘bedankt’ te copy-
pasten. Dankjewel voor alles, schatje, ik hou verschrikkelijk veel van jou.
Proefschrift DRIES BUDDING_1sep2016_version 2_chapperrol.indd   260 21-9-2016   15:10:36
Bas, Piet en Mies, jullie zijn alledrie geboren terwijl ik bezig was met al het werk 
dat hier nu in dit boekje staat. En jullie worden al die tijd niet één keer genoemd. 
Pas in de allerlaatste regels!! Maarja, jullie hebben me ook zoveel van m’n werk 
afgehouden dat ik daar allemaal geen tijd meer voor had. Ik heb het boekje wel 
aan jullie opgedragen, ik hoop dat dat een troost is. Jullie zijn fantastisch! Ik zie 
een grootse toekomst voor jullie! 
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